No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2294 |
4. Check minimum number of eventsNone |
2294 |
5. Include endpointsNone |
2294 |
6. Filter based on genotype QC (FinnGen only) |
2193 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- TOBACCO_USE
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z72
Similar endpoints
↥List of similar endpoints to
Tobacco use
based on the number of shared cases.
Similar with more cases:
- Problems related to lifestyle
- Persons encountering health services in other circumstances, wide
- Excluding asthma or asthma-COPD overlap
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15107 | 8245 | 6808 |
| Only index persons | 14765 | 8149 | 6616 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.21 | 0.24 | 0.19 |
| Only index persons | 0.28 | 0.30 | 0.25 |
| Median age at first event (years) | |||
| Whole population | 47.75 | 38.80 | 58.70 |
| Only index persons | 47.47 | 38.45 | 58.59 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2193 | 1151 | 1042 |
| Unadjusted period prevalence (%) | 0.44 | 0.41 | 0.48 |
| Median age at first event (years) | 54.23 | 49.27 | 59.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2294
- Matched controls
- 22940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z72.0
ICD-10 Finland
Tobacco use
+∞
307.7
2294
180
N07BA03
ATC
varenicline; oral
9.7
307.7
479
605
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
8.8
307.7
618
919
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
8.6
221.9
303
397
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
11.7
193.9
206
192
R03BB04
ATC
tiotropium bromide; inhalant
5.2
192.0
464
1075
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
9.8
188.5
228
255
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
7.7
172.1
255
365
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.2
151.3
346
757
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.7
143.7
374
910
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.5
125.4
259
515
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.9
119.6
193
301
P17
ICPC
Tobacco abuse
10.2
115.2
132
136
K05.31
ICD-10 Finland
Periodontitis pronounced
3.5
112.6
456
1509
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
107.8
1297
7647
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
37.1
104.5
65
18
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.7
104.0
203
382
R95
ICPC
Chron obstructive pulmonary disease
6.7
99.1
164
262
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
97.3
733
3413
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
90.7
352
1124
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
8.0
89.7
125
165
EBA00
NOMESCO Finland
Extraction of tooth
2.4
89.4
1120
6545
N07BB01
ATC
disulfiram; oral
4.5
85.1
223
538
B01AC04
ATC
clopidogrel; oral
2.9
83.7
472
1874
N05AH04
ATC
quetiapine; oral
2.6
82.9
605
2743
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
82.6
507
2105
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
82.0
478
1931
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
79.5
476
1947
N06AB04
ATC
citalopram; systemic
2.6
79.3
623
2919
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.2
78.5
228
594
Z72.1
ICD-10 Finland
Alcohol use
8.3
77.5
104
131
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.6
76.2
192
448
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.2
73.8
157
318
SPAT1254
SPAT
Administration of medicine
2.8
72.1
426
1724
N02AX02
ATC
tramadol; systemic, rectal
2.2
71.3
1133
7098
AA1AD
NOMESCO Finland
CT of head and brain
2.3
70.3
739
3914
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.3
69.9
145
287
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
68.8
363
1380
C03CA01
ATC
furosemide; systemic
2.4
68.6
635
3178
N06AX12
ATC
bupropion; oral
3.2
67.0
303
1054
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
6.8
64.5
103
158
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
63.5
364
1443
J43.9
ICD-10 Finland
Emphysema, unspecified
8.1
63.2
86
110
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.0
61.5
138
292
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.0
61.1
111
194
N03AX16
ATC
[U] pregabalin
2.3
60.7
619
3206
SPAT1263
SPAT
Sampling
2.1
60.7
1066
6807
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
60.0
238
763
N05BA04
ATC
oxazepam; oral
2.2
59.1
710
3923
P15
ICPC
Chronic alcohol abuse
4.4
58.2
153
368
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.3
58.0
535
2650
H02AB06
ATC
prednisolone; systemic
2.0
57.6
1185
7956
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
57.5
560
2836
R03AC02
ATC
salbutamol; inhalant
2.0
57.4
1401
9988
Z72.2
ICD-10 Finland
Drug use
12.2
56.7
57
48
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
7.7
56.6
80
107
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.5
56.4
111
209
N06AX11
ATC
mirtazapine; oral
2.0
56.4
900
5511
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.0
56.1
269
964
N06AX16
ATC
venlafaxine; oral
2.4
56.1
457
2140
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
54.2
523
2631
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
10.2
53.2
60
60
N03AX12
ATC
[U] gabapentin; oral
2.4
52.6
455
2182
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
8.5
52.4
68
82
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
52.3
397
1796
P01AB01
ATC
metronidazole; oral, rectal
2.0
52.0
1014
6610
J01FF01
ATC
clindamycin; systemic
2.1
51.6
729
4243
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
8.8
51.3
65
76
R02
ICPC
Shortness of breath/dyspnoea
2.5
51.1
384
1727
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
50.3
326
1366
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
6.0
49.9
90
156
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.8
49.6
275
1064
K08.3
ICD-10 Finland
Retained dental root
2.9
49.5
257
960
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.7
49.2
94
172
N05AA02
ATC
levomepromazine; systemic
3.8
48.6
156
434
E66.01
ICD-10 Finland
Obesity due to excess calories
2.5
48.4
334
1441
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
47.1
1089
7434
SPAT1301
SPAT
No procedures
2.0
46.6
745
4500
N05AH03
ATC
olanzapine; systemic
2.9
46.6
234
858
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
45.7
626
3576
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
45.7
587
3276
N05CF01
ATC
zopiclone; oral
1.9
45.5
756
4620
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
45.3
646
3743
R06.0
ICD-10 Finland
Dyspnoea
2.0
45.3
674
3964
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
45.1
270
1085
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
44.9
816
5131
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.8
43.6
232
877
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.8
43.3
244
950
S10
ICPC
Boil/carbuncle
3.0
43.3
208
743
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
43.0
735
4516
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
43.0
239
924
SPAT1240
SPAT
Therapeutic discussion
2.4
42.5
342
1578
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
42.0
291
1254
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.6
41.5
100
224
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
12.3
41.1
41
34
C10AA05
ATC
atorvastatin; oral
1.8
40.6
943
6358
N06AB10
ATC
escitalopram; oral
2.0
40.2
581
3362
C07AB07
ATC
bisoprolol; oral
1.8
40.0
1042
7262
SPAT1262
SPAT
Handing over of treatment supplies
2.1
39.7
429
2232
P76
ICPC
Depressive disorder
2.6
39.0
238
963
S97
ICPC
Chronic ulcer skin
3.0
39.0
184
650
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
4.9
39.0
88
187
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.8
38.9
89
191
N05BA01
ATC
diazepam; systemic, rectal
2.3
38.9
339
1615
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
38.9
682
4200
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.9
38.8
117
311
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
6.9
38.2
59
87
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.8
38.2
87
186
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
11.3
38.0
40
36
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
38.0
265
1143
M54.5
ICD-10 Finland
Low back pain
1.8
37.6
932
6366
A10BA02
ATC
metformin; oral
1.9
37.5
664
4095
N05AF03
ATC
chlorprothixene; systemic
4.2
37.4
102
252
N02AA05
ATC
oxycodone; systemic
2.1
37.3
414
2171
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
36.9
704
4441
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
36.6
188
696
N02BF01
ATC
gabapentin; oral
2.3
36.4
296
1367
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
36.1
548
3207
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
36.1
494
2791
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.1
36.0
102
259
F10.24
ICD-10 Finland
Alcohol depence active use
4.8
35.9
81
172
ZXD05
NOMESCO Finland
Urgent procedure
1.8
35.8
733
4714
N02BE01
ATC
paracetamol; systemic, rectal
2.5
35.8
2084
18344
SPAT1310
SPAT
Counselling related to known health issue
1.8
35.7
758
4929
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
35.7
1065
7636
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
35.6
939
6502
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
8.3
35.5
47
58
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.2
35.1
143
463
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
34.8
500
2869
SPAT1260
SPAT
Consultation of another employee
2.0
34.7
423
2292
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.2
34.5
71
139
A46
ICD-10 Finland
Erysipelas
2.1
34.5
365
1876
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.5
34.4
124
372
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
34.3
719
4647
SPAT1283
SPAT
Restricted health certificate
1.9
34.1
499
2878
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
6.0
33.9
60
102
P29
ICPC
Psychological sympt/compl other
2.4
33.7
249
1101
EBA30
NOMESCO Finland
Extraction of root of tooth
2.8
33.7
183
697
A10AE04
ATC
insulin glargine; parenteral
2.3
33.5
267
1221
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.0
33.5
449
2513
E66.9
ICD-10 Finland
Obesity, unspecified
3.2
33.3
135
436
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
10.7
33.1
36
34
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
33.1
272
1260
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.8
33.0
75
160
N06AX21
ATC
duloxetine; oral
2.2
33.0
332
1671
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
32.9
296
1425
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.3
32.8
267
1232
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
32.8
347
1781
A02BC02
ATC
pantoprazole; systemic
1.7
32.7
1559
12579
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
32.4
292
1405
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
32.4
1264
9650
L28
ICPC
Limited function/disability (L)
2.0
32.4
402
2187
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
32.4
272
1272
N03AG01
ATC
valproic acid; systemic, rectal
2.7
32.2
183
713
PEN23
NOMESCO Finland
Plastic repair of femoral artery
8.4
32.1
42
51
L73.2
ICD-10 Finland
Hidradenitis suppurativa
5.4
31.9
63
119
N05CD07
ATC
temazepam; oral
2.3
31.9
251
1141
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.8
31.8
591
3669
V03AA01, ,
ATC
5.0
31.8
68
138
WZC30
NOMESCO Finland
Teaching
2.0
31.6
426
2384
J45.8
ICD-10 Finland
Mixed asthma
3.7
31.4
100
276
W84
ICPC
Pregnancy high risk
3.1
31.4
134
446
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
6.0
31.4
56
96
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
31.3
214
912
R96
ICPC
Asthma
2.3
31.3
256
1183
T90
ICPC
Diabetes non-insulin dependent
1.8
31.2
559
3430
P03
ICPC
Feeling depressed
2.2
31.2
310
1551
S18
ICPC
Laceration/cut
1.7
31.1
1087
8033
P19
ICPC
Drug abuse
7.0
31.0
47
68
N05BA02
ATC
chlordiazepoxide; systemic
4.0
31.0
90
233
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.2
31.0
127
413
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
5.2
30.9
64
126
K10.3
ICD-10 Finland
Alveolitis of jaws
2.8
30.9
168
640
SPAT1312
SPAT
General health counselling
1.7
30.7
739
4937
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
5.9
30.6
55
95
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
30.4
363
1944
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
30.4
559
3453
M79.7
ICD-10 Finland
Fibromyalgia
3.4
30.4
113
346
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.6
30.3
187
759
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.8
30.2
47
70
N06AB03
ATC
fluoxetine; oral
2.1
30.1
322
1655
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.9
30.1
54
93
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
30.0
603
3822
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
29.8
881
6212
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
5.1
29.2
62
125
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
29.1
898
6392
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
28.9
318
1651
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.0
28.7
344
1843
A28
ICPC
Limited function/disability NOS
2.0
28.5
336
1788
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.5
28.4
102
305
IHZ05, ,
SPAT
2.8
28.4
148
551
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
28.3
1055
7860
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
28.3
267
1307
SPAT1059
SPAT
Spirometry at the office
2.9
28.2
138
497
R05
ICPC
Cough
1.7
28.1
607
3919
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
5.1
28.0
59
118
J01AA02
ATC
doxycycline; systemic
1.7
27.8
1746
14812
A10AB05
ATC
insulin aspart; parenteral
2.4
27.8
207
917
SPAT1104
SPAT
Monitoring of emergency patient
2.6
27.8
167
669
N05BE01
ATC
buspirone; oral
3.3
27.7
105
325
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.3
27.6
222
1016
TUPKY, ,
NOMESCO Finland
6.2
27.6
47
77
I50.0
ICD-10 Finland
Congestive heart failure
2.8
27.4
139
510
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
27.3
191
822
E66.00
ICD-10 Finland
Metabolic syndrome
2.6
27.3
171
699
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
27.2
1714
14498
N05AB01
ATC
dixyrazine; systemic
5.5
27.2
53
99
PD3AT
NOMESCO Finland
Pelvic artery PTA
9.5
27.1
32
34
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.9
27.1
132
474
N05AX12
ATC
aripiprazole; systemic
2.8
27.1
144
542
PE1AT
NOMESCO Finland
Femoral artery PTA
6.5
26.9
44
69
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
9.0
26.9
33
37
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
26.8
176
735
WZA90
NOMESCO Finland
Other medical or dental certificate
1.7
26.8
586
3787
XPX08
NOMESCO Finland
Intraoperative flow measurement
7.1
26.7
40
57
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
26.6
153
599
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.9
26.6
127
451
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
26.5
309
1636
WX882
NOMESCO Finland
High dependency care
3.8
26.3
80
214
N06AB06
ATC
sertraline; oral
2.0
26.2
313
1671
M79.6
ICD-10 Finland
Pain in limb
1.6
26.2
1016
7595
J01MA14
ATC
moxifloxacin; systemic
2.2
26.1
233
1113
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
26.1
172
720
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
5.5
26.0
50
92
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
25.7
178
763
IGY02, ,
SPAT
4.3
25.7
66
156
Z3231
NOMESCO Finland
Registered nurse
1.7
25.6
601
3952
O80.9
ICD-10 Finland
Single spontaneous delivery, unspecified
6.0
25.6
45
76
T74.1
ICD-10 Finland
Physical abuse
3.9
25.5
77
205
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
25.5
402
2355
SPAT1216
SPAT
Assessment of functional ability
2.0
25.5
302
1608
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
25.4
141
542
N05AX08
ATC
risperidone; systemic
2.3
25.1
200
911
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.4
25.1
63
146
A07AA02
ATC
nystatin; oral
2.7
25.1
139
534
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
7.4
25.0
36
49
J01DA01
ATC
[U] cefalexin
1.6
24.9
1382
11186
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
23.7
24.8
35
15
C08CA01
ATC
amlodipine; oral
1.6
24.7
767
5412
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
2.8
24.5
123
449
WX290
NOMESCO Finland
Other blockage of nerve
1.6
24.4
1206
9486
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
24.4
168
718
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
24.3
288
1532
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
3.0
24.3
109
374
SPAT1360
SPAT
Extensive global examination
2.5
24.2
157
652
R51.80
ICD-10 Finland
Headache
1.8
24.2
406
2421
J96.1
ICD-10 Finland
Chronic respiratory failure
4.3
24.1
63
151
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
23.9
148
601
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
23.9
1305
10478
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
23.9
243
1222
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
23.8
306
1673
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.0
23.7
270
1416
N02BF02
ATC
pregabalin; oral
2.3
23.6
185
837
A01
ICPC
Pain general/multiple sites
2.1
23.5
250
1277
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
23.4
255
1315
A06AD11
ATC
lactulose; oral
2.0
23.4
278
1479
J01DB01
ATC
cefalexin; oral
1.8
23.4
1911
16887
WX892
NOMESCO Finland
Monitored bed care
2.3
23.4
188
860
L03
ICPC
Low back symptom/complaint
1.6
23.2
696
4856
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
3.3
23.0
86
264
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
23.0
188
865
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
22.8
141
572
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
22.8
469
2963
B01AB05
ATC
enoxaparin; parenteral
1.6
22.7
661
4572
IHZ04, ,
SPAT
3.8
22.6
69
185
C09AA05
ATC
ramipril; oral
1.7
22.6
495
3180
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
22.5
500
3227
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
22.4
429
2655
J01MA12
ATC
levofloxacin; systemic
1.8
22.4
400
2426
SPE90
NOMESCO Finland
Other partial denture
4.0
22.4
64
164
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.4
22.4
82
249
P99
ICPC
Psychological disorders other
2.9
22.3
106
375
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.5
22.3
139
566
SPAT1211
SPAT
Application of soft bandage
2.2
22.2
202
971
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
22.2
275
1484
L17
ICPC
Foot/toe symptom/complaint
1.6
22.1
683
4790
SPAT1058
SPAT
PEF monitoring instruction
2.2
22.0
185
861
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.6
21.9
74
213
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.0
21.9
256
1354
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
6.4
21.8
36
57
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
21.8
311
1758
N03AE01
ATC
clonazepam; systemic
2.5
21.8
145
609
A29
ICPC
General symptom/complaint other
1.9
21.8
300
1677
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
4.6
21.8
52
116
C01DA14
ATC
isosorbide mononitrate; oral
2.0
21.7
254
1344
J20
ICD-10 Finland
Acute bronchitis
2.0
21.6
263
1409
K02.1
ICD-10 Finland
Caries of dentine
1.5
21.6
1421
11764
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
21.6
267
1439
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
21.6
121
468
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
21.5
508
3325
R60.0
ICD-10 Finland
Localized oedema
1.9
21.5
276
1506
N03AX09
ATC
lamotrigine; oral
2.4
21.4
154
670
R04.2
ICD-10 Finland
Haemoptysis
3.0
21.3
94
319
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
21.3
101
357
R06.2
ICD-10 Finland
Wheezing
2.6
21.3
130
524
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
21.3
218
1097
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.7
21.2
114
431
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
21.1
228
1170
R03DA04
ATC
theophylline; systemic, rectal
2.8
21.1
108
398
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
21.1
322
1860
C10AA01
ATC
simvastatin; oral
1.6
21.0
750
5425
F61.0
ICD-10 Finland
Mixed personality disorders
3.9
20.9
62
163
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.3
20.9
165
748
OAB40, ,
SPAT
6.7
20.9
33
50
N05AB03
ATC
perphenazine; systemic, rectal
2.9
20.7
99
352
SPAT1255
SPAT
Intravenous administration of medicine
2.3
20.7
162
732
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
20.7
131
538
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
4.8
20.6
46
97
J46
ICD-10 Finland
Status asthmaticus
3.3
20.6
80
252
A03
ICPC
Fever
1.7
20.5
443
2827
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
20.5
1087
8554
R52.0
ICD-10 Finland
Acute pain
2.8
20.5
103
376
Z72.8
ICD-10 Finland
Other problems related to lifestyle
6.6
20.5
33
51
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
2.3
20.4
163
743
K04.08
ICD-10 Finland
Other specified pulpit
2.0
20.3
236
1244
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
20.2
610
4236
OAB43, ,
SPAT
0.6
20.2
419
6276
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
8.0
20.0
27
34
SPAT1057
SPAT
Peak expiratory flow measurement
3.6
20.0
66
187
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.5
19.9
48
108
A10BK01
ATC
dapagliflozin; oral
2.1
19.8
195
966
A10AC01
ATC
insulin (human); parenteral
2.2
19.8
181
872
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.6
19.8
114
447
P01
ICPC
Feeling anxious/nervous/tense
1.8
19.8
343
2057
J01FA06
ATC
roxithromycin; oral
1.5
19.7
853
6417
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
19.6
258
1418
N05BA12
ATC
alprazolam; oral
2.0
19.5
232
1232
R03AC18
ATC
indacaterol; inhalant
7.2
19.5
29
41
T89
ICPC
Diabetes insulin dependent
2.5
19.5
122
498
D10
ICPC
Vomiting
2.2
19.5
168
790
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.6
19.5
111
433
Z2446
NOMESCO Finland
Social worker
2.2
19.5
165
771
P16
ICPC
Acute alcohol abuse
3.6
19.4
65
186
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
19.4
503
3362
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.3
19.4
156
713
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
19.4
1575
13483
R03AK08
ATC
formoterol and beclometasone; inhalant
2.5
19.3
120
488
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
19.3
306
1786
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.8
19.1
95
345
C10AX09
ATC
ezetimibe; oral
1.7
19.0
387
2426
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.5
19.0
118
480
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
19.0
238
1287
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
18.8
1200
9742
Z29
ICPC
Social problem NOS
3.4
18.8
68
205
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.2
18.7
171
823
SPAT1265
SPAT
Breathalyser
4.7
18.7
43
93
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
18.6
576
4014
SPAT1234
SPAT
Support of social functional capacity
2.6
18.5
110
438
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.4
18.5
46
106
D11
ICPC
Diarrhoea
1.8
18.4
297
1741
P18
ICPC
Medication abuse
5.5
18.4
35
64
B01AC24
ATC
ticagrelor; oral
2.7
18.3
101
388
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
18.1
75
246
PA6AD
NOMESCO Finland
CT of neck arteries
2.6
18.1
102
396
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.6
18.0
626
4471
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
18.0
143
650
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
3.8
18.0
55
148
N06AX03
ATC
mianserin; oral
2.5
18.0
117
487
E66.8
ICD-10 Finland
Other obesity
2.2
17.9
156
737
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
17.9
164
791
SPAT1097
SPAT
Recording of ECG
1.8
17.9
289
1695
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.6
17.8
101
393
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
4.9
17.8
39
81
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
17.7
130
572
PD4AD
NOMESCO Finland
CT of lower extremity arteries
5.5
17.6
34
63
L86
ICPC
Back syndrome with radiating pain
2.2
17.6
154
729
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
17.6
833
6348
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
4.8
17.5
39
82
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.5
17.5
114
475
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
17.4
118
500
L12
ICPC
Hand/finger symptom/complaint
1.7
17.4
398
2569
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
6.8
17.4
27
40
F41.01
ICD-10 Finland
Severe panic disorder
5.4
17.3
34
64
WX722
NOMESCO Finland
PEEP
2.5
17.3
112
465
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.2
17.2
45
108
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.8
17.2
52
139
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.4
17.2
121
522
P74
ICPC
Anxiety disorder/anxiety state
2.2
17.2
141
650
L04AX03
ATC
methotrexate; systemic
1.9
17.1
230
1273
S22.3
ICD-10 Finland
Fracture of rib
2.1
17.0
179
909
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
17.0
145
679
IAB01, ,
SPAT
5.9
17.0
30
51
R03BB07
ATC
umeclidinium bromide; inhalant
5.6
17.0
32
58
SPAT1274
SPAT
Brief intervention in person with addiction symptoms
7.2
17.0
25
35
JN4AD
NOMESCO Finland
Body CT examination
1.8
17.0
252
1439
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.1
16.9
35
69
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
16.9
209
1123
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.5
16.9
105
427
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
3.8
16.9
51
136
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
5.7
16.8
31
55
R63.4
ICD-10 Finland
Abnormal weight loss
2.6
16.7
98
388
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.1
16.7
46
115
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
5.5
16.7
32
59
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
16.7
1672
14679
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.8
16.7
81
291
SGA01
NOMESCO Finland
Emergency treatment
1.6
16.6
420
2778
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.5
16.5
56
162
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
5.6
16.5
31
56
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
3.4
16.5
58
172
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
3.1
16.4
69
228
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.4
16.4
120
526
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
16.4
141
662
ZX120
NOMESCO Finland
Intravenous
1.9
16.4
206
1113
A05
ICPC
Feeling ill
2.1
16.4
159
783
K04.0
ICD-10 Finland
Pulpitis
1.8
16.3
248
1425
K92.0
ICD-10 Finland
Haematemesis
3.2
16.3
63
198
R03BA05
ATC
fluticasone; inhalant
1.6
16.3
389
2537
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
6.8
16.1
25
37
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
16.1
318
1972
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.9
16.1
74
258
R03AC03
ATC
terbutaline; inhalant
1.7
16.0
299
1827
XG410
NOMESCO Finland
Flow-volume spirometry
2.6
15.9
96
385
AB5CT
NOMESCO Finland
Blockage of nerv root with CT guidance
5.0
15.9
34
69
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.1
15.7
163
823
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
15.7
734
5547
OAA68, ,
SPAT
3.6
15.7
52
148
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
15.6
180
944
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
4.1
15.6
42
103
A04
ICPC
Weakness/tiredness general
1.7
15.6
343
2187
A10AE06
ATC
insulin degludec; parenteral
2.5
15.5
100
414
SPAT1153
SPAT
Removal of sutures
1.5
15.5
628
4610
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.3
15.5
58
179
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
15.4
508
3568
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.0
15.3
69
238
R10.0
ICD-10 Finland
Acute abdomen
2.7
15.3
85
328
H02AB07
ATC
prednisone; oral
1.8
15.2
267
1600
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.4
15.1
54
162
SPAT1357
SPAT
Monitoring of problem during pregnancy
2.9
15.1
71
251
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
5.0
15.0
32
65
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.1
15.0
41
102
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
4.6
14.9
35
77
N06AA09
ATC
amitriptyline; systemic
1.9
14.9
188
1017
R4110
NOMESCO Finland
Physiotherapy
1.5
14.9
569
4121
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
14.8
203
1128
I25.2
ICD-10 Finland
Old myocardial infarction
2.2
14.8
123
570
F32
ICD-10 Finland
Depressive episode
2.1
14.8
139
677
OAA67, ,
SPAT
0.5
14.8
171
3050
R42
ICD-10 Finland
Dizziness and giddiness
1.6
14.7
444
3055
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.0
14.7
170
894
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
14.7
330
2116
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.5
14.6
91
371
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
4.2
14.6
38
91
R41.0
ICD-10 Finland
Disorientation, unspecified
3.0
14.6
63
212
A02BC03
ATC
lansoprazole; oral
1.5
14.6
556
4024
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.0
14.6
65
223
M48.0
ICD-10 Finland
Spinal stenosis
1.8
14.5
230
1337
J01CA04
ATC
amoxicillin; systemic
1.5
14.5
1847
16718
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.5
14.5
35
79
R81
ICPC
Pneumonia
2.4
14.4
95
398
R53
ICD-10 Finland
Malaise and fatigue
1.5
14.4
542
3910
H02AB04
ATC
methylprednisolone; systemic
1.7
14.3
293
1831
F34.1
ICD-10 Finland
Dysthymia
2.4
14.3
100
430
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.6
14.2
82
322
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
4.5
14.2
34
76
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
14.2
301
1898
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
5.3
14.2
28
53
ECB00
NOMESCO Finland
Suture of gingiva
2.4
14.2
95
401
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.6
14.2
82
323
R52.9
ICD-10 Finland
Pain, unspecified
1.8
14.1
235
1386
F41.00
ICD-10 Finland
Moderate panic disorder
3.2
14.1
56
179
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
14.1
172
920
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
14.1
233
1372
W19
ICD-10 Finland
Unspecified fall
1.8
14.1
211
1207
SPD00
NOMESCO Finland
Mucosa borne complete denture
4.7
14.0
32
69
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
13.9
191
1062
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.6
13.9
46
131
WX872
NOMESCO Finland
Intensive care
2.2
13.9
117
545
J45
ICD-10 Finland
Asthma
1.8
13.9
231
1362
N05AN01
ATC
lithium; oral
2.7
13.9
72
268
R03DX07
ATC
roflumilast; oral
30.2
13.9
18
6
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.6
13.9
78
303
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.7
13.9
44
122
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
13.8
96
412
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.1
13.8
58
192
Z25
ICPC
Assault/harmful event problem
4.5
13.8
33
74
E87.6
ICD-10 Finland
Hypokalaemia
2.5
13.7
83
334
F92.0
ICD-10 Finland
Depressive conduct disorder
13.7
13.7
23
17
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.1
13.7
58
193
R11
ICD-10 Finland
Nausea and vomiting
1.9
13.7
191
1068
LCH11
NOMESCO Finland
Pharmacologic abortion
2.3
13.6
101
446
S29
ICPC
Skin symptom/complaint other
1.5
13.6
427
2958
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
4.3
13.6
35
83
N05AH02
ATC
clozapine; systemic
3.0
13.6
59
199
SBA00
NOMESCO Finland
Microbiological examinations
2.9
13.6
65
232
N06AA12
ATC
doxepin; systemic
2.3
13.5
107
486
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
3.0
13.5
58
195
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
5.0
13.4
28
56
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
5.6
13.4
25
45
R78
ICPC
Acute bronchitis/bronchiolitis
3.1
13.4
54
175
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.7
13.3
69
257
R50.9
ICD-10 Finland
Fever, unspecified
1.6
13.3
332
2181
S04
ICPC
Lump/swelling localized
1.7
13.3
253
1550
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
6.3
13.3
22
35
ZXA00
NOMESCO Finland
Right side
1.5
13.3
479
3419
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
13.2
183
1020
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.1
13.2
54
176
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.7
13.2
280
1767
C03DA01
ATC
spironolactone; oral
1.8
13.2
224
1330
SPAT1227
SPAT
Substance abuse rehabilitation
5.1
13.2
27
53
J01CF05
ATC
flucloxacillin; systemic
1.9
13.2
176
971
-60
ICPC
Result test/procedure
2.1
13.1
118
565
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.6
13.1
78
312
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.7
13.1
71
271
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.7
13.0
41
113
TQW80
NOMESCO Finland
Local dermatologic skincare
2.7
13.0
69
260
N06AX26
ATC
vortioxetine; oral
1.8
13.0
188
1063
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
13.0
575
4274
P01BA02
ATC
hydroxychloroquine; oral
1.9
12.9
168
918
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.2
12.9
103
470
N05AD01
ATC
haloperidol; systemic
2.7
12.8
68
257
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
5.4
12.8
25
47
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
12.8
260
1622
PEN24
NOMESCO Finland
Plastic repair of deep femoral artery
14.1
12.7
21
15
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
12.7
91
396
SPAT1193
SPAT
Pap smear
1.8
12.7
209
1228
H01
ICPC
Ear pain/earache
1.7
12.7
268
1687
G47.3
ICD-10 Finland
Sleep apnoea
1.5
12.7
536
3944
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
12.7
131
661
M54.8
ICD-10 Finland
Other dorsalgia
2.2
12.7
111
526
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.5
12.7
81
335
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
12.6
178
1000
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
12.5
413
2889
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
12.5
132
672
Z00.0
ICD-10 Finland
General medical examination
1.5
12.5
406
2832
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
12.5
99
451
H3601, E103,
ICD-10 Finland
4.4
12.4
31
72
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
1.9
12.4
162
887
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.0
12.4
134
688
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
12.4
65
244
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
12.3
315
2079
A01AB09
ATC
miconazole; local oral
1.9
12.3
159
868
A10AE05
ATC
insulin detemir; parenteral
2.1
12.3
119
587
TGC00
NOMESCO Finland
Bronchial lavation
2.8
12.3
60
217
R74
ICPC
Upper respiratory infection acute
1.4
12.3
765
6037
SPAT1395
SPAT
Health check-up of persons outside student and working life
2.7
12.2
64
240
L05
ICPC
Flank/axilla symptom/complaint
1.9
12.2
152
819
SDA05
NOMESCO Finland
Very demanding periodontal treatment
1.8
12.2
180
1024
L05.0
ICD-10 Finland
Pilonidal cyst with abscess
4.3
12.2
31
73
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
4.0
12.2
34
86
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
3.8
12.2
36
95
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
3.8
12.2
36
95
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.6
12.2
72
287
-50
ICPC
Medication/prescr/renewal
2.3
12.2
87
379
S76
ICPC
Skin infection other
2.0
12.2
126
637
348
Kela drug reimbursment
Roflumilast
16.0
12.1
19
12
N06AB05
ATC
paroxetine; oral
2.0
12.1
139
729
J96.0
ICD-10 Finland
Acute respiratory failure
3.9
12.1
35
91
M54.3
ICD-10 Finland
Sciatica
2.0
12.1
131
673
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
12.1
254
1598
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
4.1
12.1
32
78
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
12.0
156
852
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.9
12.0
55
192
-1, ,
NOMESCO Finland
1.4
12.0
731
5741
L20
ICPC
Joint symptom/complaint NOS
2.3
12.0
89
394
EB1VA, ,
NOMESCO Finland
1.5
12.0
412
2905
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
12.0
147
789
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
5.7
11.9
22
39
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
11.9
35
92
L84
ICD-10 Finland
Corns and callosities
2.4
11.9
81
345
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
11.9
103
486
Z50.1
ICD-10 Finland
Other physical therapy
2.1
11.9
110
533
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
2.9
11.9
55
193
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.6
11.9
296
1942
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
11.9
148
798
EJ2S1
NOMESCO Finland
Photography of oral mucosa
4.1
11.9
32
79
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
11.8
107
514
L84
ICPC
Back syndrome without radiat pain
2.1
11.8
115
568
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
11.8
79
334
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.2
11.8
94
429
C07AA05
ATC
propranolol; systemic
1.5
11.8
438
3138
K28
ICPC
Limited function/disability (K)
3.1
11.7
49
162
R4120
NOMESCO Finland
Occupational therapy
1.9
11.7
143
765
SPAT1229
SPAT
Assessment of need for aid
2.0
11.7
128
659
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
4.0
11.7
33
84
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.5
11.7
28
63
RS221, ,
NOMESCO Finland
3.4
11.7
41
122
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.0
11.6
49
163
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.9
11.6
54
190
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.8
11.6
162
906
SPAT1243
SPAT
Psychiatric/psychological examination
2.5
11.6
73
300
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.3
11.6
84
368
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
11.6
234
1456
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
5.3
11.5
23
44
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.2
11.5
96
446
T82
ICPC
Obesity
2.1
11.5
107
519
M03BX02
ATC
tizanidine; oral
1.4
11.5
1377
12017
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
4.3
11.5
29
68
Y07
ICD-10 Finland
Other maltreatment
4.3
11.5
29
68
ZPB22
NOMESCO Finland
Autograft of vein
5.7
11.5
21
37
E86
ICD-10 Finland
Volume depletion
3.0
11.5
51
175
R29
ICPC
Respiratory symptom/complaint other
1.9
11.5
158
880
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
5.0
11.5
24
48
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.9
11.5
53
186
F17.3
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, withdrawal state
13.7
11.4
19
14
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.8
11.4
58
214
R03BA01
ATC
beclometasone; inhalant
1.6
11.4
274
1780
SPAT1172
SPAT
Guidance concerning hydration
3.5
11.4
38
109
SPAT1151
SPAT
Treatment of major wounds
4.1
11.4
31
77
SPAT1379
SPAT
Health check-up of pregnant person
1.6
11.4
250
1590
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
11.4
376
2628
A08
ICPC
Swelling
2.1
11.3
113
564
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.4
11.3
79
341
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
11.2
132
698
F40.1
ICD-10 Finland
Social phobias
2.5
11.2
71
293
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
4.6
11.2
26
57
K90
ICPC
Stroke/cerebrovascular accident
2.6
11.1
63
246
I50.1
ICD-10 Finland
Left ventricular failure
2.3
11.1
87
394
NHQ40
NOMESCO Finland
Amputation of toe
3.5
11.1
38
111
SPAT1252
SPAT
Overall medication plan or its review
2.0
11.1
121
623
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.9
11.1
32
83
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
11.1
534
4014
K05.30
ICD-10 Finland
Periodontitis complex
1.5
11.1
321
2180
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
4.0
11.0
31
79
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
4.0
11.0
31
79
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
11.0
864
7047
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.1
11.0
105
515
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
5.8
11.0
20
35
K05.3
ICD-10 Finland
Chronic periodontitis
2.1
11.0
102
495
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
11.0
394
2799
R03BA02
ATC
budesonide; inhalant
1.5
11.0
364
2545
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.7
10.9
200
1211
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
4.0
10.9
30
75
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.6
10.9
60
231
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.2
10.9
86
391
IAA01, ,
SPAT
4.1
10.9
29
71
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
10.9
523
3930
R55
ICD-10 Finland
Syncope and collapse
1.7
10.8
200
1214
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.1
10.8
106
525
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
5.2
10.8
22
43
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.4
10.7
72
305
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
5.6
10.7
20
36
A02BC01
ATC
omeprazole; systemic
1.4
10.7
515
3869
P06
ICPC
Sleep disturbance
1.6
10.6
297
1999
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
10.6
136
740
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
10.6
105
522
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
2.3
10.6
82
370
S01
ICPC
Pain/tenderness of skin
2.1
10.6
103
509
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
10.6
183
1092
SPAT1251
SPAT
Organisation of medication
2.4
10.6
69
289
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.5
10.5
67
277
J96.9
ICD-10 Finland
Respiratory failure, unspecified
5.0
10.5
22
44
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.1
10.5
44
146
W01
ICPC
Question of pregnancy
3.8
10.5
31
82
Z08
ICPC
Social welfare problem
3.1
10.5
43
141
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
4.8
10.5
23
48
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
4.8
10.5
23
48
F17.1
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, harmful use
14.3
10.5
17
12
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
10.5
133
722
E0000UV, ,
ATC
1.4
10.5
860
7051
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
10.5
151
854
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
10.4
78
347
-69
ICPC
Other reason for encounter NEC
2.3
10.4
78
347
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
110.5
10.4
11
*
OAB95, ,
SPAT
0.4
10.4
58
1347
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.9
10.4
47
163
TGA30
NOMESCO Finland
Thoracocentesis
5.4
10.4
20
37
Y09
ICD-10 Finland
Assault by unspecified means
5.4
10.4
20
37
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
10.4
179
1066
J42
ICD-10 Finland
Unspecified chronic bronchitis
3.9
10.4
30
78
R5110, ,
SPAT
1.8
10.4
161
930
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
10.4
245
1585
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
10.4
272
1804
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
2.6
10.4
61
243
A10BJ06
ATC
semaglutide; parenteral
1.9
10.4
130
703
E000003, ,
ATC
2.1
10.3
97
473
SPAT1196
SPAT
Monitoring of normal pregnancy
1.8
10.3
143
798
UJF32
NOMESCO Finland
Coloscopy
1.4
10.3
486
3634
K29.2
ICD-10 Finland
Alcoholic gastritis
9.6
10.2
20
21
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
9.6
10.2
20
21
Z03
ICPC
Housing/neighbourhood problem
4.6
10.2
24
53
R03AC13
ATC
formoterol; inhalant
2.1
10.2
102
509
K86.1
ICD-10 Finland
Other chronic pancreatitis
4.0
10.2
28
70
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.7
10.2
55
210
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
10.2
546
4176
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
10.2
302
2060
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.2
10.1
39
123
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.6
10.1
58
228
TNX30
NOMESCO Finland
Soft bandage, unspecified region
3.3
10.1
37
113
-62
ICPC
Administrative procedure
2.5
10.1
63
258
L02
ICPC
Back symptom/complaint
1.6
10.1
234
1506
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.9
10.1
135
745
130
Kela drug reimbursment
Malignant tumour
1.8
10.1
165
968
L14
ICPC
Leg/thigh symptom/complaint
1.8
10.1
165
968
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
5.0
10.0
21
42
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
5.0
10.0
21
42
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.1
10.0
40
129
K61.0
ICD-10 Finland
Anal abscess
2.8
10.0
48
172
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.7
10.0
179
1077
S06.0
ICD-10 Finland
Concussion
1.6
10.0
228
1462
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
4.8
10.0
22
46
SPAT1285
SPAT
Provision of consultation response
2.0
10.0
104
527
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
4.6
10.0
23
50
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
2.3
10.0
71
309
N05CF02
ATC
zolpidem; oral
1.5
10.0
350
2473
A10AB04
ATC
insulin lispro; parenteral
2.3
9.9
76
342
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
4.2
9.9
26
63
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
9.9
98
488
L88
ICPC
Rheumatoid/seropositive arthritis
2.1
9.9
87
414
R03BB01
ATC
ipratropium bromide; inhalant
2.5
9.9
62
255
Z00.8
ICD-10 Finland
Other general examinations
1.7
9.9
172
1028
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.4
9.9
35
105
Z51.5
ICD-10 Finland
Palliative care
1.8
9.9
143
810
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
9.8
139
781
R33
ICD-10 Finland
Retention of urine
1.8
9.8
141
796
R04
ICPC
Breathing problem other
2.1
9.8
92
449
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.5
9.8
61
250
250, ,
Kela drug reimbursment
3.0
9.8
43
147
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
8.8
9.8
20
23
N18.8
ICD-10 Finland
Other chronic renal failure
2.9
9.8
45
158
XPX00
NOMESCO Finland
Intraoperative angiography
9.6
9.8
19
20
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
9.8
165
978
E87.5
ICD-10 Finland
Hyperkalaemia
3.2
9.7
38
121
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.7
9.7
51
192
I50
ICD-10 Finland
Heart failure
2.9
9.7
44
153
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
7.4
9.7
22
30
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
7.4
9.7
22
30
D07AC01
ATC
betamethasone; topical
1.4
9.7
736
5946
J36
ICD-10 Finland
Peritonsillar abscess
2.2
9.7
81
378
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
2.9
9.7
43
148
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.6
9.7
55
216
P73
ICPC
Affective psychosis
5.3
9.6
19
36
SPAT1284
SPAT
Extensive health certificate
2.4
9.6
67
289
F60.8
ICD-10 Finland
Other specific personality disorders
3.9
9.6
27
69
D07BC01
ATC
betamethasone and antiseptics; topical
1.6
9.6
240
1575
L30.3
ICD-10 Finland
Infective dermatitis
2.2
9.6
83
393
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.7
9.6
50
188
IHZ07, ,
SPAT
4.5
9.5
23
52
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
4.8
9.5
21
44
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
4.6
9.5
22
48
K04.1
ICD-10 Finland
Necrosis of pulp
1.6
9.5
251
1666
A10BH01
ATC
sitagliptin; oral
1.7
9.5
174
1054
PDQ22
NOMESCO Finland
Insertion of endovascular graft into a. iliaca externa
15.1
9.5
15
10
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
2.3
9.5
70
310
F43.0
ICD-10 Finland
Acute stress reaction
1.8
9.5
140
798
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.9
9.4
43
150
K07
ICPC
Swollen ankles/oedema
2.1
9.4
90
442
S16
ICPC
Bruise/contusion
2.4
9.4
61
255
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
17.6
9.4
14
8
P25
ICPC
Phase of life problem adult
2.0
9.4
104
540
Z35.6
ICD-10 Finland
Supervision of very young primigravida
12.4
9.4
16
13
D09AB01
ATC
zinc bandage without supplements; topical
2.9
9.3
43
151
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
4.0
9.3
26
66
N06AX05
ATC
trazodone; oral
2.5
9.3
59
244
SPAT1247
SPAT
Outpatient detoxication and monitoring
6.9
9.3
22
32
R21
ICPC
Throat symptom/complaint
1.4
9.3
468
3534
KAY40, ,
NOMESCO Finland
0.1
9.3
*
320
WZC00, ,
SPAT
1.5
9.3
318
2235
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
2.8
9.2
45
163
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
9.2
208
1330
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.6
9.2
52
204
A11
ICPC
Chest pain NOS
1.7
9.1
165
996
Y96.9
ICD-10 Finland
Unspecified type of accident
2.7
9.1
48
181
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
3.9
9.1
26
67
M05BA04
ATC
alendronic acid; oral
1.9
9.1
119
653
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.0
9.1
40
137
N01
ICPC
Headache
1.6
9.1
250
1676
188
Kela drug reimbursment
Psychosis requiring demanding treatment
3.5
9.1
30
86
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
11.5
9.1
16
14
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.8
9.1
134
764
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
2.2
9.1
77
362
LCH03
NOMESCO Finland
Evacuation of products of conception and curettage of uterus
3.2
9.0
34
106
SPF10
NOMESCO Finland
Demanding reparation of dental prosthesis
3.4
9.0
32
96
R28
ICPC
Limited function/disability (R)
3.3
9.0
33
101
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.7
9.0
157
938
N06AA04
ATC
clomipramine; systemic
2.9
9.0
41
143
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
9.0
550
4285
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.8
9.0
146
855
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
9.0
109
583
K92
ICPC
Atherosclerosis/periph vascular dis
3.7
9.0
28
77
K05.38
ICD-10 Finland
Other chronic periodontitis
2.3
9.0
65
286
P28
ICPC
Limited function/disability (P)
3.6
9.0
29
82
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.0
8.9
101
528
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
7.5
8.9
20
27
X84
ICD-10 Finland
Intentional self-harm by unspecified means
7.5
8.9
20
27
S80.0
ICD-10 Finland
Contusion of knee
1.7
8.9
162
980
IGY99, ,
SPAT
2.6
8.9
51
201
R03AC12
ATC
salmeterol; inhalant
2.1
8.9
78
371
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
8.9
494
3789
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.1
8.9
85
418
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
8.9
436
3275
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.2
8.9
72
332
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.9
8.9
109
586
T08
ICPC
Weight loss
2.9
8.9
40
139
N05AE04
ATC
ziprasidone; systemic
4.3
8.9
22
51
I73.9
ICD-10 Finland
Peripheral vascular disease, unspecified
4.3
8.9
22
51
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.2
8.9
71
326
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
4.9
8.8
19
39
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
4.9
8.8
19
39
D05AX52
ATC
calcipotriol, combinations; topical
1.9
8.8
114
623
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.5
8.8
53
214
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
8.8
275
1894
M25.5
ICD-10 Finland
Pain in joint
1.3
8.8
704
5715
N05AD03
ATC
melperone; systemic
3.8
8.8
26
69
D06
ICPC
Abdominal pain localized other
1.6
8.8
182
1140
SPAT1210
SPAT
Application of cast or individual aid
2.1
8.8
83
407
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.5
8.8
244
1640
A77
ICPC
Viral disease other/NOS
2.1
8.7
78
374
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
8.7
123
691
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
7.2
8.7
20
28
C07AB02
ATC
metoprolol; systemic
1.5
8.7
308
2176
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.1
8.7
36
119
U04
ICPC
Incontinence urine
1.9
8.7
99
519
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
8.7
104
555
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
4.3
8.7
22
52
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.3
8.7
22
52
SPAT1304
SPAT
Counselling and guidance related to ageing
2.0
8.6
93
478
N88
ICPC
Epilepsy
4.4
8.6
21
48
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
4.0
8.6
24
61
L72.1
ICD-10 Finland
Trichilemmal cyst
1.7
8.6
148
882
L11
ICPC
Wrist symptom/complaint
1.6
8.6
198
1273
T51.0
ICD-10 Finland
Toxic effect: Ethanol
4.8
8.6
19
40
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
4.8
8.6
19
40
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.7
8.6
44
164
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
8.6
190
1210
G44.2
ICD-10 Finland
Tension-type headache
1.5
8.6
284
1980
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
2.5
8.6
53
217
N05AF05
ATC
zuclopenthixol; systemic
3.6
8.6
27
75
R06.4
ICD-10 Finland
Hyperventilation
2.9
8.6
38
131
SPAT1146
SPAT
Puncture of abscess or incision of skin
2.6
8.5
46
176
L76
ICPC
Fracture: other
2.3
8.5
59
255
J03.0
ICD-10 Finland
Streptococcal tonsillitis
2.0
8.5
85
426
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
8.5
550
4322
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.6
8.5
226
1504
F43.01
ICD-10 Finland
Acute stress reaction moderate
2.7
8.5
45
171
WVA20
NOMESCO Finland
Medicine administration
2.2
8.4
66
300
N05AA01
ATC
chlorpromazine; systemic, rectal
3.0
8.4
35
116
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.7
8.4
413
5381
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.2
8.4
69
320
SPA47
NOMESCO Finland
Precision impression for denture
2.3
8.4
62
275
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
8.4
95
497
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
4.3
8.4
21
49
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.6
8.4
27
76
NFQ20
NOMESCO Finland
Amputation of femur
4.7
8.3
19
41
N05AC02
ATC
thioridazine; oral
2.6
8.3
47
184
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
8.3
116
650
P02
ICPC
Acute stress reaction
1.8
8.3
130
754
SPAT1189
SPAT
Other ultrasound examination during pregnancy
2.2
8.3
71
335
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.8
8.3
39
139
A10AB01
ATC
insulin (human); parenteral
2.1
8.3
75
362
PDQ20
NOMESCO Finland
Insertion of endovascular graft into common iliac artery
9.5
8.3
16
17
R03BA08
ATC
ciclesonide; inhalant
1.6
8.3
177
1118
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.7
8.3
42
156
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.3
8.2
61
271
A10AA02, ,
ATC
2.2
8.2
65
297
N05
ICPC
Tingling fingers/feet/toes
3.4
8.2
29
87
R60.1
ICD-10 Finland
Generalized oedema
4.2
8.2
21
50
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
4.2
8.2
21
50
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
8.2
99
530
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
8.2
458
5847
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
2.5
8.2
48
192
B37.08
ICD-10 Finland
Other candidal stomatitis
3.9
8.1
23
59
H04AA01
ATC
glucagon; nasal, parenteral
2.4
8.1
55
235
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.9
8.1
96
510
PD5AD
NOMESCO Finland
CT of aorta
2.4
8.1
54
229
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
8.1
376
2795
F91.9
ICD-10 Finland
Conduct disorder, unspecified
33.5
8.1
10
*
H3603, E103,
ICD-10 Finland
3.4
8.1
28
83
SPAT1182
SPAT
Ultrasound examination of uterus, appendages and lower abdomen
3.8
8.1
24
64
DQA10
NOMESCO Finland
Biopsy of larynx
4.0
8.1
22
55
S89.9
ICD-10 Finland
Unspecified injury of lower leg
2.1
8.1
78
386
R52.2
ICD-10 Finland
Other chronic pain
2.0
8.0
80
400
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.9
8.0
97
519
F05.9
ICD-10 Finland
Delirium, unspecified
2.8
8.0
40
147
I70
ICD-10 Finland
Atherosclerosis
10.1
8.0
15
15
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.1
8.0
33
109
WX730
NOMESCO Finland
Conventional respirator
3.1
8.0
33
109
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
8.0
113
636
L16
ICPC
Ankle symptom/complaint
1.5
8.0
247
1697
ZYY79, ,
SPAT
4.1
8.0
21
51
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
4.1
8.0
21
51
S21
ICPC
Skin texture symptom/complaint
1.5
8.0
291
2068
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.9
8.0
35
120
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.5
8.0
26
74
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.0
8.0
85
436
D06BB04
ATC
podophyllotoxin; topical
1.8
7.9
118
675
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
2.0
7.9
89
465
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
7.9
86
444
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
2.8
7.9
38
137
B86
ICD-10 Finland
Scabies
2.2
7.9
63
289
D02
ICPC
Abdominal pain epigastric
1.7
7.9
131
773
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.3
7.9
58
257
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
7.9
258
1794
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.0
7.9
22
56
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
4.6
7.9
18
39
G72.8
ICD-10 Finland
Other specified myopathies
2.9
7.9
35
121
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.2
7.8
63
290
A02BA02
ATC
ranitidine; systemic
1.4
7.8
319
2314
TK800
NOMESCO Finland
Hemodialysis
2.5
7.8
48
196
Z3226
NOMESCO Finland
Physiotherapist
1.4
7.8
328
2392
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
8.5
7.8
16
19
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.0
7.8
78
391
QBA10
NOMESCO Finland
Incision of skin of trunk
3.4
7.8
27
80
SFA30
NOMESCO Finland
Three-surface restoration
1.3
7.8
904
7689
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.0
7.8
79
398
L08
ICPC
Shoulder symptom/complaint
1.4
7.8
459
3548
XLD00, ,
SPAT
3.0
7.8
33
111
I72.4
ICD-10 Finland
Aneurysm and dissection of artery of lower extremity
9.4
7.8
15
16
L99
ICPC
Musculoskeletal disease other
2.4
7.8
50
209
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
7.0
7.8
18
26
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
7.7
57
253
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.1
7.7
75
372
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
3.5
7.7
25
71
ZXA05
NOMESCO Finland
Left side
1.4
7.7
410
3118
N04AA02
ATC
biperiden; systemic
2.6
7.7
44
174
PD4BD
NOMESCO Finland
Extensive CT of lower extremity arteries
7.4
7.7
17
23
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
1.4
7.7
431
3306
AN4
HP
Balloon angioplasty and drug eluding stent
2.3
7.6
58
261
E000001, ,
ATC
1.4
7.6
386
2910
A10BJ05
ATC
dulaglutide; parenteral
2.4
7.6
48
199
JN4BD
NOMESCO Finland
Extensive body CT
1.6
7.6
171
1094
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
7.6
116
669
EBA10
NOMESCO Finland
Operative extraction of tooth
1.4
7.6
305
2208
LX2A3, ,
SPAT
2.1
7.6
71
348
A27
ICPC
Fear of other disease NOS
1.9
7.5
95
516
P80
ICPC
Personality disorder
6.2
7.5
19
31
SPA50
NOMESCO Finland
Determination of bite and dental arch location
2.7
7.5
38
141
W79
ICPC
Unwanted pregnancy
2.5
7.5
45
182
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
7.5
337
2488
L57.0
ICD-10 Finland
Actinic keratosis
0.4
7.5
43
985
OAB50
NOMESCO Finland
Delivery of care equipment and instruction on their use
2.8
7.5
36
130
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
7.5
68
329
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.9
7.5
93
503
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.8
7.5
101
561
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
3.7
7.5
23
63
D12
ICPC
Constipation
2.1
7.5
70
343
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
7.4
47
195
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
7.4
134
810
ICB01, ,
SPAT
3.6
7.4
24
68
30180
ICD-8 Finland
Personality disorders, Immatura
6.5
7.4
18
28
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.8
7.4
101
563
SPAT1200
SPAT
Guidance for breast-feeding and breast care
2.1
7.4
64
304
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.1
7.4
67
324
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
2.8
7.4
36
131
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
3.3
7.4
27
83
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
3.4
7.4
26
78
S20.2
ICD-10 Finland
Contusion of thorax
1.8
7.4
112
645
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.6
7.4
41
160
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.0
7.4
75
379
H3600, E103,
ICD-10 Finland
3.0
7.4
31
104
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
4.0
7.3
20
50
SPAT1308
SPAT
Sexual health counselling
1.5
7.3
258
1820
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.8
7.3
35
126
R06AE07
ATC
cetirizine; oral
1.3
7.3
890
7598
D05BB02
ATC
acitretin; oral
2.4
7.3
50
215
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
3.1
7.3
30
99
PD3BT
NOMESCO Finland
Pelvic artery extensive PTA
8.4
7.3
15
18
L01
ICPC
Neck symptom/complaint
1.4
7.3
334
2473
-31
ICPC
Medical examin/health eval partial
1.7
7.3
120
707
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
7.3
114
662
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
6.8
7.3
17
25
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.3
724
6025
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.5
7.3
43
173
N06BA04
ATC
methylphenidate; oral
1.9
7.3
84
444
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.2
7.2
27
84
O04.6
ICD-10 Finland
Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage
3.2
7.2
27
84
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
3.4
7.2
25
74
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.9
7.2
82
430
SFA10
NOMESCO Finland
One-surface restoration
1.3
7.2
1198
10618
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
7.2
77
396
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.6
7.2
40
156
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
2.7
7.2
36
133
P98
ICPC
Psychosis NOS/other
3.7
7.2
22
60
D07XC01
ATC
betamethasone; topical
1.5
7.2
230
1592
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
7.3
7.2
16
22
N29
ICPC
Neurological sympt/complt other
2.5
7.2
42
168
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
3.9
7.2
20
51
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.6
7.1
38
145
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
7.1
58
269
N03AX14
ATC
levetiracetam; systemic
2.2
7.1
56
256
E66.0
ICD-10 Finland
Obesity due to excess calories
3.5
7.1
24
70
J86.9
ICD-10 Finland
Pyothorax without fistula
3.5
7.1
24
70
R4180, ,
SPAT
2.8
7.1
33
117
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.6
7.1
40
157
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
6.6
7.1
17
26
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
3.4
7.1
25
75
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
7.1
117
690
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
3.8
7.1
21
56
L82
ICD-10 Finland
Seborrhoeic keratosis
0.6
7.1
174
2584
D09
ICPC
Nausea
1.8
7.1
99
557
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.2
7.0
59
277
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
10.0
7.0
13
13
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.2
7.0
57
264
ACC53
NOMESCO Finland
Release of ulnar nerve
2.5
7.0
41
164
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
2.3
7.0
48
207
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.0
7.0
68
338
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.5
7.0
23
66
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.2
7.0
27
86
C08CA05
ATC
nifedipine; systemic
1.8
7.0
94
522
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.3
7.0
24
688
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
3.9
7.0
20
52
RD211, ,
NOMESCO Finland
1.9
7.0
83
443
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
3.2
7.0
26
81
M77.1
ICD-10 Finland
Lateral epicondylitis
1.6
7.0
175
1150
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.9
6.9
79
416
M13.9
ICD-10 Finland
Arthritis, unspecified
1.6
6.9
149
944
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.6
6.9
173
1136
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.1
6.9
28
92
M53.9
ICD-10 Finland
Dorsopathy, unspecified
4.0
6.9
19
48
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.9
287
2090
KMAK, ,
NOMESCO Finland
1.3
6.9
1094
9624
O32.1
ICD-10 Finland
Maternal care for breech presentation
1.9
6.9
82
438
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.2
6.9
54
247
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.4
6.9
44
184
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.8
6.8
32
114
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
6.8
63
307
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.1
6.8
63
307
L78
ICPC
Sprain/strain of knee
2.7
6.8
35
131
R09
ICPC
Sinus symptom/complaint
1.6
6.8
174
1147
K92.1
ICD-10 Finland
Melaena
1.8
6.8
90
497
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
4.1
6.8
18
44
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.8
6.8
93
519
A10BK03
ATC
empagliflozin; oral
1.5
6.8
201
1368
K85
ICPC
Elevated blood pressure
1.4
6.8
283
2060
N30.0
ICD-10 Finland
Acute cystitis
1.4
6.8
303
2233
S01.0
ICD-10 Finland
Open wound of scalp
1.6
6.8
147
932
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.2
6.8
57
268
Z71.6
ICD-10 Finland
Tobacco abuse counselling
9.3
6.8
13
14
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
9.3
6.8
13
14
S30.1
ICD-10 Finland
Contusion of abdominal wall
2.7
6.8
34
126
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.5
6.8
40
161
Z91.5
ICD-10 Finland
Personal history of self-harm
6.1
6.8
17
28
F60.2
ICD-10 Finland
Dissocial personality disorder
6.1
6.8
17
28
R07
ICPC
Sneezing/nasal congestion
1.6
6.7
143
902
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.7
6.7
118
708
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
16.7
6.7
10
6
F13.00
ICD-10 Finland
Intoxication caused by sedatives and hypnotics uncomplicated
16.7
6.7
10
6
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.7
6.7
35
132
D95
ICPC
Anal fissure/perianal abscess
3.1
6.7
27
88
B37.0
ICD-10 Finland
Candidal stomatitis
3.1
6.7
27
88
D22
ICD-10 Finland
Melanocytic naevi
0.4
6.7
29
748
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.8
6.7
105
610
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
6.7
69
350
KAY20, ,
NOMESCO Finland
0.0
6.7
*
201
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.0
6.7
71
364
X58
ICD-10 Finland
Exposure to other specified factors
1.4
6.7
317
2360
M01AH01
ATC
celecoxib; oral
1.4
6.7
305
2256
SPAT1235
SPAT
Mental health, emotional support
3.3
6.7
24
73
AN2
HP
Balloon angioplasty, including several vessels
2.3
6.7
47
205
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.5
6.7
40
162
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.5
6.7
40
162
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
22.6
6.7
9
*
ECB20
NOMESCO Finland
Oral alveoplasty
3.0
6.7
28
94
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
3.0
6.7
28
94
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.0
6.6
18
45
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
6.6
240
1703
D07AA02
ATC
hydrocortisone; topical
1.4
6.6
269
1950
N76.0
ICD-10 Finland
Acute vaginitis
1.6
6.6
141
891
O47.9
ICD-10 Finland
False labour, unspecified
2.5
6.6
40
163
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
6.6
40
163
S69.9
ICD-10 Finland
Unspecified injury of wrist and hand
2.3
6.6
46
200
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
3.6
6.6
21
59
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.6
6.6
21
59
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.0
6.6
67
339
D01
ICPC
Abdominal pain/cramps general
1.4
6.6
248
1773
S02
ICPC
Pruritus
1.9
6.6
73
381
C09AA02
ATC
enalapril; systemic
1.4
6.6
298
2203
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
2.6
6.6
35
134
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
2.6
6.6
35
134
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
2.6
6.6
35
134
K55.8
ICD-10 Finland
Other vascular disorders of intestine
8.7
6.5
13
15
WVA20, ,
SPAT
1.9
6.5
76
403
H25.8
ICD-10 Finland
Other senile cataract
1.6
6.5
140
887
P72
ICPC
Schizophrenia
2.3
6.5
47
208
R13
ICD-10 Finland
Dysphagia
1.6
6.5
132
825
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
6.2
6.5
16
26
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
5.3
6.5
18
34
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
6.5
231
1635
109
Kela drug reimbursment
Multiple sclerosis
2.7
6.4
32
118
K13.29
ICD-10 Finland
Indefinite leukoplakia
3.1
6.4
25
80
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.1
6.4
25
80
SPF02
NOMESCO Finland
Impression for dental prosthesis repair, restricted
3.1
6.4
25
80
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
2.0
6.4
70
363
M01AB05
ATC
diclofenac; systemic, rectal
1.3
6.4
1382
12546
I21.11
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
2.7
6.4
33
124
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
3.3
6.4
23
70
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
3.3
6.4
23
70
N95
ICD-10 Finland
Menopausal and other perimenopausal disorders
0.2
6.4
6
302
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.4
6.4
43
184
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
6.4
137
867
M54.1
ICD-10 Finland
Radiculopathy
1.9
6.4
79
428
A02BA04
ATC
nizatidine; systemic
1.7
6.4
116
704
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.7
6.4
101
590
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
6.4
202
1396
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
6.4
50
229
N04BC05
ATC
pramipexole; oral
1.6
6.4
130
813
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
3.7
6.4
19
51
R07.3
ICD-10 Finland
Other chest pain
1.5
6.4
201
1388
M54
ICD-10 Finland
Dorsalgia
1.4
6.4
257
1861
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.0
6.4
63
316
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.1
6.4
17
42
AA1ED
NOMESCO Finland
Trauma CT of head and neck
4.1
6.4
17
42
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.0
6.3
26
86
B01AA03
ATC
warfarin; systemic
1.4
6.3
256
1853
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
6.3
160
1053
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.8
6.3
86
480
R52.1
ICD-10 Finland
Chronic intractable pain
3.1
6.3
25
81
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
3.6
6.3
20
56
GDC00
NOMESCO Finland
Lobectomy of lung
6.0
6.3
16
27
M79.1
ICD-10 Finland
Myalgia
1.4
6.3
314
2358
PG2YT
NOMESCO Finland
Implantation of arterial endoprothesis not elsewhere classified
11.0
6.3
11
10
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.5
6.3
21
61
SPF13
NOMESCO Finland
Fitting of the denture in the mouth in connection with the foundation of the loose prosthesis
3.5
6.3
21
61
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
9.3
6.3
12
13
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
3.3
6.3
23
71
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
6.3
212
1484
IHZ01, ,
SPAT
2.8
6.3
29
103
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
3.9
6.3
18
47
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
6.2
479
3838
A10AA01, ,
ATC
2.1
6.2
55
264
K29.7
ICD-10 Finland
Gastritis, unspecified
2.0
6.2
67
346
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
3.0
6.2
26
87
F32.1
ICD-10 Finland
Moderate depressive episode
1.6
6.2
137
873
Z97.5
ICD-10 Finland
Presence of (intrauterine) contraceptive device
2.6
6.2
34
132
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
6.2
62
312
N19
ICD-10 Finland
Unspecified kidney failure
2.0
6.2
59
292
S72.0
ICD-10 Finland
Fracture of neck of femur
2.2
6.2
50
232
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
5.0
6.2
18
36
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
4.0
6.2
17
43
M75.8
ICD-10 Finland
Other shoulder lesions
1.8
6.2
83
462
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.3
6.2
45
200
NH3BG
NOMESCO Finland
MRI of foot
3.5
6.2
20
57
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.8
6.2
29
104
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
2.8
6.2
29
104
S20
ICPC
Corn/callosity
2.3
6.1
44
194
SPD01
NOMESCO Finland
Mucosa-supported complete denture
3.0
6.1
26
88
J01DA09
ATC
[U] cefadroxil
1.3
6.1
507
4105
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
6.1
140
901
A10BH05
ATC
linagliptin; oral
1.9
6.1
77
420
K29
ICPC
Cardiovascular sympt/complt other
1.9
6.1
69
363
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.0
6.1
64
328
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
6.1
91
523
XG466
NOMESCO Finland
Sleep oxymetry
2.0
6.1
59
294
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
8.6
6.1
12
14
O82.0
ICD-10 Finland
Delivery by elective caesarean section
1.8
6.0
83
465
G35
ICD-10 Finland
Multiple sclerosis
2.4
6.0
38
158
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
6.7
6.0
14
21
R03BB06
ATC
glycopyrronium bromide; inhalant
6.7
6.0
14
21
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.1
6.0
54
261
N05BB01
ATC
hydroxyzine; systemic
1.7
6.0
116
715
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.2
6.0
23
73
M54.6
ICD-10 Finland
Pain in thoracic spine
1.5
6.0
155
1025
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
5.2
6.0
17
33
WX234
NOMESCO Finland
Paracervical blockade
2.0
6.0
62
316
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Tobacco use
Z72.0 [45581063]
Z72.0 [45581063]
2.7e+00
3.6e+00
1.0e+50
1.0e+50
—
6.6e+00
4.7e+00
cases:2.53%
controls:0.17%
cases:1.79%
controls:0.05%
cases:0.83%
controls:0.00%
cases:99.87%
controls:0.00%
—
—
cases:35.54%
controls:0.08%
cases:18.43%
controls:0.21%
58
39
2235
22901
41
11
2252
22929
19
0
2274
22940
2290
0
3
22940
—
773
17
1402
22090
328
40
1452
18680
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
J44.1 [45601132]
J44.1 [45601132]
2.8e+00
2.7e+00
2.8e+00
1.0e+50
3.2e+00
2.6e+00
2.6e+00
cases:2.35%
controls:0.15%
cases:1.35%
controls:0.10%
cases:0.52%
controls:0.03%
cases:1.05%
controls:0.00%
cases:0.53%
controls:0.02%
cases:2.25%
controls:0.17%
cases:4.21%
controls:0.34%
54
34
2239
22906
31
22
2262
22918
12
7
2281
22933
24
0
2269
22940
12
5
2272
22880
49
38
2126
22069
75
63
1705
18657
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 [45601131]
J44.0 [45601131]
2.2e+00
2.6e+00
3.0e+00
1.0e+50
3.5e+00
2.3e+00
2.3e+00
cases:3.10%
controls:0.34%
cases:2.01%
controls:0.15%
cases:0.70%
controls:0.03%
cases:1.40%
controls:0.00%
cases:1.01%
controls:0.03%
cases:2.44%
controls:0.24%
cases:5.22%
controls:0.57%
71
77
2222
22863
46
34
2247
22906
16
8
2277
22932
32
0
2261
22940
23
7
2261
22878
53
53
2122
22054
93
106
1687
18614
Addiction caused by tobacco UNS
F17.29 [2000501845]
F17.29 [2000501845]
1.9e+00
2.6e+00
2.6e+00
1.0e+50
3.6e+00
2.6e+00
2.6e+00
cases:1.70%
controls:0.25%
cases:1.53%
controls:0.11%
cases:0.35%
controls:0.03%
cases:0.39%
controls:0.00%
cases:0.79%
controls:0.02%
cases:1.79%
controls:0.14%
cases:3.03%
controls:0.24%
39
57
2254
22883
35
26
2258
22914
8
6
2285
22934
9
0
2284
22940
18
5
2266
22880
39
30
2136
22077
54
44
1726
18676
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
1.9e+00
2.1e+00
3.1e+00
—
3.5e+00
2.8e+00
2.3e+00
cases:8.37%
controls:1.34%
cases:6.89%
controls:0.87%
cases:3.10%
controls:0.15%
—
—
cases:4.47%
controls:0.14%
cases:11.68%
controls:0.82%
cases:15.39%
controls:1.75%
192
308
2101
22632
158
200
2135
22740
71
34
2222
22906
—
102
32
2182
22853
254
181
1921
21926
274
327
1506
18393
varenicline; oral
N07BA03 [21604819]
N07BA03 [21604819]
1.8e+00
2.4e+00
2.4e+00
1.0e+50
4.1e+00
2.6e+00
2.3e+00
cases:6.67%
controls:1.22%
cases:2.88%
controls:0.28%
cases:0.57%
controls:0.05%
cases:0.39%
controls:0.00%
cases:1.80%
controls:0.03%
cases:4.32%
controls:0.33%
cases:8.15%
controls:0.91%
153
280
2140
22660
66
64
2227
22876
13
12
2280
22928
9
0
2284
22940
41
7
2243
22878
94
73
2081
22034
145
171
1635
18549
Chronic obstructive pulmonary disease, unspecified
J44.9 [45548115]
J44.9 [45548115]
2.2e+00
2.3e+00
3.0e+00
—
2.7e+00
2.6e+00
2.1e+00
cases:2.62%
controls:0.29%
cases:1.57%
controls:0.17%
cases:0.44%
controls:0.02%
—
—
cases:0.74%
controls:0.05%
cases:2.30%
controls:0.18%
cases:4.38%
controls:0.53%
60
67
2233
22873
36
38
2257
22902
10
5
2283
22935
—
17
11
2267
22874
50
40
2125
22067
78
100
1702
18620
Supervision of other high-risk pregnancies
Z35.8 [45552076]
Z35.8 [45552076]
8.0e-01
1.9e+00
3.5e+00
1.0e+50
4.1e+00
3.0e+00
1.1e+00
cases:2.01%
controls:0.91%
cases:2.22%
controls:0.33%
cases:1.40%
controls:0.04%
cases:3.14%
controls:0.00%
cases:2.54%
controls:0.04%
cases:5.24%
controls:0.27%
cases:3.31%
controls:1.10%
46
209
2247
22731
51
75
2242
22865
32
10
2261
22930
72
0
2221
22940
58
10
2226
22875
114
59
2061
22048
59
206
1721
18514
Inpatient Hospital
21 [8717]
21 [8717]
6.5e-01
7.9e-01
1.6e+00
6.3e+00
2.4e+00
1.6e+00
9.0e-01
cases:43.35%
controls:28.51%
cases:17.88%
controls:8.98%
cases:5.36%
controls:1.09%
cases:17.23%
controls:0.04%
cases:10.81%
controls:1.12%
cases:28.87%
controls:7.47%
cases:35.45%
controls:18.24%
994
6541
1299
16399
410
2059
1883
20881
123
250
2170
22690
395
9
1898
22931
247
256
2037
22629
628
1651
1547
20456
631
3414
1149
15306
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
8.5e-01
1.2e+00
1.9e+00
5.6e+00
1.8e+00
1.5e+00
1.1e+00
cases:7.24%
controls:3.21%
cases:5.36%
controls:1.69%
cases:1.79%
controls:0.28%
cases:5.32%
controls:0.02%
cases:2.19%
controls:0.37%
cases:6.90%
controls:1.70%
cases:11.52%
controls:4.15%
166
737
2127
22203
123
387
2170
22553
41
64
2252
22876
122
5
2171
22935
50
84
2234
22801
150
376
2025
21731
205
776
1575
17944
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
1.7e+00
2.2e+00
2.7e+00
—
2.9e+00
2.3e+00
1.9e+00
cases:5.15%
controls:0.99%
cases:4.97%
controls:0.57%
cases:2.31%
controls:0.16%
—
—
cases:3.06%
controls:0.17%
cases:6.21%
controls:0.65%
cases:8.09%
controls:1.31%
118
226
2175
22714
114
130
2179
22810
53
36
2240
22904
—
70
38
2214
22847
135
144
2040
21963
144
246
1636
18474
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.7e-01
9.1e-01
1.9e+00
6.3e+00
2.0e+00
1.1e+00
8.2e-01
cases:8.11%
controls:4.74%
cases:6.59%
controls:2.75%
cases:2.40%
controls:0.37%
cases:10.99%
controls:0.02%
cases:3.06%
controls:0.42%
cases:9.01%
controls:3.11%
cases:21.91%
controls:11.01%
186
1087
2107
21853
151
631
2142
22309
55
85
2238
22855
252
5
2041
22935
70
96
2214
22789
196
688
1979
21419
390
2062
1390
16658
Pregnancy high risk
W84 [2002001275]
W84 [2002001275]
7.7e-01
2.1e+00
3.6e+00
—
3.7e+00
2.4e+00
1.1e+00
cases:1.09%
controls:0.51%
cases:1.70%
controls:0.22%
cases:1.40%
controls:0.04%
—
—
cases:1.53%
controls:0.04%
cases:2.07%
controls:0.19%
cases:2.25%
controls:0.74%
25
117
2268
22823
39
50
2254
22890
32
9
2261
22931
—
35
9
2249
22876
45
41
2130
22066
40
139
1740
18581
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
1.2e+00
2.1e+00
3.0e+00
1.0e+50
3.3e+00
2.5e+00
1.5e+00
cases:2.83%
controls:0.88%
cases:2.66%
controls:0.34%
cases:1.00%
controls:0.05%
cases:2.70%
controls:0.00%
cases:1.58%
controls:0.06%
cases:3.40%
controls:0.29%
cases:4.27%
controls:0.98%
65
202
2228
22738
61
77
2232
22863
23
11
2270
22929
62
0
2231
22940
36
14
2248
22871
74
64
2101
22043
76
184
1704
18536
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
XPX99 [2001309755]
1.4e+00
2.3e+00
2.2e+00
1.0e+50
3.2e+00
2.4e+00
2.0e+00
cases:2.57%
controls:0.63%
cases:2.01%
controls:0.20%
cases:0.39%
controls:0.04%
cases:0.92%
controls:0.00%
cases:0.61%
controls:0.03%
cases:2.53%
controls:0.23%
cases:4.04%
controls:0.59%
59
145
2234
22795
46
46
2247
22894
9
10
2284
22930
21
0
2272
22940
14
6
2270
22879
55
51
2120
22056
72
111
1708
18609
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
6.1e-01
5.7e-01
1.6e+00
6.2e+00
2.5e+00
1.3e+00
5.0e-01
cases:5.76%
controls:3.21%
cases:2.88%
controls:1.65%
cases:1.35%
controls:0.27%
cases:9.90%
controls:0.02%
cases:4.20%
controls:0.35%
cases:7.13%
controls:2.08%
cases:9.33%
controls:5.87%
132
736
2161
22204
66
378
2227
22562
31
62
2262
22878
227
5
2066
22935
96
80
2188
22805
155
459
2020
21648
166
1098
1614
17622
fenoterol and ipratropium bromide
R03AL01 [43534843]
R03AL01 [43534843]
1.8e+00
2.1e+00
2.7e+00
—
2.6e+00
2.3e+00
1.8e+00
cases:2.83%
controls:0.50%
cases:2.35%
controls:0.30%
cases:1.05%
controls:0.07%
—
—
cases:1.09%
controls:0.08%
cases:2.94%
controls:0.32%
cases:4.04%
controls:0.67%
65
115
2228
22825
54
68
2239
22872
24
17
2269
22923
—
25
18
2259
22867
64
70
2111
22037
72
125
1708
18595
Emergency Room Visit
ER [9203]
ER [9203]
7.6e-01
9.4e-01
1.9e+00
5.9e+00
1.7e+00
1.1e+00
9.2e-01
cases:53.90%
controls:35.33%
cases:25.34%
controls:11.72%
cases:9.03%
controls:1.45%
cases:17.66%
controls:0.06%
cases:7.62%
controls:1.47%
cases:25.98%
controls:10.88%
cases:47.13%
controls:26.23%
1236
8105
1057
14835
581
2689
1712
20251
207
333
2086
22607
405
14
1888
22926
174
336
2110
22549
565
2405
1610
19702
839
4910
941
13810
Outpatient Hospital
22 [8756]
22 [8756]
5.4e-01
6.5e-01
1.3e+00
5.6e+00
2.3e+00
1.6e+00
9.6e-01
cases:34.15%
controls:23.14%
cases:11.99%
controls:6.63%
cases:2.83%
controls:0.77%
cases:10.51%
controls:0.04%
cases:7.14%
controls:0.78%
cases:20.78%
controls:5.19%
cases:28.60%
controls:13.24%
783
5308
1510
17632
275
1521
2018
21419
65
177
2228
22763
241
10
2052
22930
163
178
2121
22707
452
1148
1723
20959
509
2479
1271
16241
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
3.9e-01
9.7e-01
1.8e+00
5.5e+00
2.4e+00
9.2e-01
7.0e-01
cases:11.03%
controls:7.74%
cases:8.46%
controls:3.39%
cases:2.66%
controls:0.44%
cases:5.06%
controls:0.02%
cases:4.68%
controls:0.43%
cases:8.28%
controls:3.47%
cases:21.69%
controls:12.09%
253
1776
2040
21164
194
778
2099
22162
61
101
2232
22839
116
5
2177
22935
107
98
2177
22787
180
768
1995
21339
386
2264
1394
16456
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
1.4e+00
1.4e+00
2.8e+00
1.0e+50
3.4e+00
2.1e+00
1.6e+00
cases:2.31%
controls:0.58%
cases:0.92%
controls:0.23%
cases:0.44%
controls:0.03%
cases:0.35%
controls:0.00%
cases:0.66%
controls:0.02%
cases:1.47%
controls:0.18%
cases:3.54%
controls:0.77%
53
133
2240
22807
21
53
2272
22887
10
6
2283
22934
8
0
2285
22940
15
5
2269
22880
32
40
2143
22067
63
144
1717
18576
Rheumatology
66 [38004491]
66 [38004491]
6.9e-01
1.0e+00
1.0e+00
5.7e+00
1.7e+00
1.4e+00
1.1e+00
cases:7.24%
controls:3.78%
cases:6.06%
controls:2.24%
cases:1.18%
controls:0.42%
cases:6.02%
controls:0.02%
cases:2.19%
controls:0.41%
cases:7.72%
controls:2.06%
cases:10.34%
controls:3.59%
166
866
2127
22074
139
513
2154
22427
27
97
2266
22843
138
5
2155
22935
50
93
2234
22792
168
455
2007
21652
184
672
1596
18048
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.4e-01
-3.8e-01
9.4e-01
3.2e+00
2.9e+00
3.1e+00
3.2e+00
cases:17.79%
controls:27.03%
cases:6.72%
controls:9.49%
cases:2.49%
controls:0.99%
cases:1.44%
controls:0.06%
cases:1.62%
controls:0.09%
cases:10.44%
controls:0.53%
cases:25.51%
controls:1.35%
408
6200
1885
16740
154
2176
2139
20764
57
226
2236
22714
33
13
2260
22927
37
20
2247
22865
227
118
1948
21989
454
253
1326
18467
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
39480-9 [3038515]
1.4e+00
2.0e+00
2.8e+00
1.0e+50
2.7e+00
1.9e+00
1.5e+00
cases:1.05%
controls:0.26%
cases:1.00%
controls:0.14%
cases:0.35%
controls:0.02%
cases:1.13%
controls:0.00%
cases:0.53%
controls:0.03%
cases:1.29%
controls:0.20%
cases:3.54%
controls:0.81%
24
60
2269
22880
23
33
2270
22907
8
5
2285
22935
26
0
2267
22940
12
8
2272
22877
28
44
2147
22063
63
152
1717
18568
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
8.5e-01
1.6e+00
3.6e+00
1.0e+50
2.6e+00
1.8e+00
1.7e+00
cases:4.67%
controls:2.05%
cases:2.35%
controls:0.49%
cases:1.35%
controls:0.04%
cases:1.18%
controls:0.00%
cases:0.83%
controls:0.06%
cases:2.94%
controls:0.47%
cases:6.40%
controls:1.21%
107
470
2186
22470
54
113
2239
22827
31
9
2262
22931
27
0
2266
22940
19
14
2265
22871
64
105
2111
22002
114
227
1666
18493
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
8.5e-01
1.6e+00
3.6e+00
1.0e+50
2.6e+00
1.8e+00
1.7e+00
cases:4.67%
controls:2.05%
cases:2.35%
controls:0.49%
cases:1.35%
controls:0.04%
cases:1.18%
controls:0.00%
cases:0.83%
controls:0.06%
cases:2.94%
controls:0.47%
cases:6.40%
controls:1.21%
107
470
2186
22470
54
113
2239
22827
31
9
2262
22931
27
0
2266
22940
19
14
2265
22871
64
105
2111
22002
114
227
1666
18493
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
8.5e-01
1.6e+00
3.6e+00
1.0e+50
2.6e+00
1.8e+00
1.7e+00
cases:4.67%
controls:2.05%
cases:2.35%
controls:0.49%
cases:1.35%
controls:0.04%
cases:1.18%
controls:0.00%
cases:0.83%
controls:0.06%
cases:2.94%
controls:0.47%
cases:6.40%
controls:1.21%
107
470
2186
22470
54
113
2239
22827
31
9
2262
22931
27
0
2266
22940
19
14
2265
22871
64
105
2111
22002
114
227
1666
18493
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
8.5e-01
1.6e+00
3.6e+00
1.0e+50
2.6e+00
1.8e+00
1.7e+00
cases:4.67%
controls:2.05%
cases:2.35%
controls:0.49%
cases:1.35%
controls:0.04%
cases:1.18%
controls:0.00%
cases:0.83%
controls:0.06%
cases:2.94%
controls:0.47%
cases:6.40%
controls:1.21%
107
470
2186
22470
54
113
2239
22827
31
9
2262
22931
27
0
2266
22940
19
14
2265
22871
64
105
2111
22002
114
227
1666
18493
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
8.5e-01
1.6e+00
3.6e+00
1.0e+50
2.6e+00
1.8e+00
1.7e+00
cases:4.67%
controls:2.05%
cases:2.35%
controls:0.49%
cases:1.35%
controls:0.04%
cases:1.18%
controls:0.00%
cases:0.83%
controls:0.06%
cases:2.94%
controls:0.47%
cases:6.40%
controls:1.21%
107
470
2186
22470
54
113
2239
22827
31
9
2262
22931
27
0
2266
22940
19
14
2265
22871
64
105
2111
22002
114
227
1666
18493
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.7e+00
1.8e+00
2.0e+00
—
3.1e+00
2.0e+00
1.5e+00
cases:5.41%
controls:0.99%
cases:2.14%
controls:0.37%
cases:0.52%
controls:0.07%
—
—
cases:1.01%
controls:0.04%
cases:2.44%
controls:0.35%
cases:4.49%
controls:1.05%
124
228
2169
22712
49
86
2244
22854
12
17
2281
22923
—
23
10
2261
22875
53
77
2122
22030
80
196
1700
18524
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.9e-01
1.5e+00
3.2e+00
1.0e+50
2.5e+00
2.1e+00
1.9e+00
cases:5.02%
controls:2.34%
cases:2.66%
controls:0.60%
cases:1.48%
controls:0.06%
cases:1.31%
controls:0.00%
cases:0.88%
controls:0.07%
cases:4.05%
controls:0.53%
cases:8.60%
controls:1.35%
115
536
2178
22404
61
138
2232
22802
34
14
2259
22926
30
0
2263
22940
20
16
2264
22869
88
118
2087
21989
153
253
1627
18467
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.9e-01
1.5e+00
3.2e+00
1.0e+50
2.5e+00
2.1e+00
1.9e+00
cases:5.02%
controls:2.34%
cases:2.66%
controls:0.60%
cases:1.48%
controls:0.06%
cases:1.31%
controls:0.00%
cases:0.88%
controls:0.07%
cases:4.05%
controls:0.53%
cases:8.60%
controls:1.35%
115
536
2178
22404
61
138
2232
22802
34
14
2259
22926
30
0
2263
22940
20
16
2264
22869
88
118
2087
21989
153
253
1627
18467
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.9e-01
1.5e+00
3.2e+00
1.0e+50
2.5e+00
2.1e+00
1.9e+00
cases:5.02%
controls:2.34%
cases:2.66%
controls:0.60%
cases:1.48%
controls:0.06%
cases:1.31%
controls:0.00%
cases:0.88%
controls:0.07%
cases:4.05%
controls:0.53%
cases:8.60%
controls:1.35%
115
536
2178
22404
61
138
2232
22802
34
14
2259
22926
30
0
2263
22940
20
16
2264
22869
88
118
2087
21989
153
253
1627
18467
Internal Medicine
11 [38004456]
11 [38004456]
5.7e-01
8.7e-01
1.7e+00
5.5e+00
1.4e+00
1.0e+00
9.4e-01
cases:30.31%
controls:19.79%
cases:16.40%
controls:7.59%
cases:5.84%
controls:1.17%
cases:11.03%
controls:0.05%
cases:4.82%
controls:1.19%
cases:17.47%
controls:7.07%
cases:33.26%
controls:16.29%
695
4540
1598
18400
376
1741
1917
21199
134
269
2159
22671
253
12
2040
22928
110
272
2174
22613
380
1562
1795
20545
592
3049
1188
15671
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
1.4e+00
1.8e+00
3.0e+00
1.0e+50
2.6e+00
1.8e+00
1.5e+00
cases:1.09%
controls:0.28%
cases:1.09%
controls:0.19%
cases:0.52%
controls:0.03%
cases:1.22%
controls:0.00%
cases:0.57%
controls:0.04%
cases:1.33%
controls:0.23%
cases:3.76%
controls:0.90%
25
64
2268
22876
25
43
2268
22897
12
6
2281
22934
28
0
2265
22940
13
10
2271
22875
29
51
2146
22056
67
168
1713
18552
Addiction-induced dependence is currently independent but uses substitute intermittent medication
F11.22 [2000501716]
F11.22 [2000501716]
1.5e+00
1.8e+00
2.4e+00
—
1.9e+00
2.3e+00
2.1e+00
cases:0.57%
controls:0.13%
cases:0.57%
controls:0.10%
cases:0.44%
controls:0.04%
—
—
cases:0.48%
controls:0.07%
cases:0.69%
controls:0.07%
cases:0.84%
controls:0.10%
13
30
2280
22910
13
22
2280
22918
10
9
2283
22931
—
11
17
2273
22868
15
16
2160
22091
15
19
1765
18701
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
4.9e-01
6.8e-01
1.8e+00
5.0e+00
2.2e+00
1.0e+00
7.4e-01
cases:20.28%
controls:13.54%
cases:12.82%
controls:6.90%
cases:5.15%
controls:0.92%
cases:6.93%
controls:0.05%
cases:7.66%
controls:0.88%
cases:17.06%
controls:6.88%
cases:35.56%
controls:20.88%
465
3106
1828
19834
294
1584
1999
21356
118
212
2175
22728
159
12
2134
22928
175
202
2109
22683
371
1522
1804
20585
633
3909
1147
14811
Neurology
13 [38004458]
13 [38004458]
4.4e-01
6.5e-01
1.4e+00
5.4e+00
1.8e+00
1.2e+00
8.3e-01
cases:15.00%
controls:10.23%
cases:8.02%
controls:4.38%
cases:3.58%
controls:0.90%
cases:12.87%
controls:0.07%
cases:4.68%
controls:0.82%
cases:13.15%
controls:4.17%
cases:19.83%
controls:9.73%
344
2346
1949
20594
184
1004
2109
21936
82
206
2211
22734
295
15
1998
22925
107
187
2177
22698
286
921
1889
21186
353
1821
1427
16899
Otolaryngology
4 [38004449]
4 [38004449]
4.2e-01
5.9e-01
1.8e+00
5.4e+00
2.0e+00
9.4e-01
6.0e-01
cases:15.18%
controls:10.51%
cases:7.11%
controls:4.05%
cases:3.62%
controls:0.62%
cases:4.62%
controls:0.02%
cases:4.12%
controls:0.60%
cases:9.01%
controls:3.71%
cases:17.58%
controls:10.45%
348
2410
1945
20530
163
930
2130
22010
83
142
2210
22798
106
5
2187
22935
94
138
2190
22747
196
821
1979
21286
313
1956
1467
16764
Emergency Medicine
93 [38004510]
93 [38004510]
5.2e-01
7.5e-01
1.8e+00
5.5e+00
1.5e+00
8.2e-01
5.8e-01
cases:23.72%
controls:15.62%
cases:16.57%
controls:8.54%
cases:6.45%
controls:1.10%
cases:10.07%
controls:0.04%
cases:4.73%
controls:1.12%
cases:18.07%
controls:8.85%
cases:39.78%
controls:27.01%
544
3583
1749
19357
380
1960
1913
20980
148
253
2145
22687
231
10
2062
22930
108
257
2176
22628
393
1956
1782
20151
708
5056
1072
13664
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
1.2e+00
1.7e+00
2.9e+00
1.0e+50
2.4e+00
1.8e+00
1.5e+00
cases:1.53%
controls:0.45%
cases:0.87%
controls:0.16%
cases:0.39%
controls:0.02%
cases:0.44%
controls:0.00%
cases:0.44%
controls:0.04%
cases:1.20%
controls:0.21%
cases:2.30%
controls:0.53%
35
103
2258
22837
20
36
2273
22904
9
5
2284
22935
10
0
2283
22940
10
9
2274
22876
26
46
2149
22061
41
99
1739
18621
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
1.3e+00
2.1e+00
2.5e+00
1.0e+50
2.3e+00
2.0e+00
1.2e+00
cases:1.13%
controls:0.31%
cases:1.13%
controls:0.14%
cases:0.31%
controls:0.03%
cases:0.22%
controls:0.00%
cases:0.31%
controls:0.03%
cases:1.10%
controls:0.14%
cases:1.63%
controls:0.48%
26
72
2267
22868
26
31
2267
22909
7
6
2286
22934
5
0
2288
22940
7
7
2277
22878
24
32
2151
22075
29
90
1751
18630
Abdominal aortic aneurysm, without mention of rupture
I71.4 [45572130]
I71.4 [45572130]
1.6e+00
1.6e+00
2.5e+00
1.0e+50
2.5e+00
1.7e+00
1.4e+00
cases:0.83%
controls:0.17%
cases:0.61%
controls:0.12%
cases:0.31%
controls:0.03%
cases:0.52%
controls:0.00%
cases:0.31%
controls:0.03%
cases:0.74%
controls:0.14%
cases:1.12%
controls:0.27%
19
39
2274
22901
14
28
2279
22912
7
6
2286
22934
12
0
2281
22940
7
6
2277
22879
16
31
2159
22076
20
51
1760
18669
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
1.6e+00
1.8e+00
1.9e+00
—
2.0e+00
1.9e+00
1.9e+00
cases:7.72%
controls:1.58%
cases:6.50%
controls:1.17%
cases:2.75%
controls:0.43%
—
—
cases:3.06%
controls:0.44%
cases:8.32%
controls:1.31%
cases:11.69%
controls:1.95%
177
363
2116
22577
149
268
2144
22672
63
98
2230
22842
—
70
101
2214
22784
181
290
1994
21817
208
365
1572
18355
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
2.7e-01
3.9e-01
1.5e+00
4.8e+00
2.8e+00
8.6e-01
7.0e-01
cases:7.76%
controls:6.02%
cases:4.27%
controls:2.95%
cases:1.88%
controls:0.42%
cases:2.66%
controls:0.02%
cases:5.78%
controls:0.38%
cases:6.02%
controls:2.65%
cases:13.82%
controls:7.38%
178
1380
2115
21560
98
676
2195
22264
43
96
2250
22844
61
5
2232
22935
132
88
2152
22797
131
585
2044
21522
246
1382
1534
17338
olodaterol and tiotropium bromide
R03AL06 [1588644]
R03AL06 [1588644]
1.6e+00
1.9e+00
1.8e+00
—
2.9e+00
2.2e+00
2.4e+00
cases:0.74%
controls:0.14%
cases:0.87%
controls:0.14%
cases:0.22%
controls:0.03%
—
—
cases:0.70%
controls:0.04%
cases:1.43%
controls:0.15%
cases:2.30%
controls:0.22%
17
33
2276
22907
20
31
2273
22909
5
8
2288
22932
—
16
9
2268
22876
31
34
2144
22073
41
41
1739
18679
Cerebral infarction, unspecified
I63.9 [45596216]
I63.9 [45596216]
6.8e-01
1.0e+00
2.9e+00
—
3.3e+00
1.9e+00
1.0e+00
cases:1.74%
controls:0.89%
cases:0.96%
controls:0.35%
cases:1.35%
controls:0.07%
—
—
cases:1.44%
controls:0.05%
cases:2.62%
controls:0.38%
cases:2.92%
controls:1.05%
40
204
2253
22736
22
81
2271
22859
31
17
2262
22923
—
33
12
2251
22873
57
85
2118
22022
52
197
1728
18523
Vascular Surgery
77 [38004496]
77 [38004496]
9.7e-01
1.6e+00
2.4e+00
—
2.7e+00
2.0e+00
1.3e+00
cases:6.76%
controls:2.67%
cases:5.02%
controls:1.07%
cases:1.92%
controls:0.17%
—
—
cases:2.45%
controls:0.17%
cases:6.90%
controls:1.02%
cases:9.66%
controls:2.96%
155
613
2138
22327
115
246
2178
22694
44
39
2249
22901
—
56
39
2228
22846
150
226
2025
21881
172
555
1608
18165
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
1.9e-01
6.9e-01
1.5e+00
5.3e+00
1.9e+00
9.6e-01
3.3e-01
cases:17.62%
controls:14.98%
cases:12.21%
controls:6.53%
cases:4.84%
controls:1.16%
cases:10.64%
controls:0.06%
cases:7.22%
controls:1.15%
cases:13.33%
controls:5.58%
cases:19.21%
controls:14.56%
404
3436
1889
19504
280
1499
2013
21441
111
266
2182
22674
244
13
2049
22927
165
263
2119
22622
290
1233
1885
20874
342
2725
1438
15995
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.7e-01
5.9e-01
1.1e+00
5.8e+00
1.7e+00
8.6e-01
4.5e-01
cases:22.02%
controls:16.29%
cases:14.52%
controls:8.58%
cases:4.40%
controls:1.53%
cases:21.19%
controls:0.08%
cases:8.06%
controls:1.56%
cases:19.08%
controls:9.11%
cases:30.39%
controls:21.75%
505
3738
1788
19202
333
1969
1960
20971
101
351
2192
22589
486
19
1807
22921
184
358
2100
22527
415
2013
1760
20094
541
4072
1239
14648
Maternal and Fetal Medicine
OMOP4821963 [45756780]
OMOP4821963 [45756780]
5.6e-01
1.8e+00
2.8e+00
1.0e+50
3.1e+00
2.4e+00
6.4e-01
cases:1.66%
controls:0.95%
cases:2.44%
controls:0.41%
cases:1.74%
controls:0.10%
cases:4.10%
controls:0.00%
cases:2.28%
controls:0.11%
cases:4.74%
controls:0.45%
cases:2.81%
controls:1.50%
38
218
2255
22722
56
94
2237
22846
40
24
2253
22916
94
0
2199
22940
52
25
2232
22860
103
100
2072
22007
50
281
1730
18439
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
7.5e-01
1.3e+00
1.5e+00
3.4e+00
1.7e+00
1.1e+00
9.7e-01
cases:21.28%
controls:11.30%
cases:14.48%
controls:4.57%
cases:2.92%
controls:0.65%
cases:0.78%
controls:0.03%
cases:4.12%
controls:0.81%
cases:12.97%
controls:4.66%
cases:26.07%
controls:11.76%
488
2592
1805
20348
332
1049
1961
21891
67
150
2226
22790
18
6
2275
22934
94
185
2190
22700
282
1030
1893
21077
464
2201
1316
16519
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
7.5e-01
1.3e+00
1.5e+00
3.4e+00
1.7e+00
1.1e+00
9.7e-01
cases:21.33%
controls:11.36%
cases:14.52%
controls:4.61%
cases:2.97%
controls:0.65%
cases:0.78%
controls:0.03%
cases:4.12%
controls:0.82%
cases:13.01%
controls:4.70%
cases:26.18%
controls:11.83%
489
2607
1804
20333
333
1057
1960
21883
68
150
2225
22790
18
6
2275
22934
94
187
2190
22698
283
1039
1892
21068
466
2215
1314
16505
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
4.1e-01
8.4e-01
1.7e+00
4.0e+00
2.1e+00
9.0e-01
6.4e-01
cases:6.93%
controls:4.71%
cases:5.71%
controls:2.55%
cases:2.05%
controls:0.40%
cases:1.22%
controls:0.02%
cases:2.85%
controls:0.34%
cases:6.44%
controls:2.71%
cases:15.06%
controls:8.57%
159
1080
2134
21860
131
586
2162
22354
47
91
2246
22849
28
5
2265
22935
65
78
2219
22807
140
600
2035
21507
268
1604
1512
17116
Diabetes mellitus arising in pregnancy
O24.4 [45543922]
O24.4 [45543922]
3.6e-02
1.3e+00
2.8e+00
—
3.4e+00
2.5e+00
6.7e-01
cases:1.13%
controls:1.09%
cases:1.00%
controls:0.28%
cases:0.78%
controls:0.05%
—
—
cases:1.40%
controls:0.05%
cases:2.99%
controls:0.26%
cases:2.13%
controls:1.10%
26
251
2267
22689
23
65
2270
22875
18
11
2275
22929
—
32
11
2252
22874
65
57
2110
22050
38
206
1742
18514
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
2.1e-01
6.4e-01
1.7e+00
4.5e+00
2.0e+00
1.1e+00
7.4e-01
cases:12.60%
controls:10.47%
cases:8.55%
controls:4.69%
cases:3.36%
controls:0.62%
cases:1.88%
controls:0.02%
cases:4.03%
controls:0.59%
cases:11.54%
controls:4.28%
cases:24.89%
controls:13.65%
289
2401
2004
20539
196
1075
2097
21865
77
142
2216
22798
43
5
2250
22935
92
134
2192
22751
251
947
1924
21160
443
2555
1337
16165
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.4e-01
7.1e-01
1.8e+00
4.2e+00
1.9e+00
8.5e-01
7.0e-01
cases:42.17%
controls:34.10%
cases:36.37%
controls:21.97%
cases:20.24%
controls:3.94%
cases:15.74%
controls:0.27%
cases:22.11%
controls:3.94%
cases:40.74%
controls:22.78%
cases:67.58%
controls:50.80%
967
7823
1326
15117
834
5041
1459
17899
464
904
1829
22036
361
62
1932
22878
505
902
1779
21983
886
5037
1289
17070
1203
9510
577
9210
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.8e-01
7.7e-01
1.8e+00
4.1e+00
1.7e+00
9.2e-01
8.5e-01
cases:13.96%
controls:9.95%
cases:11.43%
controls:5.63%
cases:5.89%
controls:0.99%
cases:2.57%
controls:0.04%
cases:4.99%
controls:0.94%
cases:13.15%
controls:5.67%
cases:30.22%
controls:15.64%
320
2282
1973
20658
262
1291
2031
21649
135
227
2158
22713
59
10
2234
22930
114
214
2170
22671
286
1253
1889
20854
538
2927
1242
15793
Schizoaffective disorder, unspecified
F25.9 [45605490]
F25.9 [45605490]
1.6e+00
1.6e+00
1.7e+00
—
2.2e+00
2.0e+00
1.5e+00
cases:0.96%
controls:0.20%
cases:0.70%
controls:0.14%
cases:0.39%
controls:0.07%
—
—
cases:0.53%
controls:0.06%
cases:0.92%
controls:0.13%
cases:1.24%
controls:0.27%
22
47
2271
22893
16
32
2277
22908
9
16
2284
22924
—
12
14
2272
22871
20
28
2155
22079
22
51
1758
18669
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
8.8e-01
1.9e+00
2.6e+00
1.0e+50
2.0e+00
1.9e+00
1.3e+00
cases:1.22%
controls:0.51%
cases:1.70%
controls:0.25%
cases:0.39%
controls:0.03%
cases:0.65%
controls:0.00%
cases:0.44%
controls:0.06%
cases:1.61%
controls:0.25%
cases:4.04%
controls:1.11%
28
117
2265
22823
39
57
2254
22883
9
7
2284
22933
15
0
2278
22940
10
14
2274
22871
35
55
2140
22052
72
207
1708
18513
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
R03AL09 [1502099]
1.4e+00
1.5e+00
1.7e+00
1.0e+50
2.0e+00
2.1e+00
1.8e+00
cases:0.65%
controls:0.16%
cases:1.00%
controls:0.22%
cases:0.44%
controls:0.08%
cases:0.22%
controls:0.00%
cases:0.61%
controls:0.08%
cases:1.84%
controls:0.23%
cases:2.58%
controls:0.45%
15
36
2278
22904
23
50
2270
22890
10
19
2283
22921
5
0
2288
22940
14
19
2270
22866
40
50
2135
22057
46
84
1734
18636
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
3.5e-01
7.1e-01
1.7e+00
4.4e+00
1.7e+00
8.9e-01
8.0e-01
cases:12.25%
controls:8.98%
cases:9.64%
controls:4.98%
cases:4.40%
controls:0.85%
cases:2.40%
controls:0.03%
cases:4.29%
controls:0.83%
cases:11.22%
controls:4.93%
cases:25.34%
controls:13.27%
281
2060
2012
20880
221
1142
2072
21798
101
195
2192
22745
55
7
2238
22933
98
189
2186
22696
244
1089
1931
21018
451
2484
1329
16236
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
5.6e-01
6.7e-01
1.1e+00
5.3e+00
1.5e+00
8.2e-01
4.9e-01
cases:8.68%
controls:5.14%
cases:5.49%
controls:2.90%
cases:1.66%
controls:0.55%
cases:4.88%
controls:0.03%
cases:2.54%
controls:0.55%
cases:6.76%
controls:3.10%
cases:11.12%
controls:7.11%
199
1180
2094
21760
126
666
2167
22274
38
127
2255
22813
112
6
2181
22934
58
127
2226
22758
147
685
2028
21422
198
1331
1582
17389
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
8.3e-01
1.8e+00
2.7e+00
1.0e+50
1.9e+00
1.8e+00
1.4e+00
cases:1.22%
controls:0.54%
cases:1.66%
controls:0.28%
cases:0.52%
controls:0.03%
cases:0.74%
controls:0.00%
cases:0.48%
controls:0.07%
cases:1.66%
controls:0.27%
cases:4.27%
controls:1.12%
28
123
2265
22817
38
65
2255
22875
12
8
2281
22932
17
0
2276
22940
11
16
2273
22869
36
60
2139
22047
76
210
1704
18510
nicotine; chewing gum, inhalant, nasal, sublingual, transdermal
N07BA01 [21604818]
N07BA01 [21604818]
1.7e+00
3.2e+00
—
—
—
3.2e+00
2.4e+00
cases:0.74%
controls:0.14%
cases:0.61%
controls:0.03%
—
—
—
—
—
—
cases:0.78%
controls:0.03%
cases:1.18%
controls:0.11%
17
31
2276
22909
14
6
2279
22934
—
—
—
17
7
2158
22100
21
21
1759
18699
Fetal chromosomal abnormality screening
472825005 [43020943]
472825005 [43020943]
-1.0e-01
2.3e+00
3.0e+00
1.0e+50
2.4e+00
1.9e+00
8.0e-01
cases:0.61%
controls:0.68%
cases:2.66%
controls:0.28%
cases:0.44%
controls:0.02%
cases:1.35%
controls:0.00%
cases:0.39%
controls:0.03%
cases:1.43%
controls:0.21%
cases:1.80%
controls:0.81%
14
155
2279
22785
61
65
2232
22875
10
5
2283
22935
31
0
2262
22940
9
8
2275
22877
31
46
2144
22061
32
152
1748
18568
Outpatient Visit
OP [9202]
OP [9202]
5.9e-01
6.3e-01
1.0e+00
5.1e+00
1.4e+00
1.0e+00
7.0e-01
cases:85.26%
controls:76.30%
cases:68.16%
controls:53.27%
cases:26.17%
controls:11.39%
cases:44.74%
controls:0.51%
cases:32.75%
controls:11.02%
cases:74.94%
controls:52.40%
cases:90.45%
controls:82.41%
1955
17503
338
5437
1563
12220
730
10720
600
2612
1693
20328
1026
118
1267
22822
748
2522
1536
20363
1630
11583
545
10524
1610
15428
170
3292
Periodontitis pronounced
K05.31 [2000502729]
K05.31 [2000502729]
1.1e+00
1.4e+00
2.4e+00
1.0e+50
2.3e+00
1.8e+00
1.4e+00
cases:4.80%
controls:1.61%
cases:2.57%
controls:0.64%
cases:0.74%
controls:0.07%
cases:0.48%
controls:0.00%
cases:0.70%
controls:0.07%
cases:3.59%
controls:0.64%
cases:7.87%
controls:2.13%
110
369
2183
22571
59
147
2234
22793
17
16
2276
22924
11
0
2282
22940
16
16
2268
22869
78
141
2097
21966
140
399
1640
18321
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
1.2e+00
1.4e+00
1.9e+00
—
2.4e+00
1.5e+00
1.8e+00
cases:1.74%
controls:0.52%
cases:0.92%
controls:0.22%
cases:0.48%
controls:0.07%
—
—
cases:0.61%
controls:0.06%
cases:1.01%
controls:0.22%
cases:2.53%
controls:0.43%
40
119
2253
22821
21
51
2272
22889
11
16
2282
22924
—
14
13
2270
22872
22
49
2153
22058
45
81
1735
18639
Other chronic obstructive pulmonary disease
J44 [45543268]
J44 [45543268]
2.4e+00
2.7e+00
—
—
—
3.0e+00
2.1e+00
cases:2.27%
controls:0.20%
cases:1.05%
controls:0.07%
—
—
—
—
—
—
cases:1.20%
controls:0.06%
cases:2.08%
controls:0.27%
52
46
2241
22894
24
16
2269
22924
—
—
—
26
13
2149
22094
37
51
1743
18669
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
O99.3 [45606675]
1.0e+00
2.5e+00
2.7e+00
1.0e+50
—
3.5e+00
1.5e+00
cases:0.57%
controls:0.20%
cases:0.78%
controls:0.07%
cases:0.39%
controls:0.03%
cases:1.44%
controls:0.00%
—
—
cases:2.25%
controls:0.07%
cases:0.96%
controls:0.22%
13
46
2280
22894
18
15
2275
22925
9
6
2284
22934
33
0
2260
22940
—
49
16
2126
22091
17
41
1763
18679
vilanterol, umeclidinium bromide and fluticasone furoate
R03AL08 [1501769]
R03AL08 [1501769]
1.2e+00
1.6e+00
1.8e+00
—
2.8e+00
2.0e+00
2.0e+00
cases:0.44%
controls:0.14%
cases:0.65%
controls:0.13%
cases:0.31%
controls:0.05%
—
—
cases:0.35%
controls:0.02%
cases:0.87%
controls:0.12%
cases:2.08%
controls:0.29%
10
31
2283
22909
15
29
2278
22911
7
12
2286
22928
—
8
5
2276
22880
19
27
2156
22080
37
55
1743
18665
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
9.6e-01
1.2e+00
1.4e+00
2.3e+00
1.6e+00
1.4e+00
1.3e+00
cases:6.89%
controls:2.75%
cases:5.84%
controls:1.82%
cases:2.05%
controls:0.50%
cases:0.31%
controls:0.03%
cases:2.54%
controls:0.52%
cases:6.76%
controls:1.84%
cases:8.88%
controls:2.65%
158
630
2135
22310
134
417
2159
22523
47
115
2246
22825
7
7
2286
22933
58
120
2226
22765
147
407
2028
21700
158
497
1622
18223
Pulmonary Disease
29 [38004472]
29 [38004472]
7.0e-01
1.3e+00
2.3e+00
—
2.6e+00
1.9e+00
1.3e+00
cases:17.23%
controls:9.39%
cases:16.92%
controls:5.10%
cases:7.54%
controls:0.83%
—
—
cases:11.16%
controls:0.90%
cases:25.89%
controls:4.89%
cases:28.31%
controls:10.14%
395
2154
1898
20786
388
1170
1905
21770
173
191
2120
22749
—
255
205
2029
22680
563
1080
1612
21027
504
1899
1276
16821
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
5.6e-01
6.7e-01
1.2e+00
4.0e+00
1.6e+00
1.2e+00
8.7e-01
cases:11.56%
controls:6.97%
cases:4.80%
controls:2.52%
cases:1.57%
controls:0.50%
cases:1.18%
controls:0.02%
cases:2.36%
controls:0.50%
cases:7.77%
controls:2.44%
cases:15.11%
controls:6.97%
265
1598
2028
21342
110
579
2183
22361
36
114
2257
22826
27
5
2266
22935
54
114
2230
22771
169
540
2006
21567
269
1304
1511
17416
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
6.3e-01
9.0e-01
2.7e+00
1.0e+50
2.9e+00
1.5e+00
1.4e+00
cases:3.84%
controls:2.09%
cases:1.70%
controls:0.70%
cases:0.92%
controls:0.06%
cases:2.18%
controls:0.00%
cases:0.92%
controls:0.05%
cases:2.30%
controls:0.54%
cases:7.19%
controls:1.86%
88
479
2205
22461
39
160
2254
22780
21
14
2272
22926
50
0
2243
22940
21
12
2263
22873
50
120
2125
21987
128
348
1652
18372
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
93494-3 [1001926]
1.1e+00
1.1e+00
2.5e+00
1.0e+50
2.6e+00
1.6e+00
1.0e+00
cases:2.57%
controls:0.91%
cases:1.09%
controls:0.35%
cases:0.48%
controls:0.04%
cases:0.35%
controls:0.00%
cases:0.61%
controls:0.04%
cases:1.61%
controls:0.34%
cases:4.21%
controls:1.55%
59
209
2234
22731
25
80
2268
22860
11
9
2282
22931
8
0
2285
22940
14
10
2270
22875
35
75
2140
22032
75
291
1705
18429
Tobacco abuse
P17 [2002000813]
P17 [2002000813]
2.4e+00
2.5e+00
1.0e+50
—
—
2.2e+00
2.9e+00
cases:1.79%
controls:0.17%
cases:0.65%
controls:0.06%
cases:0.35%
controls:0.00%
—
—
—
—
cases:0.60%
controls:0.07%
cases:1.85%
controls:0.10%
41
38
2252
22902
15
13
2278
22927
8
0
2285
22940
—
—
13
15
2162
22092
33
19
1747
18701
ipratropium bromide; inhalant
R03BB01 [21603293]
R03BB01 [21603293]
1.5e+00
2.0e+00
2.1e+00
—
3.0e+00
1.3e+00
1.3e+00
cases:0.92%
controls:0.21%
cases:0.87%
controls:0.11%
cases:0.31%
controls:0.04%
—
—
cases:0.44%
controls:0.02%
cases:0.51%
controls:0.14%
cases:1.07%
controls:0.28%
21
49
2272
22891
20
26
2273
22914
7
9
2286
22931
—
10
5
2274
22880
11
32
2164
22075
19
53
1761
18667
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
2.9e-01
5.1e-01
9.8e-01
4.8e+00
1.6e+00
9.7e-01
7.7e-01
cases:7.24%
controls:5.54%
cases:6.28%
controls:3.88%
cases:2.09%
controls:0.79%
cases:6.50%
controls:0.06%
cases:3.37%
controls:0.73%
cases:9.70%
controls:3.90%
cases:14.94%
controls:7.55%
166
1271
2127
21669
144
891
2149
22049
48
182
2245
22758
149
13
2144
22927
77
166
2207
22719
211
862
1964
21245
266
1414
1514
17306
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
1.0e+00
2.1e+00
3.2e+00
1.0e+50
—
2.2e+00
1.4e+00
cases:1.79%
controls:0.65%
cases:1.31%
controls:0.17%
cases:0.52%
controls:0.02%
cases:0.35%
controls:0.00%
—
—
cases:1.52%
controls:0.17%
cases:2.19%
controls:0.54%
41
150
2252
22790
30
39
2263
22901
12
5
2281
22935
8
0
2285
22940
—
33
38
2142
22069
39
102
1741
18618
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
9.4e-01
1.5e+00
2.3e+00
—
2.4e+00
1.4e+00
1.3e+00
cases:1.53%
controls:0.60%
cases:1.57%
controls:0.37%
cases:0.65%
controls:0.07%
—
—
cases:0.74%
controls:0.07%
cases:1.93%
controls:0.50%
cases:5.96%
controls:1.70%
35
138
2258
22802
36
85
2257
22855
15
15
2278
22925
—
17
16
2267
22869
42
111
2133
21996
106
319
1674
18401
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
R03DA04 [21603332]
1.5e+00
1.6e+00
1.2e+00
—
3.0e+00
1.8e+00
1.8e+00
cases:1.79%
controls:0.41%
cases:1.22%
controls:0.24%
cases:0.22%
controls:0.07%
—
—
cases:0.61%
controls:0.03%
cases:1.47%
controls:0.24%
cases:2.02%
controls:0.35%
41
95
2252
22845
28
56
2265
22884
5
15
2288
22925
—
14
7
2270
22878
32
52
2143
22055
36
65
1744
18655
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
2.8e-01
5.6e-01
1.5e+00
4.2e+00
1.8e+00
7.0e-01
6.1e-01
cases:42.87%
controls:36.10%
cases:39.56%
controls:27.23%
cases:19.49%
controls:4.96%
cases:15.48%
controls:0.28%
cases:22.90%
controls:4.69%
cases:44.74%
controls:28.73%
cases:70.39%
controls:56.27%
983
8282
1310
14658
907
6246
1386
16694
447
1137
1846
21803
355
64
1938
22876
523
1074
1761
21811
973
6351
1202
15756
1253
10533
527
8187
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
C34.12 [2000500601]
C34.12 [2000500601]
2.3e+00
2.8e+00
—
1.0e+50
—
2.8e+00
1.7e+00
cases:0.35%
controls:0.03%
cases:0.57%
controls:0.03%
—
—
cases:0.52%
controls:0.00%
—
—
cases:0.69%
controls:0.04%
cases:0.56%
controls:0.10%
8
8
2285
22932
13
8
2280
22932
—
12
0
2281
22940
—
15
9
2160
22098
10
19
1770
18701
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.5e-01
7.4e-01
2.2e+00
3.1e+00
1.8e+00
8.3e-01
6.2e-01
cases:26.86%
controls:20.49%
cases:19.97%
controls:10.60%
cases:10.55%
controls:1.35%
cases:1.18%
controls:0.05%
cases:7.71%
controls:1.35%
cases:21.75%
controls:10.84%
cases:43.60%
controls:29.38%
616
4701
1677
18239
458
2431
1835
20509
242
310
2051
22630
27
12
2266
22928
176
310
2108
22575
473
2397
1702
19710
776
5500
1004
13220
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
88518-6 [36304997]
6.0e-01
1.2e+00
3.0e+00
—
2.5e+00
1.7e+00
1.3e+00
cases:0.96%
controls:0.53%
cases:0.70%
controls:0.21%
cases:0.44%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:1.06%
controls:0.20%
cases:3.09%
controls:0.87%
22
121
2271
22819
16
49
2277
22891
10
5
2283
22935
—
6
5
2278
22880
23
45
2152
22062
55
163
1725
18557
Hidradenitis suppurativa
L73.2 [45557711]
L73.2 [45557711]
2.6e+00
2.6e+00
—
1.0e+50
—
2.2e+00
2.2e+00
cases:0.83%
controls:0.06%
cases:0.61%
controls:0.04%
—
—
cases:0.39%
controls:0.00%
—
—
cases:0.51%
controls:0.06%
cases:1.12%
controls:0.13%
19
14
2274
22926
14
10
2279
22930
—
9
0
2284
22940
—
11
13
2164
22094
20
24
1760
18696
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
6.8e-01
1.1e+00
1.5e+00
2.7e+00
1.5e+00
1.1e+00
1.0e+00
cases:27.47%
controls:16.12%
cases:20.50%
controls:7.73%
cases:5.80%
controls:1.29%
cases:0.70%
controls:0.05%
cases:5.78%
controls:1.40%
cases:20.05%
controls:7.82%
cases:36.63%
controls:17.28%
630
3697
1663
19243
470
1774
1823
21166
133
297
2160
22643
16
11
2277
22929
132
321
2152
22564
436
1729
1739
20378
652
3234
1128
15486
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.7e+00
1.9e+00
1.7e+00
—
2.1e+00
1.8e+00
2.0e+00
cases:1.48%
controls:0.26%
cases:0.96%
controls:0.14%
cases:0.31%
controls:0.06%
—
—
cases:0.48%
controls:0.06%
cases:0.74%
controls:0.12%
cases:1.74%
controls:0.24%
34
60
2259
22880
22
32
2271
22908
7
13
2286
22927
—
11
14
2273
22871
16
26
2159
22081
31
45
1749
18675
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
2.8e-01
5.6e-01
1.5e+00
4.2e+00
1.8e+00
6.9e-01
6.0e-01
cases:43.13%
controls:36.41%
cases:39.95%
controls:27.58%
cases:19.41%
controls:5.03%
cases:14.70%
controls:0.27%
cases:22.99%
controls:4.78%
cases:44.97%
controls:29.07%
cases:70.39%
controls:56.68%
989
8352
1304
14588
916
6326
1377
16614
445
1154
1848
21786
337
62
1956
22878
525
1095
1759
21790
978
6426
1197
15681
1253
10611
527
8109
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
5.3e-01
1.4e+00
2.1e+00
1.0e+50
2.8e+00
1.7e+00
1.1e+00
cases:2.83%
controls:1.68%
cases:2.88%
controls:0.74%
cases:0.87%
controls:0.11%
cases:1.48%
controls:0.00%
cases:1.58%
controls:0.10%
cases:4.18%
controls:0.81%
cases:8.15%
controls:2.83%
65
386
2228
22554
66
169
2227
22771
20
25
2273
22915
34
0
2259
22940
36
23
2248
22862
91
178
2084
21929
145
529
1635
18191
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.9e-01
6.6e-01
1.9e+00
3.3e+00
1.5e+00
9.4e-01
8.7e-01
cases:17.23%
controls:12.32%
cases:14.09%
controls:7.83%
cases:8.46%
controls:1.40%
cases:1.09%
controls:0.04%
cases:6.09%
controls:1.44%
cases:17.79%
controls:7.80%
cases:34.94%
controls:18.43%
395
2827
1898
20113
323
1797
1970
21143
194
322
2099
22618
25
9
2268
22931
139
330
2145
22555
387
1724
1788
20383
622
3450
1158
15270
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.9e-01
6.6e-01
1.9e+00
3.3e+00
1.5e+00
9.3e-01
8.7e-01
cases:17.14%
controls:12.29%
cases:14.09%
controls:7.80%
cases:8.46%
controls:1.41%
cases:1.09%
controls:0.04%
cases:6.09%
controls:1.43%
cases:17.70%
controls:7.79%
cases:34.78%
controls:18.33%
393
2819
1900
20121
323
1789
1970
21151
194
323
2099
22617
25
9
2268
22931
139
328
2145
22557
385
1722
1790
20385
619
3431
1161
15289
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
5.3e-01
1.4e+00
2.1e+00
1.0e+50
2.7e+00
1.7e+00
1.1e+00
cases:2.83%
controls:1.68%
cases:2.88%
controls:0.74%
cases:0.87%
controls:0.11%
cases:1.48%
controls:0.00%
cases:1.58%
controls:0.10%
cases:4.18%
controls:0.81%
cases:8.15%
controls:2.83%
65
386
2228
22554
66
169
2227
22771
20
25
2273
22915
34
0
2259
22940
36
24
2248
22861
91
178
2084
21929
145
529
1635
18191
False labour before 37 completed weeks of gestation
O47.0 [45582556]
O47.0 [45582556]
5.2e-01
1.4e+00
2.9e+00
—
3.3e+00
1.9e+00
2.0e-01
cases:1.66%
controls:0.99%
cases:1.18%
controls:0.30%
cases:0.57%
controls:0.03%
—
—
cases:0.57%
controls:0.02%
cases:1.93%
controls:0.28%
cases:1.35%
controls:1.11%
38
228
2255
22712
27
69
2266
22871
13
7
2280
22933
—
13
5
2271
22880
42
62
2133
22045
24
208
1756
18512
Psychiatry
26 [38004469]
26 [38004469]
9.6e-01
1.0e+00
1.1e+00
2.9e+00
1.3e+00
1.2e+00
1.1e+00
cases:17.18%
controls:7.35%
cases:10.03%
controls:3.78%
cases:4.80%
controls:1.63%
cases:1.66%
controls:0.10%
cases:5.43%
controls:1.61%
cases:10.94%
controls:3.72%
cases:18.65%
controls:7.02%
394
1687
1899
21253
230
868
2063
22072
110
373
2183
22567
38
22
2255
22918
124
368
2160
22517
238
822
1937
21285
332
1315
1448
17405
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
6.0e-01
1.6e+00
2.1e+00
1.0e+50
2.4e+00
1.5e+00
1.2e+00
cases:1.66%
controls:0.92%
cases:1.79%
controls:0.37%
cases:0.48%
controls:0.06%
cases:0.48%
controls:0.00%
cases:0.66%
controls:0.06%
cases:1.98%
controls:0.44%
cases:5.34%
controls:1.63%
38
211
2255
22729
41
84
2252
22856
11
13
2282
22927
11
0
2282
22940
15
14
2269
22871
43
98
2132
22009
95
306
1685
18414
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
4.0e-01
6.6e-01
1.8e+00
3.2e+00
1.5e+00
9.5e-01
8.6e-01
cases:18.10%
controls:12.94%
cases:14.57%
controls:8.06%
cases:8.68%
controls:1.47%
cases:1.09%
controls:0.04%
cases:6.26%
controls:1.52%
cases:18.48%
controls:8.06%
cases:35.90%
controls:19.15%
415
2968
1878
19972
334
1850
1959
21090
199
338
2094
22602
25
10
2268
22930
143
348
2141
22537
402
1782
1773
20325
639
3584
1141
15136
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
5.4e-01
1.4e+00
2.0e+00
1.0e+50
2.8e+00
1.6e+00
1.1e+00
cases:2.83%
controls:1.68%
cases:2.83%
controls:0.75%
cases:0.83%
controls:0.11%
cases:1.40%
controls:0.00%
cases:1.58%
controls:0.10%
cases:4.05%
controls:0.81%
cases:8.43%
controls:2.91%
65
385
2228
22555
65
172
2228
22768
19
26
2274
22914
32
0
2261
22940
36
23
2248
22862
88
180
2087
21927
150
545
1630
18175
indacaterol; inhalant
R03AC18 [21603272]
R03AC18 [21603272]
2.0e+00
2.7e+00
—
—
—
2.3e+00
2.4e+00
cases:0.48%
controls:0.07%
cases:0.39%
controls:0.03%
—
—
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.51%
controls:0.05%
11
15
2282
22925
9
6
2284
22934
—
—
—
5
5
2170
22102
9
9
1771
18711
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.8e-01
6.2e-01
1.8e+00
3.3e+00
1.5e+00
9.1e-01
8.4e-01
cases:17.92%
controls:13.00%
cases:14.22%
controls:8.16%
cases:8.46%
controls:1.46%
cases:1.09%
controls:0.04%
cases:6.09%
controls:1.47%
cases:18.07%
controls:8.16%
cases:35.45%
controls:19.12%
411
2983
1882
19957
326
1871
1967
21069
194
336
2099
22604
25
9
2268
22931
139
337
2145
22548
393
1803
1782
20304
631
3579
1149
15141
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.7e-01
1.3e+00
2.0e+00
1.0e+50
2.7e+00
1.6e+00
1.1e+00
cases:2.92%
controls:1.68%
cases:2.66%
controls:0.74%
cases:0.78%
controls:0.10%
cases:1.31%
controls:0.00%
cases:1.53%
controls:0.10%
cases:3.91%
controls:0.80%
cases:8.48%
controls:2.88%
67
385
2226
22555
61
169
2232
22771
18
24
2275
22916
30
0
2263
22940
35
24
2249
22861
85
176
2090
21931
151
540
1629
18180
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
7.5e-01
1.3e+00
2.1e+00
—
2.3e+00
1.6e+00
1.3e+00
cases:1.88%
controls:0.89%
cases:1.61%
controls:0.44%
cases:0.65%
controls:0.08%
—
—
cases:0.88%
controls:0.09%
cases:2.62%
controls:0.54%
cases:7.13%
controls:2.04%
43
205
2250
22735
37
102
2256
22838
15
19
2278
22921
—
20
20
2264
22865
57
119
2118
21988
127
382
1653
18338
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
9.4e-01
1.1e+00
2.2e+00
—
2.3e+00
1.5e+00
1.2e+00
cases:3.14%
controls:1.25%
cases:1.96%
controls:0.64%
cases:0.96%
controls:0.10%
—
—
cases:1.05%
controls:0.10%
cases:3.31%
controls:0.76%
cases:8.26%
controls:2.55%
72
287
2221
22653
45
146
2248
22794
22
24
2271
22916
—
24
24
2260
22861
72
169
2103
21938
147
477
1633
18243
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
4.1e-01
6.5e-01
1.9e+00
3.1e+00
1.5e+00
9.3e-01
8.0e-01
cases:16.44%
controls:11.59%
cases:12.91%
controls:7.18%
cases:7.94%
controls:1.31%
cases:1.00%
controls:0.04%
cases:5.91%
controls:1.35%
cases:16.60%
controls:7.26%
cases:31.01%
controls:16.75%
377
2659
1916
20281
296
1647
1997
21293
182
301
2111
22639
23
10
2270
22930
135
309
2149
22576
361
1606
1814
20501
552
3136
1228
15584
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
4.0e-01
6.5e-01
1.9e+00
3.1e+00
1.5e+00
9.3e-01
8.0e-01
cases:16.44%
controls:11.64%
cases:12.87%
controls:7.16%
cases:7.94%
controls:1.31%
cases:1.00%
controls:0.04%
cases:5.91%
controls:1.35%
cases:16.60%
controls:7.26%
cases:30.96%
controls:16.78%
377
2670
1916
20270
295
1642
1998
21298
182
301
2111
22639
23
10
2270
22930
135
308
2149
22577
361
1604
1814
20503
551
3142
1229
15578
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
4.0e-01
6.4e-01
1.9e+00
3.1e+00
1.5e+00
9.2e-01
8.0e-01
cases:16.35%
controls:11.56%
cases:12.82%
controls:7.18%
cases:7.94%
controls:1.31%
cases:1.00%
controls:0.04%
cases:6.00%
controls:1.35%
cases:16.41%
controls:7.24%
cases:30.96%
controls:16.78%
375
2651
1918
20289
294
1646
1999
21294
182
300
2111
22640
23
10
2270
22930
137
309
2147
22576
357
1601
1818
20506
551
3142
1229
15578
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
6.6e-01
1.3e+00
2.0e+00
1.0e+50
2.5e+00
1.6e+00
1.2e+00
cases:2.66%
controls:1.39%
cases:2.40%
controls:0.64%
cases:0.78%
controls:0.10%
cases:1.35%
controls:0.00%
cases:1.27%
controls:0.10%
cases:3.72%
controls:0.76%
cases:7.81%
controls:2.59%
61
318
2232
22622
55
147
2238
22793
18
24
2275
22916
31
0
2262
22940
29
24
2255
22861
81
167
2094
21940
139
485
1641
18235
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
2.7e-01
7.8e-01
1.5e+00
3.8e+00
1.7e+00
7.3e-01
5.7e-01
cases:14.17%
controls:11.16%
cases:12.52%
controls:6.18%
cases:3.79%
controls:0.89%
cases:1.13%
controls:0.03%
cases:4.51%
controls:0.85%
cases:12.74%
controls:6.57%
cases:30.84%
controls:20.07%
325
2561
1968
20379
287
1418
2006
21522
87
205
2206
22735
26
6
2267
22934
103
195
2181
22690
277
1452
1898
20655
549
3758
1231
14962
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
8.6e-01
1.5e+00
2.0e+00
—
2.2e+00
1.5e+00
1.4e+00
cases:1.53%
controls:0.65%
cases:1.48%
controls:0.34%
cases:0.52%
controls:0.07%
—
—
cases:0.66%
controls:0.07%
cases:1.98%
controls:0.46%
cases:5.67%
controls:1.53%
35
149
2258
22791
34
79
2259
22861
12
17
2281
22923
—
15
17
2269
22868
43
101
2132
22006
101
287
1679
18433
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.4e-01
5.1e-01
1.7e+00
4.1e+00
1.6e+00
6.7e-01
5.2e-01
cases:46.23%
controls:40.38%
cases:44.66%
controls:32.53%
cases:26.52%
controls:6.43%
cases:15.70%
controls:0.31%
cases:24.69%
controls:6.20%
cases:50.30%
controls:34.17%
cases:74.33%
controls:63.36%
1060
9263
1233
13677
1024
7463
1269
15477
608
1474
1685
21466
360
70
1933
22870
564
1418
1720
21467
1094
7553
1081
14554
1323
11861
457
6859
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.8e-01
6.5e-01
1.7e+00
3.3e+00
1.4e+00
9.5e-01
8.5e-01
cases:20.19%
controls:14.76%
cases:16.53%
controls:9.37%
cases:10.86%
controls:2.11%
cases:1.70%
controls:0.06%
cases:8.06%
controls:2.15%
cases:20.97%
controls:9.34%
cases:38.31%
controls:20.90%
463
3387
1830
19553
379
2150
1914
20790
249
483
2044
22457
39
14
2254
22926
184
493
2100
22392
456
2065
1719
20042
682
3913
1098
14807
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
2.7e-01
7.7e-01
1.4e+00
3.8e+00
1.7e+00
7.2e-01
5.9e-01
cases:14.26%
controls:11.25%
cases:12.56%
controls:6.25%
cases:3.71%
controls:0.90%
cases:1.13%
controls:0.03%
cases:4.55%
controls:0.85%
cases:12.64%
controls:6.61%
cases:31.40%
controls:20.17%
327
2581
1966
20359
288
1433
2005
21507
85
207
2208
22733
26
6
2267
22934
104
195
2180
22690
275
1461
1900
20646
559
3776
1221
14944
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.7e-01
5.7e-01
1.1e+00
3.9e+00
1.5e+00
1.0e+00
8.1e-01
cases:14.30%
controls:10.31%
cases:10.03%
controls:5.93%
cases:5.19%
controls:1.73%
cases:5.67%
controls:0.12%
cases:6.87%
controls:1.70%
cases:14.02%
controls:5.68%
cases:27.42%
controls:14.42%
328
2366
1965
20574
230
1361
2063
21579
119
396
2174
22544
130
27
2163
22913
157
388
2127
22497
305
1255
1870
20852
488
2700
1292
16020
Monitoring of normal pregnancy
SPAT1196 [2001700297]
SPAT1196 [2001700297]
-1.0e-01
1.5e+00
2.8e+00
—
3.1e+00
1.9e+00
5.4e-01
cases:1.26%
controls:1.40%
cases:1.92%
controls:0.41%
cases:1.40%
controls:0.09%
—
—
cases:1.66%
controls:0.08%
cases:2.16%
controls:0.34%
cases:1.57%
controls:0.92%
29
321
2264
22619
44
95
2249
22845
32
20
2261
22920
—
38
18
2246
22867
47
76
2128
22031
28
172
1752
18548
Gestational diabetes
W85 [2002001276]
W85 [2002001276]
-3.6e-01
1.3e+00
3.3e+00
—
3.1e+00
1.5e+00
7.5e-01
cases:0.35%
controls:0.50%
cases:0.70%
controls:0.18%
cases:0.61%
controls:0.02%
—
—
cases:0.57%
controls:0.03%
cases:0.69%
controls:0.16%
cases:1.29%
controls:0.61%
8
115
2285
22825
16
42
2277
22898
14
5
2279
22935
—
13
6
2271
22879
15
35
2160
22072
23
115
1757
18605
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
2.9e-01
7.8e-01
1.5e+00
3.7e+00
1.7e+00
7.6e-01
5.9e-01
cases:11.73%
controls:9.06%
cases:9.77%
controls:4.73%
cases:2.70%
controls:0.65%
cases:1.00%
controls:0.03%
cases:3.37%
controls:0.64%
cases:9.84%
controls:4.88%
cases:24.72%
controls:15.35%
269
2078
2024
20862
224
1084
2069
21856
62
148
2231
22792
23
6
2270
22934
77
146
2207
22739
214
1078
1961
21029
440
2874
1340
15846
Cocaine [Presence] in Urine
3397-7 [3016879]
3397-7 [3016879]
1.1e+00
9.6e-01
2.5e+00
1.0e+50
2.3e+00
1.4e+00
9.3e-01
cases:2.97%
controls:1.05%
cases:1.18%
controls:0.45%
cases:0.48%
controls:0.04%
cases:0.35%
controls:0.00%
cases:0.61%
controls:0.06%
cases:1.66%
controls:0.39%
cases:4.38%
controls:1.77%
68
242
2225
22698
27
104
2266
22836
11
9
2282
22931
8
0
2285
22940
14
14
2270
22871
36
87
2139
22020
78
331
1702
18389
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
2.5e-01
7.6e-01
1.5e+00
3.7e+00
1.7e+00
7.2e-01
5.7e-01
cases:13.74%
controls:11.02%
cases:12.17%
controls:6.09%
cases:3.71%
controls:0.88%
cases:1.09%
controls:0.03%
cases:4.47%
controls:0.85%
cases:12.41%
controls:6.46%
cases:30.45%
controls:19.78%
315
2529
1978
20411
279
1397
2014
21543
85
201
2208
22739
25
6
2268
22934
102
195
2182
22690
270
1429
1905
20678
542
3702
1238
15018
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
3.5e-01
6.2e-01
1.9e+00
3.2e+00
1.6e+00
8.9e-01
7.4e-01
cases:15.87%
controls:11.74%
cases:12.69%
controls:7.26%
cases:7.94%
controls:1.32%
cases:0.92%
controls:0.04%
cases:6.00%
controls:1.31%
cases:16.41%
controls:7.44%
cases:30.45%
controls:17.24%
364
2694
1929
20246
291
1665
2002
21275
182
303
2111
22637
21
9
2272
22931
137
300
2147
22585
357
1644
1818
20463
542
3227
1238
15493
Chronic kidney disease, stage 5
N18.5 [45582394]
N18.5 [45582394]
—
2.2e+00
2.5e+00
—
2.5e+00
2.0e+00
—
—
—
cases:0.31%
controls:0.03%
cases:0.26%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.28%
controls:0.04%
—
—
—
7
8
2286
22932
6
5
2287
22935
—
6
5
2278
22880
6
8
2169
22099
—
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
2.6e-01
5.3e-01
1.4e+00
3.9e+00
1.8e+00
6.8e-01
6.0e-01
cases:10.03%
controls:7.94%
cases:6.54%
controls:3.94%
cases:2.18%
controls:0.54%
cases:1.05%
controls:0.02%
cases:3.24%
controls:0.55%
cases:7.36%
controls:3.86%
cases:18.76%
controls:11.21%
230
1822
2063
21118
150
904
2143
22036
50
124
2243
22816
24
5
2269
22935
74
127
2210
22758
160
854
2015
21253
334
2099
1446
16621
The fear of childbirth
O99.80 [2000503219]
O99.80 [2000503219]
-2.1e-01
1.3e+00
2.6e+00
—
2.9e+00
2.4e+00
5.0e-01
cases:0.44%
controls:0.54%
cases:0.70%
controls:0.20%
cases:0.57%
controls:0.04%
—
—
cases:0.92%
controls:0.05%
cases:1.70%
controls:0.15%
cases:1.12%
controls:0.68%
10
123
2283
22817
16
45
2277
22895
13
10
2280
22930
—
21
12
2263
22873
37
34
2138
22073
20
128
1760
18592
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
8.8e-01
1.7e+00
1.8e+00
—
2.2e+00
2.1e+00
1.4e+00
cases:0.57%
controls:0.24%
cases:0.61%
controls:0.12%
cases:0.39%
controls:0.07%
—
—
cases:0.44%
controls:0.05%
cases:0.74%
controls:0.09%
cases:0.73%
controls:0.19%
13
54
2280
22886
14
27
2279
22913
9
15
2284
22925
—
10
11
2274
22874
16
20
2159
22087
13
35
1767
18685
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.1e-01
4.8e-01
1.6e+00
3.9e+00
1.7e+00
6.7e-01
5.2e-01
cases:43.35%
controls:38.24%
cases:36.07%
controls:25.81%
cases:19.01%
controls:4.49%
cases:9.94%
controls:0.21%
cases:18.96%
controls:4.18%
cases:40.41%
controls:25.86%
cases:67.70%
controls:55.42%
994
8772
1299
14168
827
5921
1466
17019
436
1030
1857
21910
228
49
2065
22891
433
956
1851
21929
879
5716
1296
16391
1205
10374
575
8346
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.5e-01
6.1e-01
1.8e+00
3.1e+00
1.5e+00
8.8e-01
7.7e-01
cases:16.35%
controls:12.10%
cases:12.95%
controls:7.46%
cases:7.85%
controls:1.36%
cases:1.00%
controls:0.04%
cases:6.00%
controls:1.38%
cases:16.60%
controls:7.66%
cases:31.63%
controls:17.58%
375
2776
1918
20164
297
1711
1996
21229
180
313
2113
22627
23
10
2270
22930
137
315
2147
22570
361
1693
1814
20414
563
3291
1217
15429
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
1.1e+00
1.2e+00
2.2e+00
1.0e+50
2.4e+00
1.3e+00
9.2e-01
cases:2.31%
controls:0.76%
cases:1.13%
controls:0.35%
cases:0.39%
controls:0.04%
cases:0.35%
controls:0.00%
cases:0.61%
controls:0.06%
cases:1.29%
controls:0.37%
cases:3.71%
controls:1.51%
53
175
2240
22765
26
80
2267
22860
9
10
2284
22930
8
0
2285
22940
14
13
2270
22872
28
81
2147
22026
66
282
1714
18438
Supervision of high-risk pregnancy due to social problems
Z35.7 [45561625]
Z35.7 [45561625]
2.3e+00
3.5e+00
1.0e+50
1.0e+50
—
—
3.2e+00
cases:0.26%
controls:0.03%
cases:0.74%
controls:0.02%
cases:0.26%
controls:0.00%
cases:1.13%
controls:0.00%
—
—
—
—
cases:0.67%
controls:0.03%
6
6
2287
22934
17
5
2276
22935
6
0
2287
22940
26
0
2267
22940
—
—
12
5
1768
18715
umeclidinium bromide; inhalant
R03BB07 [45893265]
R03BB07 [45893265]
1.7e+00
2.2e+00
—
—
—
2.9e+00
2.2e+00
cases:0.35%
controls:0.06%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.60%
controls:0.03%
cases:0.67%
controls:0.07%
8
14
2285
22926
7
8
2286
22932
—
—
—
13
7
2162
22100
12
14
1768
18706
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.4e-01
7.5e-01
1.8e+00
3.4e+00
1.5e+00
7.7e-01
6.4e-01
cases:22.55%
controls:18.57%
cases:18.10%
controls:9.49%
cases:7.81%
controls:1.39%
cases:1.61%
controls:0.06%
cases:5.82%
controls:1.35%
cases:18.44%
controls:9.45%
cases:40.06%
controls:26.05%
517
4259
1776
18681
415
2178
1878
20762
179
320
2114
22620
37
13
2256
22927
133
309
2151
22576
401
2089
1774
20018
713
4877
1067
13843
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
1.1e+00
1.3e+00
2.0e+00
—
1.9e+00
1.7e+00
1.0e+00
cases:1.88%
controls:0.62%
cases:1.22%
controls:0.32%
cases:0.61%
controls:0.08%
—
—
cases:0.61%
controls:0.09%
cases:1.33%
controls:0.26%
cases:2.47%
controls:0.89%
43
142
2250
22798
28
74
2265
22866
14
19
2279
22921
—
14
21
2270
22864
29
57
2146
22050
44
167
1736
18553
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
3.0e-01
5.7e-01
1.4e+00
4.0e+00
1.9e+00
5.2e-01
4.2e-01
cases:9.73%
controls:7.36%
cases:6.80%
controls:3.98%
cases:2.31%
controls:0.58%
cases:1.13%
controls:0.02%
cases:3.33%
controls:0.54%
cases:6.94%
controls:4.23%
cases:17.92%
controls:12.55%
223
1688
2070
21252
156
913
2137
22027
53
132
2240
22808
26
5
2267
22935
76
123
2208
22762
151
935
2024
21172
319
2349
1461
16371
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
6.5e-01
1.3e+00
2.0e+00
1.0e+50
2.8e+00
1.4e+00
8.7e-01
cases:1.44%
controls:0.76%
cases:1.35%
controls:0.36%
cases:0.35%
controls:0.05%
cases:0.78%
controls:0.00%
cases:0.92%
controls:0.06%
cases:1.70%
controls:0.43%
cases:3.43%
controls:1.46%
33
174
2260
22766
31
83
2262
22857
8
11
2285
22929
18
0
2275
22940
21
13
2263
22872
37
94
2138
22013
61
273
1719
18447
Obesity due to excess calories
E66.01 [2000501501]
E66.01 [2000501501]
6.2e-01
1.0e+00
1.5e+00
1.0e+50
2.9e+00
1.9e+00
1.1e+00
cases:2.49%
controls:1.36%
cases:2.14%
controls:0.79%
cases:0.61%
controls:0.14%
cases:5.58%
controls:0.00%
cases:2.19%
controls:0.13%
cases:5.10%
controls:0.78%
cases:6.24%
controls:2.08%
57
311
2236
22629
49
181
2244
22759
14
33
2279
22907
128
0
2165
22940
50
29
2234
22856
111
173
2064
21934
111
390
1669
18330
Pustulosis palmaris et plantaris
L40.3 [45591634]
L40.3 [45591634]
2.0e+00
2.7e+00
—
1.0e+50
—
2.4e+00
1.9e+00
cases:0.87%
controls:0.11%
cases:0.70%
controls:0.05%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.69%
controls:0.06%
cases:0.96%
controls:0.15%
20
26
2273
22914
16
11
2277
22929
—
7
0
2286
22940
—
15
14
2160
22093
17
28
1763
18692
Endocrinology
46 [38004485]
46 [38004485]
3.7e-01
5.8e-01
4.0e-01
5.4e+00
9.2e-01
9.1e-01
7.4e-01
cases:6.59%
controls:4.63%
cases:5.32%
controls:3.05%
cases:0.96%
controls:0.65%
cases:4.80%
controls:0.02%
cases:1.75%
controls:0.70%
cases:7.03%
controls:2.97%
cases:11.01%
controls:5.60%
151
1062
2142
21878
122
699
2171
22241
22
148
2271
22792
110
5
2183
22935
40
161
2244
22724
153
656
2022
21451
196
1048
1584
17672
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
3390-2 [3000764]
1.0e+00
1.0e+00
2.3e+00
1.0e+50
2.3e+00
1.4e+00
8.9e-01
cases:3.05%
controls:1.12%
cases:1.26%
controls:0.46%
cases:0.48%
controls:0.05%
cases:0.35%
controls:0.00%
cases:0.66%
controls:0.07%
cases:1.70%
controls:0.43%
cases:4.44%
controls:1.88%
70
257
2223
22683
29
105
2264
22835
11
11
2282
22929
8
0
2285
22940
15
15
2269
22870
37
94
2138
22013
79
351
1701
18369
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
5.4e-01
1.5e+00
2.0e+00
1.0e+50
2.3e+00
1.8e+00
1.3e+00
cases:1.70%
controls:1.00%
cases:1.44%
controls:0.34%
cases:0.39%
controls:0.05%
cases:0.44%
controls:0.00%
cases:0.53%
controls:0.05%
cases:2.16%
controls:0.36%
cases:5.11%
controls:1.41%
39
230
2254
22710
33
77
2260
22863
9
12
2284
22928
10
0
2283
22940
12
12
2272
22873
47
79
2128
22028
91
264
1689
18456
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
8.2e-01
9.6e-01
2.1e+00
—
2.6e+00
1.4e+00
1.0e+00
cases:1.48%
controls:0.66%
cases:0.87%
controls:0.34%
cases:0.44%
controls:0.05%
—
—
cases:0.70%
controls:0.05%
cases:1.79%
controls:0.45%
cases:4.49%
controls:1.67%
34
151
2259
22789
20
77
2273
22863
10
12
2283
22928
—
16
12
2268
22873
39
99
2136
22008
80
312
1700
18408
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
9.8e-01
1.3e+00
2.1e+00
—
1.9e+00
1.6e+00
1.2e+00
cases:4.49%
controls:1.74%
cases:2.31%
controls:0.64%
cases:1.05%
controls:0.14%
—
—
cases:0.83%
controls:0.13%
cases:2.53%
controls:0.54%
cases:5.45%
controls:1.77%
103
399
2190
22541
53
147
2240
22793
24
31
2269
22909
—
19
30
2265
22855
55
120
2120
21987
97
332
1683
18388
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.5e-01
4.7e-01
1.6e+00
4.0e+00
1.6e+00
6.4e-01
4.1e-01
cases:49.45%
controls:45.60%
cases:49.15%
controls:37.68%
cases:29.66%
controls:7.89%
cases:16.70%
controls:0.35%
cases:29.20%
controls:7.72%
cases:55.31%
controls:39.39%
cases:77.70%
controls:69.90%
1134
10460
1159
12480
1127
8644
1166
14296
680
1810
1613
21130
383
81
1910
22859
667
1767
1617
21118
1203
8709
972
13398
1383
13085
397
5635
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.5e-01
4.7e-01
1.6e+00
4.0e+00
1.6e+00
6.5e-01
4.1e-01
cases:49.32%
controls:45.48%
cases:49.02%
controls:37.59%
cases:29.66%
controls:7.89%
cases:16.70%
controls:0.36%
cases:29.20%
controls:7.70%
cases:55.31%
controls:39.35%
cases:77.70%
controls:69.79%
1131
10433
1162
12507
1124
8623
1169
14317
680
1809
1613
21131
383
82
1910
22858
667
1763
1617
21122
1203
8700
972
13407
1383
13065
397
5655
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.5e-01
4.7e-01
1.6e+00
4.0e+00
1.6e+00
6.5e-01
4.0e-01
cases:49.54%
controls:45.71%
cases:49.24%
controls:37.75%
cases:29.87%
controls:7.93%
cases:16.75%
controls:0.36%
cases:29.29%
controls:7.75%
cases:55.45%
controls:39.49%
cases:77.70%
controls:69.99%
1136
10486
1157
12454
1129
8659
1164
14281
685
1818
1608
21122
384
82
1909
22858
669
1774
1615
21111
1206
8729
969
13378
1383
13103
397
5617
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.6e-01
4.7e-01
1.6e+00
4.0e+00
1.6e+00
6.4e-01
4.1e-01
cases:49.45%
controls:45.54%
cases:49.15%
controls:37.62%
cases:29.61%
controls:7.88%
cases:16.70%
controls:0.36%
cases:29.16%
controls:7.71%
cases:55.26%
controls:39.38%
cases:77.70%
controls:69.87%
1134
10447
1159
12493
1127
8629
1166
14311
679
1807
1614
21133
383
82
1910
22858
666
1765
1618
21120
1202
8706
973
13401
1383
13080
397
5640
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.5e-01
4.7e-01
1.6e+00
4.0e+00
1.6e+00
6.4e-01
4.1e-01
cases:49.41%
controls:45.62%
cases:49.15%
controls:37.71%
cases:29.70%
controls:7.91%
cases:16.75%
controls:0.36%
cases:29.25%
controls:7.74%
cases:55.31%
controls:39.43%
cases:77.70%
controls:69.91%
1133
10465
1160
12475
1127
8650
1166
14290
681
1815
1612
21125
384
82
1909
22858
668
1772
1616
21113
1203
8717
972
13390
1383
13087
397
5633
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.5e-01
4.7e-01
1.6e+00
4.0e+00
1.6e+00
6.4e-01
4.0e-01
cases:49.45%
controls:45.61%
cases:49.15%
controls:37.70%
cases:29.66%
controls:7.90%
cases:16.70%
controls:0.36%
cases:29.16%
controls:7.73%
cases:55.36%
controls:39.44%
cases:77.70%
controls:69.95%
1134
10463
1159
12477
1127
8649
1166
14291
680
1813
1613
21127
383
82
1910
22858
666
1769
1618
21116
1204
8720
971
13387
1383
13095
397
5625
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
9.6e-01
1.4e+00
2.3e+00
—
1.9e+00
1.1e+00
1.2e+00
cases:6.72%
controls:2.67%
cases:3.53%
controls:0.91%
cases:1.26%
controls:0.12%
—
—
cases:1.09%
controls:0.17%
cases:3.17%
controls:1.10%
cases:11.35%
controls:3.71%
154
613
2139
22327
81
209
2212
22731
29
28
2264
22912
—
25
38
2259
22847
69
243
2106
21864
202
695
1578
18025
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.6e-01
4.6e-01
1.6e+00
4.0e+00
1.6e+00
6.4e-01
4.0e-01
cases:49.63%
controls:45.67%
cases:49.06%
controls:37.73%
cases:29.66%
controls:7.92%
cases:16.70%
controls:0.36%
cases:29.20%
controls:7.79%
cases:55.36%
controls:39.45%
cases:77.75%
controls:69.99%
1138
10476
1155
12464
1125
8656
1168
14284
680
1817
1613
21123
383
82
1910
22858
667
1782
1617
21103
1204
8722
971
13385
1384
13103
396
5617
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
4.9e-01
6.6e-01
1.2e+00
3.3e+00
1.5e+00
8.1e-01
8.3e-01
cases:17.44%
controls:11.45%
cases:11.56%
controls:6.36%
cases:4.14%
controls:1.25%
cases:1.66%
controls:0.06%
cases:5.39%
controls:1.21%
cases:13.47%
controls:6.45%
cases:32.30%
controls:17.24%
400
2627
1893
20313
265
1458
2028
21482
95
287
2198
22653
38
14
2255
22926
123
277
2161
22608
293
1427
1882
20680
575
3227
1205
15493
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
F10.26 [2000501683]
2.0e+00
2.2e+00
—
—
—
2.4e+00
2.3e+00
cases:1.31%
controls:0.17%
cases:0.52%
controls:0.06%
—
—
—
—
—
—
cases:0.74%
controls:0.07%
cases:1.40%
controls:0.14%
30
40
2263
22900
12
14
2281
22926
—
—
—
16
15
2159
22092
25
27
1755
18693
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
4.0e-01
5.0e-01
1.8e+00
3.0e+00
1.5e+00
8.6e-01
7.8e-01
cases:10.82%
controls:7.55%
cases:8.02%
controls:5.00%
cases:5.49%
controls:0.91%
cases:0.70%
controls:0.03%
cases:4.07%
controls:0.97%
cases:10.80%
controls:4.89%
cases:20.96%
controls:10.82%
248
1731
2045
21209
184
1148
2109
21792
126
209
2167
22731
16
8
2277
22932
93
223
2191
22662
235
1082
1940
21025
373
2025
1407
16695
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
8.7e-01
1.1e+00
2.3e+00
—
2.2e+00
1.2e+00
1.1e+00
cases:1.79%
controls:0.75%
cases:1.00%
controls:0.34%
cases:0.44%
controls:0.04%
—
—
cases:0.48%
controls:0.05%
cases:1.38%
controls:0.40%
cases:3.37%
controls:1.19%
41
173
2252
22767
23
78
2270
22862
10
10
2283
22930
—
11
12
2273
22873
30
89
2145
22018
60
222
1720
18498
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
8.0e-01
9.5e-01
2.1e+00
—
2.5e+00
1.4e+00
1.0e+00
cases:1.48%
controls:0.67%
cases:0.87%
controls:0.34%
cases:0.44%
controls:0.05%
—
—
cases:0.70%
controls:0.06%
cases:1.79%
controls:0.46%
cases:4.66%
controls:1.75%
34
154
2259
22786
20
78
2273
22862
10
12
2283
22928
—
16
13
2268
22872
39
101
2136
22006
83
327
1697
18393
Opiates [Presence] in Urine
3879-4 [3027008]
3879-4 [3027008]
9.9e-01
9.0e-01
2.3e+00
1.0e+50
2.3e+00
1.4e+00
8.6e-01
cases:3.01%
controls:1.14%
cases:1.13%
controls:0.47%
cases:0.48%
controls:0.05%
cases:0.35%
controls:0.00%
cases:0.66%
controls:0.07%
cases:1.70%
controls:0.43%
cases:4.33%
controls:1.88%
69
261
2224
22679
26
107
2267
22833
11
11
2282
22929
8
0
2285
22940
15
15
2269
22870
37
94
2138
22013
77
352
1703
18368
Cannabinoids [Presence] in Urine
3427-2 [3028300]
3427-2 [3028300]
1.0e+00
9.3e-01
2.3e+00
1.0e+50
2.2e+00
1.4e+00
8.8e-01
cases:3.05%
controls:1.13%
cases:1.18%
controls:0.47%
cases:0.48%
controls:0.05%
cases:0.35%
controls:0.00%
cases:0.61%
controls:0.07%
cases:1.66%
controls:0.43%
cases:4.44%
controls:1.89%
70
260
2223
22680
27
107
2266
22833
11
11
2282
22929
8
0
2285
22940
14
15
2270
22870
36
94
2139
22013
79
353
1701
18367
Pleural effusion, not elsewhere classified
J90 [45605897]
J90 [45605897]
8.8e-01
1.8e+00
—
1.0e+50
2.6e+00
2.5e+00
1.8e+00
cases:0.52%
controls:0.22%
cases:0.61%
controls:0.10%
—
—
cases:0.39%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.69%
controls:0.05%
cases:1.01%
controls:0.17%
12
50
2281
22890
14
23
2279
22917
—
9
0
2284
22940
8
6
2276
22879
15
12
2160
22095
18
32
1762
18688
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
7.2e-01
1.0e+00
1.9e+00
—
2.8e+00
1.1e+00
1.2e+00
cases:5.49%
controls:2.75%
cases:2.75%
controls:1.00%
cases:0.70%
controls:0.10%
—
—
cases:1.36%
controls:0.09%
cases:3.03%
controls:1.03%
cases:10.45%
controls:3.50%
126
631
2167
22309
63
229
2230
22711
16
23
2277
22917
—
31
20
2253
22865
66
228
2109
21879
186
655
1594
18065
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
3.3e-01
5.5e-01
1.1e+00
3.7e+00
2.0e+00
5.6e-01
4.9e-01
cases:24.55%
controls:19.03%
cases:14.70%
controls:9.04%
cases:3.10%
controls:1.10%
cases:1.57%
controls:0.04%
cases:7.14%
controls:1.00%
cases:15.17%
controls:9.25%
cases:38.99%
controls:28.23%
563
4366
1730
18574
337
2073
1956
20867
71
252
2222
22688
36
9
2257
22931
163
229
2121
22656
330
2046
1845
20061
694
5284
1086
13436
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
2.3e-01
6.6e-01
1.3e+00
3.6e+00
1.6e+00
7.1e-01
5.9e-01
cases:20.24%
controls:16.81%
cases:15.09%
controls:8.40%
cases:4.54%
controls:1.27%
cases:1.96%
controls:0.06%
cases:5.91%
controls:1.20%
cases:16.05%
controls:8.56%
cases:36.35%
controls:23.97%
464
3857
1829
19083
346
1927
1947
21013
104
291
2189
22649
45
13
2248
22927
135
275
2149
22610
349
1892
1826
20215
647
4487
1133
14233
Other obesity
E66.8 [45533036]
E66.8 [45533036]
6.9e-01
1.4e+00
1.9e+00
—
2.1e+00
1.5e+00
1.1e+00
cases:1.79%
controls:0.90%
cases:1.61%
controls:0.38%
cases:0.48%
controls:0.07%
—
—
cases:0.74%
controls:0.10%
cases:1.93%
controls:0.42%
cases:3.03%
controls:1.03%
41
207
2252
22733
37
88
2256
22852
11
17
2282
22923
—
17
22
2267
22863
42
93
2133
22014
54
193
1726
18527
Left ventricular failure
I50.1 [45543181]
I50.1 [45543181]
8.8e-01
1.2e+00
1.8e+00
1.0e+50
2.3e+00
1.6e+00
8.9e-01
cases:0.83%
controls:0.34%
cases:0.65%
controls:0.20%
cases:0.35%
controls:0.06%
cases:0.83%
controls:0.00%
cases:0.53%
controls:0.05%
cases:1.20%
controls:0.24%
cases:1.46%
controls:0.60%
19
79
2274
22861
15
47
2278
22893
8
13
2285
22927
19
0
2274
22940
12
12
2272
22873
26
52
2149
22055
26
113
1754
18607
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
7.2e-01
1.3e+00
1.9e+00
—
2.1e+00
1.6e+00
1.0e+00
cases:2.44%
controls:1.20%
cases:1.57%
controls:0.45%
cases:0.57%
controls:0.08%
—
—
cases:0.66%
controls:0.08%
cases:2.25%
controls:0.45%
cases:3.03%
controls:1.10%
56
276
2237
22664
36
104
2257
22836
13
19
2280
22921
—
15
18
2269
22867
49
99
2126
22008
54
206
1726
18514
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
7.3e-01
9.5e-01
2.3e+00
—
2.7e+00
1.1e+00
8.6e-01
cases:6.02%
controls:2.98%
cases:2.57%
controls:1.01%
cases:1.22%
controls:0.12%
—
—
cases:1.18%
controls:0.08%
cases:3.03%
controls:1.04%
cases:8.09%
controls:3.60%
138
684
2155
22256
59
232
2234
22708
28
28
2265
22912
—
27
18
2257
22867
66
230
2109
21877
144
673
1636
18047
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
100906-7 [1761482]
1.2e+00
1.4e+00
2.0e+00
—
2.9e+00
9.7e-01
1.1e+00
cases:1.66%
controls:0.48%
cases:1.18%
controls:0.30%
cases:0.26%
controls:0.03%
—
—
cases:0.48%
controls:0.03%
cases:0.69%
controls:0.26%
cases:3.20%
controls:1.14%
38
111
2255
22829
27
68
2266
22872
6
8
2287
22932
—
11
6
2273
22879
15
58
2160
22049
57
214
1723
18506
Emphysema, unspecified
J43.9 [45567264]
J43.9 [45567264]
1.9e+00
2.4e+00
1.0e+50
1.0e+50
—
2.3e+00
2.0e+00
cases:0.61%
controls:0.09%
cases:0.52%
controls:0.05%
cases:0.26%
controls:0.00%
cases:0.70%
controls:0.00%
—
—
cases:0.74%
controls:0.07%
cases:1.24%
controls:0.17%
14
21
2279
22919
12
11
2281
22929
6
0
2287
22940
16
0
2277
22940
—
16
16
2159
22091
22
32
1758
18688
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
8.6e-01
1.2e+00
1.8e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:3.49%
controls:1.51%
cases:2.75%
controls:0.83%
cases:1.00%
controls:0.17%
—
—
cases:1.31%
controls:0.16%
cases:4.09%
controls:0.96%
cases:9.21%
controls:3.01%
80
346
2213
22594
63
190
2230
22750
23
40
2270
22900
—
30
37
2254
22848
89
212
2086
21895
164
563
1616
18157
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
9.1e-01
1.1e+00
1.8e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:3.53%
controls:1.45%
cases:2.57%
controls:0.84%
cases:1.05%
controls:0.17%
—
—
cases:1.31%
controls:0.16%
cases:4.05%
controls:0.96%
cases:8.93%
controls:3.00%
81
332
2212
22608
59
193
2234
22747
24
40
2269
22900
—
30
36
2254
22849
88
213
2087
21894
159
561
1621
18159
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
9.7e-01
1.1e+00
1.7e+00
—
2.5e+00
1.2e+00
1.1e+00
cases:2.35%
controls:0.91%
cases:1.26%
controls:0.42%
cases:0.39%
controls:0.07%
—
—
cases:0.66%
controls:0.05%
cases:1.66%
controls:0.51%
cases:4.38%
controls:1.47%
54
208
2239
22732
29
96
2264
22844
9
17
2284
22923
—
15
12
2269
22873
36
113
2139
21994
78
275
1702
18445
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
5.5e-01
1.0e+00
1.9e+00
—
2.5e+00
1.4e+00
1.1e+00
cases:3.31%
controls:1.95%
cases:2.83%
controls:1.04%
cases:0.96%
controls:0.14%
—
—
cases:1.88%
controls:0.15%
cases:4.60%
controls:1.13%
cases:10.51%
controls:3.69%
76
447
2217
22493
65
238
2228
22702
22
32
2271
22908
—
43
35
2241
22850
100
250
2075
21857
187
691
1593
18029
Obesity, unspecified
E66.9 [45576460]
E66.9 [45576460]
6.9e-01
1.9e+00
2.8e+00
1.0e+50
—
2.4e+00
1.4e+00
cases:0.74%
controls:0.37%
cases:0.83%
controls:0.12%
cases:0.44%
controls:0.03%
cases:1.96%
controls:0.00%
—
—
cases:1.47%
controls:0.14%
cases:1.57%
controls:0.37%
17
86
2276
22854
19
28
2274
22912
10
6
2283
22934
45
0
2248
22940
—
32
30
2143
22077
28
70
1752
18650
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
8.2e-01
1.0e+00
1.9e+00
1.0e+50
2.6e+00
1.3e+00
9.1e-01
cases:2.97%
controls:1.33%
cases:2.09%
controls:0.78%
cases:0.87%
controls:0.13%
cases:3.14%
controls:0.00%
cases:1.71%
controls:0.13%
cases:3.31%
controls:0.92%
cases:5.39%
controls:2.24%
68
306
2225
22634
48
179
2245
22761
20
29
2273
22911
72
0
2221
22940
39
29
2245
22856
72
204
2103
21903
96
420
1684
18300
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
9.1e-01
1.2e+00
1.7e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:3.49%
controls:1.43%
cases:2.53%
controls:0.79%
cases:0.92%
controls:0.17%
—
—
cases:1.27%
controls:0.16%
cases:4.00%
controls:0.95%
cases:8.99%
controls:2.90%
80
329
2213
22611
58
182
2235
22758
21
38
2272
22902
—
29
36
2255
22849
87
210
2088
21897
160
543
1620
18177
Other obstetric ultrasound examination
MA2XE [2001306838]
MA2XE [2001306838]
-7.2e-02
1.4e+00
2.4e+00
1.0e+50
2.7e+00
2.0e+00
4.4e-01
cases:0.70%
controls:0.75%
cases:0.87%
controls:0.22%
cases:0.35%
controls:0.03%
cases:0.92%
controls:0.00%
cases:0.53%
controls:0.03%
cases:1.29%
controls:0.17%
cases:1.12%
controls:0.73%
16
172
2277
22768
20
51
2273
22889
8
7
2285
22933
21
0
2272
22940
12
8
2272
22877
28
38
2147
22069
20
136
1760
18584
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.8e-01
4.8e-01
1.4e+00
3.7e+00
1.6e+00
7.1e-01
6.5e-01
cases:12.21%
controls:10.39%
cases:12.30%
controls:7.96%
cases:6.93%
controls:1.75%
cases:3.36%
controls:0.09%
cases:7.75%
controls:1.69%
cases:15.54%
controls:8.31%
cases:28.54%
controls:17.20%
280
2383
2013
20557
282
1826
2011
21114
159
401
2134
22539
77
20
2216
22920
177
386
2107
22499
338
1836
1837
20271
508
3220
1272
15500
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
1.7e-01
4.4e-01
1.5e+00
3.5e+00
1.7e+00
7.2e-01
7.0e-01
cases:6.80%
controls:5.83%
cases:5.02%
controls:3.28%
cases:2.49%
controls:0.55%
cases:0.70%
controls:0.02%
cases:2.80%
controls:0.54%
cases:6.34%
controls:3.18%
cases:16.01%
controls:8.65%
156
1337
2137
21603
115
753
2178
22187
57
127
2236
22813
16
5
2277
22935
64
124
2220
22761
138
703
2037
21404
285
1619
1495
17101
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
1.4e+00
1.4e+00
—
—
2.0e+00
1.6e+00
2.0e+00
cases:0.96%
controls:0.23%
cases:0.65%
controls:0.16%
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.83%
controls:0.16%
cases:1.24%
controls:0.17%
22
53
2271
22887
15
37
2278
22903
—
—
9
12
2275
22873
18
36
2157
22071
22
31
1758
18689
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
3.4e-01
7.3e-01
1.7e+00
2.6e+00
1.4e+00
9.3e-01
1.0e+00
cases:5.10%
controls:3.70%
cases:3.36%
controls:1.65%
cases:1.18%
controls:0.21%
cases:0.31%
controls:0.02%
cases:0.92%
controls:0.22%
cases:3.77%
controls:1.52%
cases:9.44%
controls:3.61%
117
848
2176
22092
77
379
2216
22561
27
48
2266
22892
7
5
2286
22935
21
50
2263
22835
82
336
2093
21771
168
675
1612
18045
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
5.5e-01
1.1e+00
1.8e+00
1.0e+50
3.1e+00
1.5e+00
9.9e-01
cases:1.31%
controls:0.76%
cases:1.09%
controls:0.38%
cases:0.35%
controls:0.06%
cases:0.92%
controls:0.00%
cases:1.05%
controls:0.05%
cases:1.84%
controls:0.40%
cases:3.65%
controls:1.38%
30
174
2263
22766
25
88
2268
22852
8
13
2285
22927
21
0
2272
22940
24
11
2260
22874
40
89
2135
22018
65
259
1715
18461
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
7.8e-01
4.6e-01
2.3e+00
1.0e+50
2.9e+00
1.5e+00
9.5e-01
cases:2.44%
controls:1.14%
cases:0.61%
controls:0.39%
cases:0.26%
controls:0.03%
cases:0.39%
controls:0.00%
cases:0.48%
controls:0.03%
cases:1.61%
controls:0.35%
cases:2.70%
controls:1.06%
56
261
2237
22679
14
89
2279
22851
6
6
2287
22934
9
0
2284
22940
11
6
2273
22879
35
78
2140
22029
48
199
1732
18521
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
9.3e-01
1.1e+00
1.8e+00
—
2.3e+00
1.2e+00
1.1e+00
cases:2.35%
controls:0.94%
cases:1.40%
controls:0.47%
cases:0.52%
controls:0.08%
—
—
cases:0.74%
controls:0.08%
cases:1.98%
controls:0.58%
cases:4.94%
controls:1.73%
54
216
2239
22724
32
108
2261
22832
12
19
2281
22921
—
17
18
2267
22867
43
129
2132
21978
88
323
1692
18397
Alcohol dependence currently independent
F10.20 [2000501677]
F10.20 [2000501677]
1.7e+00
2.0e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:1.31%
controls:0.23%
cases:0.65%
controls:0.09%
—
—
cases:0.26%
controls:0.00%
—
—
cases:0.87%
controls:0.05%
cases:1.07%
controls:0.15%
30
53
2263
22887
15
21
2278
22919
—
6
0
2287
22940
—
19
12
2156
22095
19
29
1761
18691
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.0e-01
5.3e-01
1.5e+00
2.6e+00
1.8e+00
8.4e-01
7.9e-01
cases:13.30%
controls:9.35%
cases:8.85%
controls:5.42%
cases:4.32%
controls:0.97%
cases:0.57%
controls:0.04%
cases:4.86%
controls:0.86%
cases:11.49%
controls:5.33%
cases:25.79%
controls:13.61%
305
2145
1988
20795
203
1243
2090
21697
99
223
2194
22717
13
10
2280
22930
111
196
2173
22689
250
1178
1925
20929
459
2547
1321
16173
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.1e-01
6.3e-01
1.7e+00
2.8e+00
1.3e+00
7.9e-01
7.7e-01
cases:29.13%
controls:21.46%
cases:22.33%
controls:13.32%
cases:12.17%
controls:2.54%
cases:2.01%
controls:0.12%
cases:8.19%
controls:2.39%
cases:26.21%
controls:13.85%
cases:49.61%
controls:31.35%
668
4923
1625
18017
512
3056
1781
19884
279
583
2014
22357
46
28
2247
22912
187
546
2097
22339
570
3062
1605
19045
883
5868
897
12852
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
1.0e+00
1.0e+00
7.6e-01
1.5e+00
1.2e+00
1.4e+00
1.4e+00
cases:98.39%
controls:95.62%
cases:94.42%
controls:86.09%
cases:65.15%
controls:46.62%
cases:10.16%
controls:2.37%
cases:74.65%
controls:46.59%
cases:96.18%
controls:86.49%
cases:99.16%
controls:96.59%
2256
21936
37
1004
2165
19750
128
3190
1494
10695
799
12245
233
544
2060
22396
1705
10663
579
12222
2092
19120
83
2987
1765
18081
15
639
Guidance related to psychoactive substances / risk behaviour
SPAT1309 [2001700410]
SPAT1309 [2001700410]
1.7e+00
2.5e+00
—
—
2.1e+00
1.9e+00
2.1e+00
cases:2.22%
controls:0.41%
cases:1.48%
controls:0.12%
—
—
—
—
cases:0.22%
controls:0.03%
cases:0.78%
controls:0.11%
cases:2.64%
controls:0.32%
51
95
2242
22845
34
27
2259
22913
—
—
5
6
2279
22879
17
25
2158
22082
47
59
1733
18661
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
6.4e-01
9.2e-01
1.9e+00
—
2.5e+00
1.4e+00
9.3e-01
cases:2.49%
controls:1.33%
cases:1.48%
controls:0.60%
cases:0.48%
controls:0.07%
—
—
cases:1.05%
controls:0.08%
cases:2.67%
controls:0.66%
cases:5.96%
controls:2.44%
57
304
2236
22636
34
137
2259
22803
11
17
2282
22923
—
24
19
2260
22866
58
145
2117
21962
106
456
1674
18264
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2639-3 [3005895]
5.8e-01
1.5e+00
2.9e+00
—
2.8e+00
7.5e-01
1.2e+00
cases:1.13%
controls:0.64%
cases:0.87%
controls:0.20%
cases:0.39%
controls:0.02%
—
—
cases:0.44%
controls:0.03%
cases:0.51%
controls:0.24%
cases:2.98%
controls:0.95%
26
146
2267
22794
20
47
2273
22893
9
5
2284
22935
—
10
6
2274
22879
11
53
2164
22054
53
178
1727
18542
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
5.2e-01
1.3e+00
1.9e+00
1.0e+50
2.6e+00
1.5e+00
1.1e+00
cases:2.14%
controls:1.28%
cases:2.22%
controls:0.61%
cases:0.57%
controls:0.09%
cases:1.05%
controls:0.00%
cases:1.23%
controls:0.10%
cases:3.08%
controls:0.71%
cases:6.91%
controls:2.43%
49
294
2244
22646
51
140
2242
22800
13
20
2280
22920
24
0
2269
22940
28
22
2256
22863
67
157
2108
21950
123
455
1657
18265
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
5.7e-01
1.0e+00
1.9e+00
1.0e+50
2.8e+00
1.5e+00
1.1e+00
cases:1.35%
controls:0.77%
cases:1.13%
controls:0.41%
cases:0.39%
controls:0.06%
cases:0.74%
controls:0.00%
cases:0.88%
controls:0.05%
cases:2.11%
controls:0.47%
cases:4.61%
controls:1.59%
31
176
2262
22764
26
94
2267
22846
9
14
2284
22926
17
0
2276
22940
20
12
2264
22873
46
105
2129
22002
82
298
1698
18422
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
9.3e-01
1.1e+00
1.7e+00
—
2.2e+00
1.2e+00
1.1e+00
cases:2.35%
controls:0.95%
cases:1.44%
controls:0.48%
cases:0.52%
controls:0.09%
—
—
cases:0.79%
controls:0.09%
cases:1.98%
controls:0.61%
cases:5.28%
controls:1.78%
54
217
2239
22723
33
109
2260
22831
12
21
2281
22919
—
18
20
2266
22865
43
135
2132
21972
94
334
1686
18386
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
3.6e-01
8.1e-01
2.7e+00
—
2.7e+00
1.2e+00
8.9e-01
cases:4.01%
controls:2.83%
cases:2.31%
controls:1.05%
cases:1.70%
controls:0.12%
—
—
cases:1.88%
controls:0.13%
cases:3.31%
controls:1.02%
cases:8.20%
controls:3.55%
92
650
2201
22290
53
240
2240
22700
39
27
2254
22913
—
43
29
2241
22856
72
226
2103
21881
146
664
1634
18056
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
5.4e-01
1.0e+00
1.7e+00
1.0e+50
3.0e+00
1.4e+00
1.1e+00
cases:1.35%
controls:0.79%
cases:1.18%
controls:0.42%
cases:0.35%
controls:0.06%
cases:0.74%
controls:0.00%
cases:0.92%
controls:0.05%
cases:2.07%
controls:0.50%
cases:4.61%
controls:1.56%
31
182
2262
22758
27
96
2266
22844
8
14
2285
22926
17
0
2276
22940
21
11
2263
22874
45
111
2130
21996
82
292
1698
18428
Psychosocial counselling and guidance
SPAT1307 [2001700408]
SPAT1307 [2001700408]
8.5e-01
1.0e+00
1.9e+00
—
2.2e+00
1.3e+00
1.1e+00
cases:2.57%
controls:1.11%
cases:0.92%
controls:0.34%
cases:0.35%
controls:0.05%
—
—
cases:0.31%
controls:0.03%
cases:1.06%
controls:0.29%
cases:2.75%
controls:0.98%
59
255
2234
22685
21
77
2272
22863
8
12
2285
22928
—
7
8
2277
22877
23
65
2152
22042
49
183
1731
18537
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
9.7e-02
3.1e-01
1.4e+00
4.2e+00
1.6e+00
5.2e-01
2.3e-01
cases:30.70%
controls:28.68%
cases:28.96%
controls:22.94%
cases:16.88%
controls:4.97%
cases:14.04%
controls:0.24%
cases:20.53%
controls:4.79%
cases:34.11%
controls:23.50%
cases:52.53%
controls:46.70%
704
6580
1589
16360
664
5263
1629
17677
387
1139
1906
21801
322
56
1971
22884
469
1097
1815
21788
742
5195
1433
16912
935
8743
845
9977
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.6e-01
3.3e-01
1.4e+00
4.1e+00
1.5e+00
4.4e-01
3.5e-01
cases:30.61%
controls:27.26%
cases:28.26%
controls:22.04%
cases:15.53%
controls:4.32%
cases:11.16%
controls:0.21%
cases:16.51%
controls:4.25%
cases:32.23%
controls:23.42%
cases:56.35%
controls:47.53%
702
6253
1591
16687
648
5057
1645
17883
356
990
1937
21950
256
49
2037
22891
377
973
1907
21912
701
5178
1474
16929
1003
8897
777
9823
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
4.5e-01
7.8e-01
2.2e+00
—
2.9e+00
1.1e+00
8.2e-01
cases:8.77%
controls:5.79%
cases:5.32%
controls:2.52%
cases:2.62%
controls:0.28%
—
—
cases:4.68%
controls:0.27%
cases:6.76%
controls:2.46%
cases:17.30%
controls:8.45%
201
1329
2092
21611
122
578
2171
22362
60
65
2233
22875
—
107
61
2177
22824
147
544
2028
21563
308
1582
1472
17138
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
7.9e-01
1.1e+00
1.4e+00
—
2.7e+00
1.1e+00
1.1e+00
cases:7.28%
controls:3.44%
cases:3.71%
controls:1.31%
cases:0.48%
controls:0.11%
—
—
cases:1.84%
controls:0.12%
cases:3.77%
controls:1.27%
cases:11.40%
controls:4.25%
167
789
2126
22151
85
301
2208
22639
11
26
2282
22914
—
42
28
2242
22857
82
280
2093
21827
203
795
1577
17925
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
2.2e-01
1.1e+00
3.2e+00
—
2.1e+00
1.1e+00
8.1e-01
cases:3.66%
controls:2.96%
cases:3.10%
controls:1.05%
cases:1.83%
controls:0.08%
—
—
cases:0.92%
controls:0.12%
cases:2.85%
controls:1.00%
cases:8.09%
controls:3.76%
84
680
2209
22260
71
240
2222
22700
42
18
2251
22922
—
21
27
2263
22858
62
222
2113
21885
144
704
1636
18016
Type 2 diabetes mellitus, with other specified complications
E11.6 [45552387]
E11.6 [45552387]
1.4e+00
2.7e+00
—
—
—
2.8e+00
1.4e+00
cases:0.83%
controls:0.21%
cases:0.44%
controls:0.03%
—
—
—
—
—
—
cases:0.74%
controls:0.05%
cases:0.67%
controls:0.17%
19
49
2274
22891
10
7
2283
22933
—
—
—
16
10
2159
22097
12
32
1768
18688
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
3.9e-01
5.1e-01
1.0e+00
3.4e+00
1.7e+00
6.5e-01
5.6e-01
cases:11.95%
controls:8.38%
cases:6.28%
controls:3.87%
cases:1.57%
controls:0.57%
cases:0.74%
controls:0.03%
cases:2.58%
controls:0.48%
cases:7.36%
controls:3.97%
cases:19.27%
controls:12.04%
274
1923
2019
21017
144
888
2149
22052
36
131
2257
22809
17
6
2276
22934
59
109
2225
22776
160
878
2015
21229
343
2254
1437
16466
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
6.4e-01
1.0e+00
1.8e+00
1.0e+50
2.9e+00
1.4e+00
1.1e+00
cases:1.44%
controls:0.77%
cases:1.13%
controls:0.42%
cases:0.39%
controls:0.07%
cases:0.78%
controls:0.00%
cases:0.92%
controls:0.05%
cases:2.07%
controls:0.50%
cases:4.66%
controls:1.67%
33
176
2260
22764
26
96
2267
22844
9
15
2284
22925
18
0
2275
22940
21
12
2263
22873
45
110
2130
21997
83
312
1697
18408
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.9e-01
1.0e+00
2.1e+00
—
1.9e+00
1.4e+00
1.1e+00
cases:15.05%
controls:8.91%
cases:8.59%
controls:3.32%
cases:3.10%
controls:0.38%
—
—
cases:2.41%
controls:0.37%
cases:10.53%
controls:2.79%
cases:23.26%
controls:8.98%
345
2043
1948
20897
197
761
2096
22179
71
87
2222
22853
—
55
85
2229
22800
229
617
1946
21490
414
1681
1366
17039
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
13969-1 [3005785]
8.7e-02
1.0e+00
2.4e+00
1.0e+50
2.5e+00
1.1e+00
1.2e+00
cases:1.70%
controls:1.56%
cases:1.40%
controls:0.51%
cases:0.52%
controls:0.05%
cases:0.31%
controls:0.00%
cases:0.61%
controls:0.05%
cases:1.70%
controls:0.57%
cases:5.11%
controls:1.63%
39
358
2254
22582
32
118
2261
22822
12
11
2281
22929
7
0
2286
22940
14
12
2270
22873
37
126
2138
21981
91
305
1689
18415
clopidogrel; oral
B01AC04 [21600989]
B01AC04 [21600989]
6.3e-01
9.7e-01
1.1e+00
—
2.4e+00
1.8e+00
1.3e+00
cases:4.40%
controls:2.41%
cases:3.92%
controls:1.53%
cases:1.05%
controls:0.37%
—
—
cases:5.17%
controls:0.51%
cases:8.87%
controls:1.53%
cases:10.34%
controls:3.04%
101
552
2192
22388
90
351
2203
22589
24
84
2269
22856
—
118
117
2166
22768
193
338
1982
21769
184
570
1596
18150
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
N02BA01 [21604305]
6.8e-01
1.1e+00
1.5e+00
—
2.2e+00
1.5e+00
1.1e+00
cases:3.27%
controls:1.69%
cases:2.79%
controls:0.92%
cases:1.05%
controls:0.24%
—
—
cases:2.58%
controls:0.28%
cases:4.37%
controls:0.99%
cases:6.91%
controls:2.39%
75
388
2218
22552
64
212
2229
22728
24
55
2269
22885
—
59
65
2225
22820
95
219
2080
21888
123
447
1657
18273
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
7.4e-01
1.2e+00
2.1e+00
1.0e+50
2.0e+00
1.1e+00
9.4e-01
cases:4.97%
controls:2.45%
cases:2.92%
controls:0.88%
cases:0.74%
controls:0.09%
cases:0.22%
controls:0.00%
cases:0.66%
controls:0.09%
cases:2.99%
controls:1.04%
cases:8.37%
controls:3.45%
114
561
2179
22379
67
203
2226
22737
17
20
2276
22920
5
0
2288
22940
15
20
2269
22865
65
229
2110
21878
149
645
1631
18075
formoterol and beclometasone
R03AK08 [43534839]
R03AK08 [43534839]
9.1e-01
1.1e+00
1.4e+00
—
1.5e+00
1.7e+00
1.4e+00
cases:1.53%
controls:0.62%
cases:1.83%
controls:0.59%
cases:0.87%
controls:0.21%
—
—
cases:0.96%
controls:0.22%
cases:3.49%
controls:0.63%
cases:5.11%
controls:1.27%
35
142
2258
22798
42
136
2251
22804
20
48
2273
22892
—
22
51
2262
22834
76
139
2099
21968
91
238
1689
18482
Oral Surgery
19 [38004464]
19 [38004464]
5.9e-01
1.1e+00
2.2e+00
—
2.3e+00
1.5e+00
9.4e-01
cases:1.57%
controls:0.88%
cases:0.83%
controls:0.27%
cases:0.31%
controls:0.03%
—
—
cases:0.31%
controls:0.03%
cases:1.24%
controls:0.27%
cases:2.19%
controls:0.87%
36
201
2257
22739
19
61
2274
22879
7
8
2286
22932
—
7
7
2277
22878
27
60
2148
22047
39
162
1741
18558
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
8.0e-01
1.0e+00
2.3e+00
1.0e+50
1.5e+00
1.3e+00
1.1e+00
cases:3.27%
controls:1.49%
cases:1.44%
controls:0.54%
cases:0.83%
controls:0.08%
cases:1.96%
controls:0.00%
cases:0.39%
controls:0.09%
cases:2.30%
controls:0.62%
cases:6.40%
controls:2.22%
75
342
2218
22598
33
123
2260
22817
19
19
2274
22921
45
0
2248
22940
9
20
2275
22865
50
136
2125
21971
114
416
1666
18304
formoterol; inhalant
R03AC13 [21603267]
R03AC13 [21603267]
9.9e-01
1.6e+00
1.6e+00
—
1.6e+00
1.2e+00
1.0e+00
cases:1.35%
controls:0.51%
cases:1.13%
controls:0.23%
cases:0.35%
controls:0.07%
—
—
cases:0.44%
controls:0.09%
cases:0.87%
controls:0.27%
cases:1.12%
controls:0.40%
31
116
2262
22824
26
53
2267
22887
8
16
2285
22924
—
10
20
2274
22865
19
59
2156
22048
20
75
1760
18645
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
1.8e-01
7.2e-01
1.4e+00
3.1e+00
1.5e+00
7.3e-01
5.4e-01
cases:5.63%
controls:4.74%
cases:5.58%
controls:2.79%
cases:1.74%
controls:0.44%
cases:0.48%
controls:0.02%
cases:1.93%
controls:0.42%
cases:6.34%
controls:3.15%
cases:14.78%
controls:9.18%
129
1088
2164
21852
128
641
2165
22299
40
100
2253
22840
11
5
2282
22935
44
96
2240
22789
138
696
2037
21411
263
1718
1517
17002
Fibromyalgia
M79.7 [45553272]
M79.7 [45553272]
1.2e+00
9.4e-01
1.6e+00
1.0e+50
2.9e+00
2.3e+00
1.7e+00
cases:1.31%
controls:0.41%
cases:0.48%
controls:0.19%
cases:0.22%
controls:0.04%
cases:1.31%
controls:0.00%
cases:0.39%
controls:0.02%
cases:1.43%
controls:0.15%
cases:2.53%
controls:0.47%
30
95
2263
22845
11
43
2282
22897
5
10
2288
22930
30
0
2263
22940
9
5
2275
22880
31
33
2144
22074
45
88
1735
18632
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
74661-0 [44816559]
1.2e+00
1.2e+00
1.2e+00
—
3.0e+00
1.3e+00
1.3e+00
cases:1.53%
controls:0.49%
cases:1.05%
controls:0.33%
cases:0.22%
controls:0.07%
—
—
cases:1.18%
controls:0.06%
cases:1.47%
controls:0.41%
cases:4.83%
controls:1.37%
35
112
2258
22828
24
76
2269
22864
5
15
2288
22925
—
27
13
2257
22872
32
91
2143
22016
86
257
1694
18463
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
6.6e-01
1.1e+00
2.5e+00
1.0e+50
1.7e+00
8.3e-01
1.2e+00
cases:3.31%
controls:1.74%
cases:1.44%
controls:0.51%
cases:0.61%
controls:0.05%
cases:0.83%
controls:0.00%
cases:0.39%
controls:0.07%
cases:0.97%
controls:0.43%
cases:3.93%
controls:1.25%
76
400
2217
22540
33
116
2260
22824
14
12
2279
22928
19
0
2274
22940
9
16
2275
22869
21
94
2154
22013
70
234
1710
18486
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
6.4e-01
9.5e-01
1.5e+00
—
2.4e+00
1.6e+00
9.3e-01
cases:2.35%
controls:1.25%
cases:1.74%
controls:0.68%
cases:0.61%
controls:0.14%
—
—
cases:1.23%
controls:0.12%
cases:3.40%
controls:0.74%
cases:5.79%
controls:2.37%
54
287
2239
22653
40
157
2253
22783
14
32
2279
22908
—
28
27
2256
22858
74
164
2101
21943
103
443
1677
18277
nystatin; oral
A07AA02 [21600604]
A07AA02 [21600604]
1.0e+00
1.4e+00
—
—
2.6e+00
1.5e+00
1.3e+00
cases:2.27%
controls:0.82%
cases:0.92%
controls:0.23%
—
—
—
—
cases:0.48%
controls:0.03%
cases:1.20%
controls:0.27%
cases:2.53%
controls:0.68%
52
189
2241
22751
21
52
2272
22888
—
—
11
8
2273
22877
26
60
2149
22047
45
127
1735
18593
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.2e-01
5.0e-01
1.4e+00
3.2e+00
1.4e+00
6.1e-01
4.6e-01
cases:43.96%
controls:38.63%
cases:40.21%
controls:29.04%
cases:18.62%
controls:5.17%
cases:4.45%
controls:0.18%
cases:17.82%
controls:4.95%
cases:44.64%
controls:30.52%
cases:71.29%
controls:60.99%
1008
8862
1285
14078
922
6662
1371
16278
427
1185
1866
21755
102
42
2191
22898
407
1132
1877
21753
971
6748
1204
15359
1269
11418
511
7302
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
1.1e+00
1.4e+00
—
1.0e+50
2.3e+00
1.6e+00
1.5e+00
cases:2.35%
controls:0.81%
cases:0.70%
controls:0.18%
—
—
cases:0.48%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.78%
controls:0.15%
cases:1.40%
controls:0.32%
54
186
2239
22754
16
41
2277
22899
—
11
0
2282
22940
8
8
2276
22877
17
34
2158
22073
25
60
1755
18660
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
4.0e-01
1.1e+00
2.6e+00
—
2.3e+00
1.2e+00
6.8e-01
cases:1.22%
controls:0.82%
cases:0.83%
controls:0.29%
cases:0.35%
controls:0.03%
—
—
cases:0.44%
controls:0.04%
cases:0.87%
controls:0.26%
cases:1.97%
controls:1.00%
28
188
2265
22752
19
66
2274
22874
8
6
2285
22934
—
10
10
2274
22875
19
58
2156
22049
35
188
1745
18532
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
7.8e-01
1.1e+00
1.9e+00
—
1.8e+00
1.3e+00
9.2e-01
cases:17.58%
controls:8.93%
cases:6.98%
controls:2.50%
cases:2.35%
controls:0.36%
—
—
cases:2.32%
controls:0.38%
cases:7.31%
controls:2.00%
cases:12.58%
controls:5.42%
403
2049
1890
20891
160
573
2133
22367
54
83
2239
22857
—
53
87
2231
22798
159
443
2016
21664
224
1014
1556
17706
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
7.6e-01
1.1e+00
2.1e+00
—
1.5e+00
1.1e+00
1.2e+00
cases:2.49%
controls:1.18%
cases:2.57%
controls:0.86%
cases:1.22%
controls:0.15%
—
—
cases:0.79%
controls:0.17%
cases:3.03%
controls:1.00%
cases:7.92%
controls:2.60%
57
271
2236
22669
59
197
2234
22743
28
34
2265
22906
—
18
39
2266
22846
66
220
2109
21887
141
487
1639
18233
Chron obstructive pulmonary disease
R95 [2002000960]
R95 [2002000960]
1.9e+00
2.5e+00
—
—
—
1.9e+00
1.6e+00
cases:1.57%
controls:0.25%
cases:1.22%
controls:0.10%
—
—
—
—
—
—
cases:0.87%
controls:0.13%
cases:1.85%
controls:0.38%
36
57
2257
22883
28
24
2265
22916
—
—
—
19
29
2156
22078
33
71
1747
18649
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.5e-01
3.7e-01
1.4e+00
3.7e+00
1.3e+00
5.4e-01
2.9e-01
cases:55.17%
controls:51.46%
cases:57.92%
controls:48.68%
cases:39.99%
controls:14.58%
cases:22.11%
controls:0.68%
cases:38.49%
controls:14.08%
cases:64.51%
controls:51.47%
cases:81.35%
controls:76.46%
1265
11805
1028
11135
1328
11168
965
11772
917
3344
1376
19596
507
155
1786
22785
879
3223
1405
19662
1403
11378
772
10729
1448
14313
332
4407
acetylsalicylic acid; oral
B01AC06 [21600991]
B01AC06 [21600991]
6.9e-01
1.0e+00
1.1e+00
—
2.2e+00
1.5e+00
1.2e+00
cases:4.75%
controls:2.45%
cases:4.27%
controls:1.57%
cases:1.35%
controls:0.44%
—
—
cases:4.33%
controls:0.49%
cases:7.36%
controls:1.66%
cases:9.83%
controls:3.29%
109
561
2184
22379
98
361
2195
22579
31
101
2262
22839
—
99
111
2185
22774
160
368
2015
21739
175
616
1605
18104
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
8.2e-01
1.1e+00
2.2e+00
—
1.4e+00
1.1e+00
1.2e+00
cases:2.31%
controls:1.03%
cases:2.57%
controls:0.85%
cases:1.35%
controls:0.15%
—
—
cases:0.70%
controls:0.17%
cases:2.80%
controls:0.98%
cases:7.64%
controls:2.53%
53
237
2240
22703
59
195
2234
22745
31
35
2262
22905
—
16
39
2268
22846
61
217
2114
21890
136
473
1644
18247
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
4.5e-01
1.2e+00
2.6e+00
—
2.7e+00
1.2e+00
5.5e-01
cases:1.22%
controls:0.78%
cases:0.83%
controls:0.25%
cases:0.31%
controls:0.02%
—
—
cases:0.39%
controls:0.03%
cases:0.64%
controls:0.19%
cases:1.46%
controls:0.85%
28
179
2265
22761
19
58
2274
22882
7
5
2286
22935
—
9
6
2275
22879
14
42
2161
22065
26
159
1754
18561
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
8.4e-02
2.8e-01
1.3e+00
4.1e+00
1.5e+00
4.1e-01
1.8e-01
cases:36.37%
controls:34.44%
cases:32.05%
controls:26.20%
cases:17.05%
controls:5.38%
cases:12.39%
controls:0.23%
cases:19.70%
controls:5.27%
cases:36.23%
controls:27.33%
cases:56.91%
controls:52.51%
834
7901
1459
15039
735
6010
1558
16930
391
1234
1902
21706
284
53
2009
22887
450
1206
1834
21679
788
6042
1387
16065
1013
9829
767
8891
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
4.3e-01
1.1e+00
2.1e+00
1.0e+50
2.0e+00
1.4e+00
1.1e+00
cases:1.96%
controls:1.28%
cases:1.09%
controls:0.38%
cases:0.44%
controls:0.05%
cases:0.48%
controls:0.00%
cases:0.39%
controls:0.05%
cases:1.56%
controls:0.38%
cases:3.71%
controls:1.25%
45
294
2248
22646
25
87
2268
22853
10
12
2283
22928
11
0
2282
22940
9
12
2275
22873
34
84
2141
22023
66
234
1714
18486
Midwife
Z3232 [2001311563]
Z3232 [2001311563]
-3.3e-02
1.6e+00
2.1e+00
1.0e+50
2.6e+00
1.5e+00
7.1e-01
cases:1.31%
controls:1.35%
cases:1.61%
controls:0.34%
cases:0.31%
controls:0.04%
cases:0.39%
controls:0.00%
cases:0.48%
controls:0.03%
cases:1.33%
controls:0.31%
cases:1.46%
controls:0.72%
30
310
2263
22630
37
78
2256
22862
7
9
2286
22931
9
0
2284
22940
11
8
2273
22877
29
69
2146
22038
26
135
1754
18585
Extracorporeal dialysis
Z49.1 [45537649]
Z49.1 [45537649]
1.1e+00
2.0e+00
1.8e+00
—
2.0e+00
2.3e+00
1.4e+00
cases:0.31%
controls:0.10%
cases:0.48%
controls:0.07%
cases:0.26%
controls:0.04%
—
—
cases:0.35%
controls:0.05%
cases:0.74%
controls:0.07%
cases:0.56%
controls:0.14%
7
23
2286
22917
11
15
2282
22925
6
10
2287
22930
—
8
11
2276
22874
16
16
2159
22091
10
26
1770
18694
Amphetamines [Presence] in Urine
3349-8 [3027944]
3349-8 [3027944]
9.6e-01
8.7e-01
1.9e+00
1.0e+50
1.9e+00
1.2e+00
8.8e-01
cases:2.83%
controls:1.10%
cases:1.09%
controls:0.46%
cases:0.31%
controls:0.05%
cases:0.31%
controls:0.00%
cases:0.44%
controls:0.07%
cases:1.38%
controls:0.40%
cases:4.33%
controls:1.84%
65
253
2228
22687
25
105
2268
22835
7
11
2286
22929
7
0
2286
22940
10
15
2274
22870
30
89
2145
22018
77
345
1703
18375
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
SPAT1217 [2001700318]
1.1e+00
1.5e+00
2.1e+00
—
2.8e+00
1.2e+00
1.1e+00
cases:1.05%
controls:0.35%
cases:0.74%
controls:0.17%
cases:0.22%
controls:0.03%
—
—
cases:0.35%
controls:0.02%
cases:0.69%
controls:0.21%
cases:2.13%
controls:0.70%
24
80
2269
22860
17
39
2276
22901
5
6
2288
22934
—
8
5
2276
22880
15
47
2160
22060
38
131
1742
18589
Dentistry
C5 [903277]
C5 [903277]
7.6e-01
1.0e+00
1.3e+00
1.0e+50
1.9e+00
1.5e+00
1.1e+00
cases:5.02%
controls:2.40%
cases:2.83%
controls:1.04%
cases:0.70%
controls:0.19%
cases:1.53%
controls:0.00%
cases:1.40%
controls:0.21%
cases:3.95%
controls:0.88%
cases:7.25%
controls:2.44%
115
551
2178
22389
65
239
2228
22701
16
44
2277
22896
35
0
2258
22940
32
48
2252
22837
86
195
2089
21912
129
456
1651
18264
Sacroiliitis, not elsewhere classified
M46.1 [45577263]
M46.1 [45577263]
1.2e+00
1.7e+00
—
1.0e+50
2.3e+00
2.0e+00
1.7e+00
cases:0.39%
controls:0.11%
cases:0.35%
controls:0.07%
—
—
cases:0.39%
controls:0.00%
cases:0.26%
controls:0.03%
cases:0.55%
controls:0.08%
cases:0.79%
controls:0.14%
9
26
2284
22914
8
15
2285
22925
—
9
0
2284
22940
6
6
2278
22879
12
17
2163
22090
14
27
1766
18693
Pregnancy confirmed
Z32.1 [45566418]
Z32.1 [45566418]
6.9e-01
1.9e+00
2.7e+00
—
1.6e+00
1.5e+00
8.3e-01
cases:2.53%
controls:1.29%
cases:3.36%
controls:0.50%
cases:0.83%
controls:0.06%
—
—
cases:0.22%
controls:0.04%
cases:2.02%
controls:0.45%
cases:3.37%
controls:1.50%
58
296
2235
22644
77
114
2216
22826
19
13
2274
22927
—
5
10
2279
22875
44
100
2131
22007
60
281
1720
18439
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
7.3e-01
8.4e-01
1.7e+00
—
2.6e+00
9.9e-01
8.4e-01
cases:2.92%
controls:1.43%
cases:1.57%
controls:0.68%
cases:0.52%
controls:0.10%
—
—
cases:1.09%
controls:0.08%
cases:2.07%
controls:0.78%
cases:6.69%
controls:3.01%
67
328
2226
22612
36
157
2257
22783
12
23
2281
22917
—
25
19
2259
22866
45
173
2130
21934
119
564
1661
18156
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
3.2e-01
8.2e-01
2.2e+00
1.0e+50
2.6e+00
1.0e+00
9.3e-01
cases:1.88%
controls:1.37%
cases:1.48%
controls:0.66%
cases:0.61%
controls:0.07%
cases:0.26%
controls:0.00%
cases:1.09%
controls:0.08%
cases:1.93%
controls:0.72%
cases:4.55%
controls:1.85%
43
314
2250
22626
34
151
2259
22789
14
15
2279
22925
6
0
2287
22940
25
18
2259
22867
42
159
2133
21948
81
346
1699
18374
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
7.7e-01
1.1e+00
2.0e+00
—
1.4e+00
1.1e+00
1.2e+00
cases:2.40%
controls:1.12%
cases:2.49%
controls:0.83%
cases:1.13%
controls:0.15%
—
—
cases:0.66%
controls:0.17%
cases:2.90%
controls:0.95%
cases:7.70%
controls:2.46%
55
258
2238
22682
57
191
2236
22749
26
34
2267
22906
—
15
38
2269
22847
63
211
2112
21896
137
461
1643
18259
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
5.4e-01
6.8e-01
1.1e+00
2.5e+00
1.4e+00
7.2e-01
7.1e-01
cases:42.78%
controls:30.27%
cases:17.10%
controls:9.46%
cases:2.92%
controls:0.98%
cases:0.31%
controls:0.03%
cases:3.98%
controls:1.01%
cases:17.15%
controls:9.11%
cases:42.13%
controls:26.42%
981
6945
1312
15995
392
2171
1901
20769
67
225
2226
22715
7
6
2286
22934
91
231
2193
22654
373
2015
1802
20092
750
4946
1030
13774
Moderate panic disorder
F41.00 [2000501994]
F41.00 [2000501994]
1.4e+00
2.6e+00
—
—
—
1.9e+00
1.7e+00
cases:0.57%
controls:0.14%
cases:0.52%
controls:0.04%
—
—
—
—
—
—
cases:0.37%
controls:0.05%
cases:0.73%
controls:0.14%
13
31
2280
22909
12
9
2281
22931
—
—
—
8
12
2167
22095
13
26
1767
18694
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
1.0e+00
1.2e+00
—
—
2.3e+00
2.0e+00
1.1e+00
cases:2.40%
controls:0.89%
cases:0.70%
controls:0.21%
—
—
—
—
cases:0.31%
controls:0.03%
cases:1.29%
controls:0.18%
cases:2.08%
controls:0.69%
55
204
2238
22736
16
49
2277
22891
—
—
7
7
2277
22878
28
39
2147
22068
37
130
1743
18590
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
9.1e-01
1.1e+00
1.4e+00
—
1.8e+00
1.4e+00
1.1e+00
cases:3.40%
controls:1.40%
cases:2.31%
controls:0.81%
cases:1.09%
controls:0.28%
—
—
cases:1.58%
controls:0.27%
cases:3.45%
controls:0.90%
cases:6.63%
controls:2.27%
78
322
2215
22618
53
185
2240
22755
25
65
2268
22875
—
36
61
2248
22824
75
198
2100
21909
118
425
1662
18295
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
7.1e-01
1.0e+00
1.5e+00
—
2.0e+00
1.4e+00
1.0e+00
cases:2.09%
controls:1.04%
cases:1.53%
controls:0.56%
cases:0.57%
controls:0.13%
—
—
cases:0.74%
controls:0.10%
cases:2.44%
controls:0.59%
cases:4.49%
controls:1.70%
48
239
2245
22701
35
128
2258
22812
13
30
2280
22910
—
17
24
2267
22861
53
131
2122
21976
80
318
1700
18402
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
6.6e-01
8.3e-01
1.6e+00
—
2.7e+00
9.9e-01
8.4e-01
cases:2.66%
controls:1.39%
cases:1.57%
controls:0.69%
cases:0.52%
controls:0.10%
—
—
cases:1.23%
controls:0.09%
cases:2.21%
controls:0.83%
cases:6.97%
controls:3.15%
61
320
2232
22620
36
159
2257
22781
12
24
2281
22916
—
28
20
2256
22865
48
183
2127
21924
124
589
1656
18131
Extraction of multiple teeth
EBA15 [2001301927]
EBA15 [2001301927]
1.3e+00
2.1e+00
—
—
—
2.2e+00
2.0e+00
cases:1.53%
controls:0.41%
cases:0.78%
controls:0.10%
—
—
—
—
—
—
cases:0.97%
controls:0.11%
cases:2.87%
controls:0.38%
35
94
2258
22846
18
23
2275
22917
—
—
—
21
25
2154
22082
51
72
1729
18648
folic acid
V04CX02 [715877]
V04CX02 [715877]
1.1e+00
1.2e+00
1.6e+00
—
1.5e+00
1.4e+00
8.1e-01
cases:3.01%
controls:1.06%
cases:2.79%
controls:0.84%
cases:0.83%
controls:0.17%
—
—
cases:0.74%
controls:0.17%
cases:3.91%
controls:1.00%
cases:6.01%
controls:2.76%
69
243
2224
22697
64
193
2229
22747
19
39
2274
22901
—
17
39
2267
22846
85
222
2090
21885
107
517
1673
18203
folic acid; oral, parenteral
B03BB01 [21601129]
B03BB01 [21601129]
1.1e+00
1.2e+00
1.6e+00
—
1.5e+00
1.4e+00
8.1e-01
cases:3.01%
controls:1.06%
cases:2.79%
controls:0.84%
cases:0.83%
controls:0.17%
—
—
cases:0.74%
controls:0.17%
cases:3.91%
controls:1.00%
cases:6.01%
controls:2.76%
69
243
2224
22697
64
193
2229
22747
19
39
2274
22901
—
17
39
2267
22846
85
222
2090
21885
107
517
1673
18203
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
MA2AE [2001306829]
MA2AE [2001306829]
-3.3e-02
1.3e+00
2.3e+00
—
2.6e+00
1.4e+00
1.1e-01
cases:2.49%
controls:2.57%
cases:2.97%
controls:0.85%
cases:1.48%
controls:0.14%
—
—
cases:1.58%
controls:0.12%
cases:3.36%
controls:0.88%
cases:3.31%
controls:2.98%
57
589
2236
22351
68
196
2225
22744
34
33
2259
22907
—
36
28
2248
22857
73
194
2102
21913
59
558
1721
18162
Retained dental root
K08.3 [45543292]
K08.3 [45543292]
9.9e-01
1.2e+00
—
1.0e+50
2.6e+00
1.6e+00
1.2e+00
cases:2.44%
controls:0.92%
cases:0.92%
controls:0.28%
—
—
cases:0.22%
controls:0.00%
cases:0.53%
controls:0.04%
cases:1.66%
controls:0.33%
cases:3.60%
controls:1.15%
56
211
2237
22729
21
65
2272
22875
—
5
0
2288
22940
12
9
2272
22876
36
74
2139
22033
64
215
1716
18505
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
8.1e-01
1.1e+00
1.9e+00
—
1.5e+00
1.0e+00
1.2e+00
cases:2.35%
controls:1.06%
cases:2.31%
controls:0.79%
cases:1.00%
controls:0.15%
—
—
cases:0.70%
controls:0.16%
cases:2.57%
controls:0.94%
cases:7.47%
controls:2.41%
54
243
2239
22697
53
181
2240
22759
23
34
2270
22906
—
16
36
2268
22849
56
207
2119
21900
133
452
1647
18268
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
5.6e-01
9.3e-01
1.6e+00
—
2.4e+00
1.0e+00
1.0e+00
cases:7.63%
controls:4.51%
cases:4.84%
controls:1.97%
cases:1.48%
controls:0.30%
—
—
cases:2.71%
controls:0.25%
cases:5.84%
controls:2.20%
cases:17.64%
controls:7.20%
175
1034
2118
21906
111
452
2182
22488
34
69
2259
22871
—
62
58
2222
22827
127
487
2048
21620
314
1348
1466
17372
Headache
R51.80 [2000503603]
R51.80 [2000503603]
6.0e-01
7.7e-01
2.5e+00
—
1.9e+00
9.8e-01
7.8e-01
cases:3.79%
controls:2.11%
cases:1.35%
controls:0.63%
cases:0.57%
controls:0.05%
—
—
cases:0.35%
controls:0.05%
cases:1.61%
controls:0.61%
cases:4.89%
controls:2.30%
87
485
2206
22455
31
144
2262
22796
13
11
2280
22929
—
8
12
2276
22873
35
135
2140
21972
87
430
1693
18290
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
3.4e-01
1.2e+00
3.2e+00
—
1.7e+00
7.8e-01
5.7e-01
cases:4.62%
controls:3.35%
cases:3.88%
controls:1.18%
cases:1.61%
controls:0.07%
—
—
cases:0.53%
controls:0.09%
cases:2.62%
controls:1.22%
cases:7.98%
controls:4.67%
106
768
2187
22172
89
271
2204
22669
37
16
2256
22924
—
12
21
2272
22864
57
270
2118
21837
142
875
1638
17845
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
1.3e-01
1.0e+00
2.8e+00
—
2.5e+00
1.4e+00
8.5e-01
cases:0.61%
controls:0.54%
cases:0.52%
controls:0.19%
cases:0.35%
controls:0.02%
—
—
cases:0.26%
controls:0.02%
cases:0.64%
controls:0.17%
cases:1.52%
controls:0.66%
14
123
2279
22817
12
43
2281
22897
8
5
2285
22935
—
6
5
2278
22880
14
37
2161
22070
27
123
1753
18597
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
4.5e-01
8.6e-01
1.5e+00
—
2.0e+00
1.6e+00
1.1e+00
cases:3.27%
controls:2.10%
cases:2.31%
controls:0.99%
cases:0.74%
controls:0.17%
—
—
cases:1.14%
controls:0.15%
cases:4.28%
controls:0.90%
cases:8.26%
controls:3.04%
75
482
2218
22458
53
228
2240
22712
17
40
2276
22900
—
26
34
2258
22851
93
198
2082
21909
147
570
1633
18150
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
7.1e-01
8.2e-01
1.8e+00
—
2.1e+00
1.2e+00
8.1e-01
cases:4.36%
controls:2.18%
cases:1.70%
controls:0.76%
cases:0.52%
controls:0.09%
—
—
cases:0.61%
controls:0.08%
cases:2.57%
controls:0.76%
cases:5.22%
controls:2.39%
100
501
2193
22439
39
174
2254
22766
12
20
2281
22920
—
14
18
2270
22867
56
167
2119
21940
93
447
1687
18273
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
5.4e-01
7.4e-01
1.2e+00
2.1e+00
1.2e+00
8.2e-01
7.5e-01
cases:27.00%
controls:17.74%
cases:13.04%
controls:6.66%
cases:3.62%
controls:1.07%
cases:0.39%
controls:0.05%
cases:3.81%
controls:1.14%
cases:13.01%
controls:6.18%
cases:28.31%
controls:15.71%
619
4069
1674
18871
299
1527
1994
21413
83
246
2210
22694
9
11
2284
22929
87
260
2197
22625
283
1366
1892
20741
504
2940
1276
15780
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
8.8e-01
1.3e+00
—
—
2.8e+00
1.4e+00
1.1e+00
cases:1.05%
controls:0.44%
cases:0.70%
controls:0.18%
—
—
—
—
cases:0.48%
controls:0.03%
cases:0.78%
controls:0.20%
cases:1.85%
controls:0.65%
24
100
2269
22840
16
42
2277
22898
—
—
11
7
2273
22878
17
44
2158
22063
33
121
1747
18599
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
4.9e-01
6.8e-01
1.1e+00
1.1e+00
1.8e+00
1.4e+00
7.8e-01
cases:8.50%
controls:5.41%
cases:5.19%
controls:2.69%
cases:2.44%
controls:0.83%
cases:0.61%
controls:0.20%
cases:4.82%
controls:0.80%
cases:11.40%
controls:3.04%
cases:16.74%
controls:8.41%
195
1241
2098
21699
119
616
2174
22324
56
190
2237
22750
14
46
2279
22894
110
182
2174
22703
248
671
1927
21436
298
1575
1482
17145
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
6.5e-02
2.8e-01
8.5e-01
4.5e+00
1.4e+00
7.0e-01
2.0e-01
cases:4.54%
controls:4.26%
cases:2.97%
controls:2.25%
cases:0.96%
controls:0.41%
cases:2.66%
controls:0.03%
cases:1.66%
controls:0.42%
cases:4.18%
controls:2.13%
cases:5.90%
controls:4.87%
104
978
2189
21962
68
516
2225
22424
22
95
2271
22845
61
7
2232
22933
38
97
2246
22788
91
470
2084
21637
105
911
1675
17809
General Surgery
2 [38004447]
2 [38004447]
6.0e-01
6.5e-01
8.3e-01
2.9e+00
8.8e-01
8.5e-01
7.3e-01
cases:23.16%
controls:14.15%
cases:7.33%
controls:3.98%
cases:1.18%
controls:0.52%
cases:0.61%
controls:0.03%
cases:1.36%
controls:0.57%
cases:7.68%
controls:3.43%
cases:17.75%
controls:9.44%
531
3246
1762
19694
168
912
2125
22028
27
119
2266
22821
14
8
2279
22932
31
130
2253
22755
167
758
2008
21349
316
1768
1464
16952
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
6.6e-02
3.1e-01
1.2e+00
3.5e+00
1.6e+00
4.1e-01
3.8e-01
cases:20.72%
controls:19.66%
cases:13.39%
controls:10.14%
cases:4.01%
controls:1.23%
cases:1.00%
controls:0.03%
cases:5.21%
controls:1.12%
cases:14.57%
controls:10.15%
cases:36.97%
controls:28.68%
475
4509
1818
18431
307
2326
1986
20614
92
283
2201
22657
23
7
2270
22933
119
256
2165
22629
317
2244
1858
19863
658
5368
1122
13352
Mixed asthma
J45.8 [45548118]
J45.8 [45548118]
1.6e+00
2.2e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:1.26%
controls:0.25%
cases:0.78%
controls:0.09%
—
—
cases:0.44%
controls:0.00%
—
—
cases:0.97%
controls:0.10%
cases:1.07%
controls:0.30%
29
58
2264
22882
18
20
2275
22920
—
10
0
2283
22940
—
21
22
2154
22085
19
56
1761
18664
Urine methamphetamine measurement
313579004 [4198724]
313579004 [4198724]
1.6e+00
1.7e+00
—
—
—
2.1e+00
2.1e+00
cases:0.92%
controls:0.19%
cases:0.35%
controls:0.07%
—
—
—
—
—
—
cases:0.32%
controls:0.04%
cases:1.12%
controls:0.14%
21
44
2272
22896
8
15
2285
22925
—
—
—
7
9
2168
22098
20
27
1760
18693
Nephrology
39 [38004479]
39 [38004479]
6.0e-01
7.7e-01
8.5e-01
3.1e+00
1.3e+00
9.5e-01
7.4e-01
cases:2.09%
controls:1.16%
cases:1.96%
controls:0.92%
cases:0.78%
controls:0.34%
cases:0.83%
controls:0.04%
cases:0.96%
controls:0.28%
cases:2.11%
controls:0.83%
cases:2.58%
controls:1.24%
48
267
2245
22673
45
211
2248
22729
18
77
2275
22863
19
9
2274
22931
22
63
2262
22822
46
184
2129
21923
46
233
1734
18487
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
6.6e-01
9.0e-01
1.4e+00
—
2.5e+00
1.0e+00
8.7e-01
cases:4.01%
controls:2.11%
cases:2.27%
controls:0.94%
cases:0.65%
controls:0.16%
—
—
cases:1.31%
controls:0.11%
cases:3.03%
controls:1.12%
cases:9.55%
controls:4.25%
92
483
2201
22457
52
215
2241
22725
15
37
2278
22903
—
30
25
2254
22860
66
247
2109
21860
170
795
1610
17925
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
6.4e-01
1.6e+00
2.9e+00
—
—
1.5e+00
1.3e+00
cases:1.00%
controls:0.53%
cases:1.00%
controls:0.20%
cases:0.39%
controls:0.02%
—
—
—
—
cases:0.69%
controls:0.15%
cases:2.47%
controls:0.68%
23
122
2270
22818
23
47
2270
22893
9
5
2284
22935
—
—
15
33
2160
22074
44
127
1736
18593
vilanterol and umeclidinium bromide
R03AL03 [43534845]
R03AL03 [43534845]
2.0e+00
1.6e+00
—
—
1.8e+00
2.1e+00
1.6e+00
cases:0.61%
controls:0.08%
cases:0.48%
controls:0.10%
—
—
—
—
cases:0.22%
controls:0.03%
cases:0.69%
controls:0.08%
cases:1.07%
controls:0.22%
14
19
2279
22921
11
23
2282
22917
—
—
5
8
2279
22877
15
18
2160
22089
19
41
1761
18679
carbimazole; oral
H03BB01 [21602765]
H03BB01 [21602765]
-1.6e-02
8.8e-02
1.9e+00
—
2.6e+00
1.4e+00
1.4e+00
cases:0.52%
controls:0.53%
cases:0.26%
controls:0.24%
cases:0.39%
controls:0.06%
—
—
cases:0.53%
controls:0.04%
cases:0.78%
controls:0.19%
cases:1.69%
controls:0.42%
12
122
2281
22818
6
55
2287
22885
9
14
2284
22926
—
12
9
2272
22876
17
41
2158
22066
30
79
1750
18641
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
PD4CG [2001309216]
PD4CG [2001309216]
2.0e+00
—
—
—
—
2.5e+00
2.8e+00
cases:0.65%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.32%
controls:0.03%
cases:0.96%
controls:0.06%
15
20
2278
22920
—
—
—
—
7
6
2168
22101
17
11
1763
18709
Other extensive ultrasound examination of artery
PG1DE [2001309713]
PG1DE [2001309713]
8.5e-01
2.2e+00
—
1.0e+50
—
2.8e+00
1.5e+00
cases:1.22%
controls:0.53%
cases:1.26%
controls:0.15%
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.47%
controls:0.09%
cases:1.91%
controls:0.42%
28
121
2265
22819
29
34
2264
22906
—
15
0
2278
22940
—
32
21
2143
22086
34
78
1746
18642
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
1.9e-01
4.4e-01
1.3e+00
3.0e+00
1.5e+00
4.1e-01
4.6e-01
cases:33.01%
controls:28.99%
cases:24.99%
controls:17.64%
cases:7.98%
controls:2.27%
cases:1.09%
controls:0.06%
cases:9.50%
controls:2.28%
cases:25.56%
controls:18.54%
cases:57.30%
controls:45.94%
757
6650
1536
16290
573
4047
1720
18893
183
521
2110
22419
25
13
2268
22927
217
521
2067
22364
556
4099
1619
18008
1020
8600
760
10120
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
3.3e-01
6.9e-01
9.7e-01
3.3e+00
1.1e+00
5.3e-01
3.1e-01
cases:10.12%
controls:7.50%
cases:5.80%
controls:3.01%
cases:1.35%
controls:0.51%
cases:0.70%
controls:0.03%
cases:1.66%
controls:0.54%
cases:5.15%
controls:3.08%
cases:10.73%
controls:8.08%
232
1721
2061
21219
133
690
2160
22250
31
118
2262
22822
16
6
2277
22934
38
123
2246
22762
112
682
2063
21425
191
1513
1589
17207
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1961-2 [3015235]
1.3e+00
1.0e+00
1.9e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:1.05%
controls:0.29%
cases:0.57%
controls:0.21%
cases:0.31%
controls:0.04%
—
—
cases:0.39%
controls:0.06%
cases:0.92%
controls:0.32%
cases:2.92%
controls:0.98%
24
67
2269
22873
13
48
2280
22892
7
10
2286
22930
—
9
14
2275
22871
20
71
2155
22036
52
184
1728
18536
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
4.0e-01
1.0e+00
1.9e+00
—
1.9e+00
1.1e+00
9.7e-01
cases:4.23%
controls:2.88%
cases:3.40%
controls:1.24%
cases:0.83%
controls:0.13%
—
—
cases:0.83%
controls:0.13%
cases:2.94%
controls:1.01%
cases:8.26%
controls:3.30%
97
661
2196
22279
78
284
2215
22656
19
29
2274
22911
—
19
30
2265
22855
64
223
2111
21884
147
618
1633
18102
acetylcysteine
V03AB23 [21605248]
V03AB23 [21605248]
1.5e+00
2.8e+00
—
—
—
1.6e+00
1.2e+00
cases:0.96%
controls:0.22%
cases:0.74%
controls:0.04%
—
—
—
—
—
—
cases:0.46%
controls:0.09%
cases:1.12%
controls:0.33%
22
51
2271
22889
17
10
2276
22930
—
—
—
10
20
2165
22087
20
61
1760
18659
acetylcysteine; inhalant, oral
R05CB01 [21603380]
R05CB01 [21603380]
1.5e+00
2.8e+00
—
—
—
1.6e+00
1.2e+00
cases:0.96%
controls:0.22%
cases:0.74%
controls:0.04%
—
—
—
—
—
—
cases:0.46%
controls:0.09%
cases:1.12%
controls:0.33%
22
51
2271
22889
17
10
2276
22930
—
—
—
10
20
2165
22087
20
61
1760
18659
Type 2 diabetes mellitus, with peripheral circulatory complications
E11.5 [45557114]
E11.5 [45557114]
1.6e+00
2.0e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:0.48%
controls:0.10%
cases:0.44%
controls:0.06%
—
—
cases:0.35%
controls:0.00%
—
—
cases:0.51%
controls:0.05%
cases:0.67%
controls:0.19%
11
23
2282
22917
10
14
2283
22926
—
8
0
2285
22940
—
11
11
2164
22096
12
35
1768
18685
Health check-up of pregnant person
SPAT1379 [2001700479]
SPAT1379 [2001700479]
8.9e-02
1.4e+00
2.1e+00
—
2.2e+00
1.4e+00
4.1e-01
cases:2.53%
controls:2.32%
cases:4.93%
controls:1.26%
cases:3.88%
controls:0.50%
—
—
cases:4.03%
controls:0.45%
cases:4.74%
controls:1.20%
cases:4.21%
controls:2.85%
58
532
2235
22408
113
288
2180
22652
89
114
2204
22826
—
92
104
2192
22781
103
265
2072
21842
75
533
1705
18187
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
7.2e-01
7.3e-01
9.7e-01
2.1e+00
1.1e+00
7.4e-01
7.3e-01
cases:13.13%
controls:6.88%
cases:7.54%
controls:3.80%
cases:2.31%
controls:0.88%
cases:0.35%
controls:0.04%
cases:2.80%
controls:0.91%
cases:7.59%
controls:3.77%
cases:12.53%
controls:6.45%
301
1578
1992
21362
173
872
2120
22068
53
203
2240
22737
8
10
2285
22930
64
209
2220
22676
165
834
2010
21273
223
1207
1557
17513
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
8.9e-01
1.2e+00
2.5e+00
1.0e+50
1.8e+00
1.3e+00
1.3e+00
cases:1.92%
controls:0.80%
cases:1.13%
controls:0.34%
cases:0.31%
controls:0.03%
cases:0.78%
controls:0.00%
cases:0.22%
controls:0.03%
cases:1.29%
controls:0.37%
cases:3.54%
controls:1.01%
44
183
2249
22757
26
78
2267
22862
7
6
2286
22934
18
0
2275
22940
5
8
2279
22877
28
81
2147
22026
63
190
1717
18530
Biopsy of tongue or floor of mouth
EJA10 [2001302171]
EJA10 [2001302171]
1.5e+00
1.8e+00
1.0e+50
—
—
2.3e+00
1.5e+00
cases:0.78%
controls:0.18%
cases:0.44%
controls:0.07%
cases:0.22%
controls:0.00%
—
—
—
—
cases:0.32%
controls:0.03%
cases:0.84%
controls:0.18%
18
42
2275
22898
10
17
2283
22923
5
0
2288
22940
—
—
7
7
2168
22100
15
34
1765
18686
Plastic repair of femoral artery
PEN23 [2001309286]
PEN23 [2001309286]
2.0e+00
2.6e+00
—
—
—
—
2.5e+00
cases:0.35%
controls:0.05%
cases:0.31%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.05%
8
11
2285
22929
7
5
2286
22935
—
—
—
—
11
10
1769
18710
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
2.8e-01
4.4e-01
8.4e-01
3.5e+00
9.8e-01
6.7e-01
3.2e-01
cases:80.72%
controls:76.04%
cases:76.80%
controls:68.07%
cases:47.01%
controls:27.65%
cases:37.77%
controls:1.73%
cases:50.44%
controls:27.56%
cases:82.57%
controls:70.77%
cases:91.24%
controls:88.32%
1851
17444
442
5496
1761
15615
532
7325
1078
6343
1215
16597
866
398
1427
22542
1152
6308
1132
16577
1796
15646
379
6461
1624
16534
156
2186
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
9.3e-01
9.8e-01
1.5e+00
1.0e+50
1.4e+00
1.1e+00
1.2e+00
cases:2.53%
controls:1.01%
cases:1.05%
controls:0.40%
cases:0.48%
controls:0.11%
cases:0.26%
controls:0.00%
cases:0.44%
controls:0.10%
cases:1.10%
controls:0.38%
cases:2.47%
controls:0.77%
58
232
2235
22708
24
91
2269
22849
11
25
2282
22915
6
0
2287
22940
10
24
2274
22861
24
85
2151
22022
44
145
1736
18575
Multiple sclerosis
G35 [45571794]
G35 [45571794]
5.6e-01
9.9e-01
1.6e+00
—
1.7e+00
1.4e+00
1.4e+00
cases:0.65%
controls:0.37%
cases:0.83%
controls:0.31%
cases:0.65%
controls:0.13%
—
—
cases:0.57%
controls:0.11%
cases:1.33%
controls:0.34%
cases:1.74%
controls:0.43%
15
86
2278
22854
19
71
2274
22869
15
29
2278
22911
—
13
25
2271
22860
29
76
2146
22031
31
81
1749
18639
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
1.3e+00
1.0e+00
1.6e+00
—
8.8e-01
1.5e+00
1.7e+00
cases:2.18%
controls:0.63%
cases:1.00%
controls:0.36%
cases:0.44%
controls:0.09%
—
—
cases:0.31%
controls:0.13%
cases:1.47%
controls:0.35%
cases:2.70%
controls:0.51%
50
145
2243
22795
23
82
2270
22858
10
20
2283
22920
—
7
29
2277
22856
32
77
2143
22030
48
95
1732
18625
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
7.4e-01
7.7e-01
1.9e+00
—
1.8e+00
9.0e-01
8.3e-01
cases:4.49%
controls:2.20%
cases:1.48%
controls:0.69%
cases:0.39%
controls:0.06%
—
—
cases:0.44%
controls:0.07%
cases:1.75%
controls:0.72%
cases:4.83%
controls:2.17%
103
504
2190
22436
34
159
2259
22781
9
13
2284
22927
—
10
16
2274
22869
38
159
2137
21948
86
406
1694
18314
Drug use
Z72.2 [45571385]
Z72.2 [45571385]
2.2e+00
2.9e+00
—
1.0e+50
1.0e+50
—
1.9e+00
cases:0.61%
controls:0.07%
cases:0.57%
controls:0.03%
—
—
cases:1.00%
controls:0.00%
cases:0.48%
controls:0.00%
—
—
cases:0.39%
controls:0.06%
14
16
2279
22924
13
7
2280
22933
—
23
0
2270
22940
11
0
2273
22885
—
7
11
1773
18709
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
113016006 [4010399]
8.3e-01
1.4e+00
2.4e+00
—
1.3e+00
1.4e+00
9.9e-01
cases:4.54%
controls:2.03%
cases:2.83%
controls:0.72%
cases:0.78%
controls:0.07%
—
—
cases:0.35%
controls:0.10%
cases:2.76%
controls:0.73%
cases:6.40%
controls:2.47%
104
465
2189
22475
65
166
2228
22774
18
16
2275
22924
—
8
22
2276
22863
60
161
2115
21946
114
463
1666
18257
chlorprothixene; oral, parenteral
N05AF03 [21604533]
N05AF03 [21604533]
1.6e+00
1.7e+00
1.5e+00
—
—
1.7e+00
2.1e+00
cases:1.53%
controls:0.32%
cases:0.87%
controls:0.16%
cases:0.26%
controls:0.06%
—
—
—
—
cases:0.83%
controls:0.16%
cases:1.74%
controls:0.22%
35
74
2258
22866
20
37
2273
22903
6
14
2287
22926
—
—
18
35
2157
22072
31
42
1749
18678
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
1.0e+00
1.1e+00
1.2e+00
—
1.3e+00
1.1e+00
1.1e+00
cases:2.44%
controls:0.89%
cases:1.83%
controls:0.59%
cases:0.65%
controls:0.19%
—
—
cases:0.61%
controls:0.16%
cases:1.75%
controls:0.59%
cases:2.58%
controls:0.84%
56
205
2237
22735
42
136
2251
22804
15
44
2278
22896
—
14
37
2270
22848
38
131
2137
21976
46
158
1734
18562
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.9e+00
1.7e+00
—
—
—
1.5e+00
1.9e+00
cases:2.49%
controls:0.39%
cases:0.78%
controls:0.15%
—
—
—
—
—
—
cases:0.55%
controls:0.12%
cases:1.97%
controls:0.31%
57
90
2236
22850
18
34
2275
22906
—
—
—
12
26
2163
22081
35
58
1745
18662
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
8.4e-01
1.0e+00
1.4e+00
—
1.4e+00
1.2e+00
1.1e+00
cases:16.79%
controls:8.03%
cases:7.63%
controls:2.93%
cases:2.40%
controls:0.61%
—
—
cases:2.58%
controls:0.63%
cases:8.18%
controls:2.73%
cases:18.54%
controls:6.85%
385
1841
1908
21099
175
672
2118
22268
55
140
2238
22800
—
59
144
2225
22741
178
604
1997
21503
330
1282
1450
17438
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
6.4e-01
8.5e-01
1.6e+00
—
1.7e+00
1.2e+00
1.0e+00
cases:3.14%
controls:1.68%
cases:2.35%
controls:1.02%
cases:1.22%
controls:0.26%
—
—
cases:1.40%
controls:0.27%
cases:3.40%
controls:1.02%
cases:6.29%
controls:2.37%
72
386
2221
22554
54
235
2239
22705
28
60
2265
22880
—
32
62
2252
22823
74
226
2101
21881
112
443
1668
18277
Protein [Mass/volume] in Urine
2888-6 [3037121]
2888-6 [3037121]
8.9e-01
1.0e+00
2.4e+00
—
—
1.7e+00
9.2e-01
cases:1.57%
controls:0.65%
cases:0.92%
controls:0.33%
cases:0.39%
controls:0.03%
—
—
—
—
cases:1.56%
controls:0.30%
cases:2.25%
controls:0.91%
36
149
2257
22791
21
75
2272
22865
9
8
2284
22932
—
—
34
67
2141
22040
40
170
1740
18550
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
4548-4 [3004410]
2.2e-01
4.1e-01
1.2e+00
2.9e+00
1.4e+00
4.0e-01
4.0e-01
cases:31.88%
controls:27.39%
cases:26.38%
controls:19.21%
cases:8.02%
controls:2.56%
cases:1.35%
controls:0.08%
cases:9.85%
controls:2.60%
cases:28.00%
controls:20.63%
cases:57.92%
controls:48.02%
731
6284
1562
16656
605
4406
1688
18534
184
588
2109
22352
31
18
2262
22922
225
596
2059
22289
609
4561
1566
17546
1031
8990
749
9730
Alcohol use
Z72.1 [45552103]
Z72.1 [45552103]
1.6e+00
2.0e+00
1.0e+50
1.0e+50
—
3.3e+00
1.3e+00
cases:0.65%
controls:0.14%
cases:0.35%
controls:0.05%
cases:0.35%
controls:0.00%
cases:1.88%
controls:0.00%
—
—
cases:1.10%
controls:0.04%
cases:0.39%
controls:0.11%
15
31
2278
22909
8
11
2285
22929
8
0
2285
22940
43
0
2250
22940
—
24
9
2151
22098
7
21
1773
18699
budesonide; inhalant
R03BA02 [21603285]
R03BA02 [21603285]
4.6e-01
8.2e-01
1.1e+00
2.5e+00
8.3e-01
7.1e-01
5.3e-01
cases:8.94%
controls:5.82%
cases:6.59%
controls:3.00%
cases:1.96%
controls:0.69%
cases:0.31%
controls:0.03%
cases:1.58%
controls:0.69%
cases:5.93%
controls:3.00%
cases:8.15%
controls:4.98%
205
1336
2088
21604
151
688
2142
22252
45
158
2248
22782
7
6
2286
22934
36
159
2248
22726
129
663
2046
21444
145
932
1635
17788
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
511
1896
3.18
104.10
4.6
3.8
5.91
5.82
kpa
0.81
504
1843
453
1576
3.34
102.61
3.9
3.1
4.71
4.61
kpa
0.44
447
1529
491
1839
3.12
97.91
4.7
3.8
1.88
1.82
mmol/l
0.10
429
1581
1470
9503
2.52
95.79
9.6
7.5
1.20
1.21
mmol/l
4.62
1349
8274
1693
11788
2.66
92.65
7.4
5.2
6.86
6.64
mmol/l
3.58
1631
11091
537
2231
2.84
87.92
8.7
9.2
11.03
12.44
kpa
8.70
519
2156
537
2231
2.84
87.92
8.7
9.2
5.36
5.11
kpa
4.72
520
2153
1361
8698
2.39
87.82
13.3
12.8
1.16
1.20
inr
2.43
1150
7225
500
2015
2.89
86.53
8.9
9.6
94.04
95.76
%
5.19
484
1956
529
2207
2.82
85.70
8.7
9.2
1.36
0.79
mmol/l
1.88
443
1838
348
1176
3.31
81.50
3.6
3.2
133.11
130.98
g/l
0.82
340
1148
1520
10410
2.36
80.41
7.1
6.7
9.45
11.41
umol/l
6.75
1453
9966
1022
6016
2.26
76.79
2.8
2.2
203.65
226.52
u/l
0.34
986
5729
1058
6372
2.23
74.52
3.9
2.7
68.83
72.87
u/l
0.08
998
5939
1513
10520
2.29
74.50
7.9
6.6
0.05
0.04
e9/l
16.62
1368
9145
1510
10499
2.28
74.22
7.9
6.6
0.66
0.58
e9/l
28.71
1368
9130
1296
8502
2.21
73.18
9.0
6.8
1.20
1.21
mmol/l
4.33
1228
7921
616
2981
2.46
72.26
2.7
1.9
1.73
1.47
%
9.30
550
2641
1153
7253
2.19
72.03
5.0
3.5
48.44
58.58
ng/l
0.33
858
4738
1525
10761
2.24
70.59
8.0
6.6
2.09
1.96
e9/l
3.78
1394
9597
1615
11678
2.29
70.22
11.3
9.8
5.07
4.09
e9/l
47.55
1484
10210
1534
10865
2.24
70.13
8.4
6.8
0.21
0.19
e9/l
5.49
1404
9605
252
802
3.41
64.38
4.5
3.5
25.64
25.09
mmol/l
1.37
245
773
436
1894
2.61
63.49
9.8
10.1
123.08
122.94
g/l
0.04
424
1854
612
3124
2.31
62.34
2.3
1.9
—
—
—
0
0
1917
15257
2.56
61.76
10.2
8.3
83.08
76.87
u/l
3.52
1864
14580
329
1269
2.86
60.25
4.4
3.5
5.32
5.13
kpa
2.89
317
1227
878
5241
2.09
59.81
3.3
3.1
1591.82
1091.72
ng/l
2.34
769
4429
251
845
3.21
58.35
4.4
5.6
2.81
1.62
%
14.23
239
797
1245
8572
1.99
55.59
6.0
5.2
34.45
36.17
g/l
19.52
1195
8100
576
3043
2.19
52.79
2.2
2.1
29.66
29.50
s
0.21
563
2957
352
1508
2.58
52.03
1.6
1.4
—
—
—
0
0
281
1079
2.83
51.53
4.2
3.3
1.71
1.60
mmol/l
0.16
213
785
226
770
3.15
51.30
4.5
5.9
0.80
0.87
%
1.62
215
724
293
1168
2.73
49.95
9.0
7.6
25.13
24.46
mmol/l
1.79
281
1117
1842
14861
2.22
49.83
5.6
4.3
13.87
10.69
mm/h
14.80
1765
14008
278
1084
2.78
49.44
2.4
1.7
0.34
0.31
mg/l
0.27
161
535
313
1313
2.60
48.11
11.0
11.3
2.11
1.31
%
12.54
313
1308
385
1779
2.40
48.09
8.1
8.2
9.53
9.29
mmol/l
0.23
366
1722
1343
9809
1.89
46.87
3.1
2.8
—
—
estimate
—
0
0
310
1314
2.57
46.56
11.4
11.5
91.72
93.95
%
4.96
310
1309
456
2319
2.21
45.19
2.2
1.8
—
—
—
0
0
528
2846
2.11
45.07
1.8
1.7
1144.73
1162.05
nmol/l
0.15
406
2196
1346
9923
1.86
44.67
8.2
6.7
25.33
28.22
%
22.65
1314
9455
1328
9769
1.85
44.17
8.2
6.6
60.08
57.02
%
20.32
1296
9374
431
2208
2.17
41.63
2.2
1.8
—
—
—
0
0
1011
6954
1.81
40.77
5.7
3.5
7.52
8.12
mmol/l
3.61
901
6001
896
5958
1.83
40.28
4.7
3.7
0.00
0.00
estimate
1.54
256
2165
477
2570
2.08
40.26
7.5
6.5
1.08
1.03
mmol/l
3.48
452
2400
1434
10971
1.82
40.18
4.7
3.6
10.45
5.74
estimate
0.27
291
2341
416
2133
2.16
39.95
8.3
6.3
—
—
—
0
0
1438
11021
1.82
39.94
4.8
3.6
0.04
0.15
estimate
0.35
267
2172
1418
10852
1.80
39.25
4.7
3.6
0.00
0.00
estimate
0.50
284
2317
574
3344
1.96
38.71
3.1
3.6
0.80
0.82
mmol/l
3.89
552
3182
179
635
2.97
37.64
3.2
2.7
—
—
—
0
0
190
717
2.80
35.63
2.5
2.3
500.35
434.51
ug/l
0.12
180
679
1620
13095
1.81
35.21
5.5
4.3
487.83
1043.87
e6/l
0.59
29
168
412
2224
2.04
34.07
3.1
4.6
225.40
244.09
u/l
1.43
397
2125
721
4725
1.77
32.44
1.9
1.7
1.19
1.12
mg/l
0.23
570
3608
766
5111
1.75
32.34
2.7
2.3
—
—
—
0
0
726
4775
1.76
32.21
4.8
3.6
1.02
1.65
kg/l
0.80
478
3172
1136
8493
1.67
31.03
2.2
2.0
93.95
95.78
pmol/l
0.70
702
4690
225
986
2.42
31.00
1.7
1.5
—
—
—
0
0
244
1132
2.29
29.48
11.7
12.1
15.47
16.21
%
3.03
237
1090
181
734
2.59
29.38
1.5
1.6
110.06
0.23
iu/ml
0.49
30
109
77
185
4.27
29.28
1.8
1.5
1.69
1.09
promille
2.42
61
146
761
5199
1.69
28.76
2.6
2.2
3.03
2.71
mg/l
3.88
676
4493
781
5387
1.68
28.38
1.9
1.7
17.74
20.11
nmol/l
2.51
677
4655
168
681
2.58
27.27
4.5
3.6
24.61
24.83
mmol/l
0.45
161
632
981
7224
1.63
27.26
4.0
3.3
45.03
35.83
u/l
0.42
927
6830
1095
8295
1.61
26.99
4.6
3.5
2.11
0.04
estimate
0.49
238
1944
888
6400
1.63
26.79
5.2
4.3
15.68
9.17
mg/mmol
2.02
654
4120
2171
19913
2.68
26.42
26.3
14.8
22.66
23.20
mg/l
0.37
2023
16357
347
1920
1.95
26.24
2.3
2.3
0.21
0.22
g/l
0.80
313
1803
128
463
2.87
25.91
2.6
3.1
31.66
36.58
umol/l
1.16
120
423
292
1544
2.02
25.08
1.9
2.8
66.40
66.95
g/l
0.57
276
1452
2178
20074
2.68
25.00
29.0
16.8
139.05
139.67
mmol/l
21.47
2166
19709
1714
14624
1.68
24.88
5.0
3.3
63.49
47.04
u/l
5.50
1629
13938
50
96
5.30
24.88
1.7
3.2
90.57
117.66
umol/l
0.40
21
59
176
766
2.41
24.52
2.1
2.0
2.05
1.81
ug/l
0.14
162
695
2180
20130
2.67
24.39
28.8
17.0
4.01
3.96
mmol/l
14.20
2165
19730
233
1154
2.13
23.81
3.1
2.3
10338.66
6454.21
u/l
0.60
90
483
520
3345
1.72
23.81
3.2
2.6
11.46
13.84
umol/l
10.08
493
3126
763
5433
1.61
23.42
2.8
2.7
331.23
341.56
umol/l
1.89
669
4871
97
318
3.14
23.34
6.8
6.3
354.93
360.15
umol/l
0.12
82
283
223
1105
2.13
22.73
2.1
1.6
—
—
—
0
0
100
340
3.03
22.62
1.4
1.3
15.28
20.59
u/l
1.24
85
282
639
4426
1.62
21.67
3.3
2.7
7.19
5.70
e6/l
1.82
605
4023
725
5192
1.58
21.28
5.3
4.1
91.97
91.10
%
0.40
700
5088
880
6589
1.54
21.17
3.0
3.4
2.34
2.35
mmol/l
2.38
814
6060
866
6466
1.55
21.08
4.4
3.3
65.08
92.75
e6/l
0.48
720
4910
346
2047
1.81
20.94
2.4
2.2
379.66
376.91
nmol/l
0.08
323
1914
286
1594
1.91
20.91
3.1
2.5
0.61
0.45
e6/l
0.38
273
1519
479
3109
1.68
20.89
3.2
2.6
2.41
2.34
g/l
1.39
446
2892
121
478
2.62
20.68
1.4
1.5
—
—
—
0
0
275
1520
1.92
20.61
2.7
2.3
6.73
8.46
ug/l
0.27
244
1381
156
698
2.33
20.38
1.5
1.5
—
—
—
0
0
93
323
2.96
20.28
1.8
1.5
426.32
342.57
mu/l
0.74
77
265
442
2854
1.68
19.52
3.3
2.7
19.69
23.77
%
7.87
422
2668
545
3721
1.61
19.26
1.4
1.3
17.90
10.25
u/ml
1.34
227
1521
128
2746
0.43
19.25
1.5
2.0
3.90
3.52
ratio
1.29
90
2096
181
889
2.12
18.82
4.6
3.0
1.02
1.02
ratio
0.66
165
814
1128
9059
1.48
18.60
2.7
2.4
68.42
75.55
nmol/l
15.49
1045
8358
278
1605
1.83
18.10
2.5
2.7
79.00
71.03
e9/l
2.15
210
1166
1138
9194
1.47
17.97
15.1
11.2
0.00
0.00
e9/l
0.09
968
7568
575
4037
1.57
17.85
1.4
1.3
58.78
28.68
iu/ml
2.05
188
1211
101
395
2.63
17.63
1.5
1.5
—
—
—
0
0
88
322
2.80
17.48
1.4
1.5
—
—
—
0
0
73
241
3.10
17.41
1.2
1.1
—
—
—
0
0
95
367
2.66
17.00
1.1
1.2
730.00
539.20
titre
—
6
25
263
1521
1.82
16.99
1.3
1.3
348.59
272.82
u/ml
0.48
247
1411
102
411
2.55
16.77
1.4
1.5
—
—
—
0
0
286
1712
1.77
16.44
2.2
2.8
10.16
10.65
g/l
0.94
262
1600
99
400
2.54
16.19
1.4
1.5
—
—
—
0
0
167
843
2.06
16.14
2.0
1.9
1.72
1.50
g/l
2.33
152
739
176
911
2.01
15.87
1.6
1.9
10.18
6.31
iu/ml
0.45
56
209
735
5568
1.47
15.51
4.3
3.2
0.46
0.39
e6/l
0.46
586
4054
237
1366
1.82
15.44
1.6
1.7
—
—
—
0
0
2017
18586
1.71
15.32
6.5
5.2
1.78
1.85
mu/l
1.46
1917
17439
53
160
3.37
14.66
1.5
1.4
24320.07
68971.05
e6/l
0.87
30
86
61
202
3.07
14.52
4.8
6.2
8.01
7.33
mmol/l
0.58
54
171
490
3469
1.52
14.22
3.8
2.9
1.38
0.96
e6/l
2.25
304
1816
113
515
2.26
14.17
1.3
1.2
1.60
3.93
u/ml
—
5
30
95
2045
0.44
14.16
1.3
1.7
3.48
3.45
mmol/l
0.07
55
1408
62
211
2.99
14.09
1.5
1.5
34.01
33.01
g/l
0.23
53
188
70
257
2.78
13.87
1.5
1.3
—
—
—
0
0
125
601
2.14
13.74
2.1
3.8
67.21
59.67
mg/l
0.09
103
508
183
1009
1.88
13.70
2.7
2.1
0.00
0.76
estimate
0.51
45
334
125
602
2.14
13.68
2.1
3.8
53.29
66.61
mg/l
0.49
103
509
515
3717
1.50
13.55
4.9
3.6
749.56
493.14
ng/l
0.47
406
2695
2065
19268
1.72
13.46
21.7
13.9
88.30
85.84
ml/min/173m2
5.27
1953
17745
56
186
3.06
13.28
1.5
1.4
2002.45
6685.72
e6/l
0.46
40
123
1749
15746
1.47
13.21
5.3
4.3
14.92
14.61
pmol/l
5.85
1648
14625
110
514
2.20
13.00
1.3
1.3
—
—
—
0
0
138
709
2.01
12.72
2.4
2.0
—
—
—
0
0
228
1382
1.72
12.44
4.7
4.2
99.65
88.22
ng/l
0.66
208
1234
125
630
2.04
12.16
1.3
1.2
9.57
2.27
u/ml
0.59
16
47
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
576
2.09
12.12
2.8
3.0
0.32
0.34
iu/ml
0.19
61
300
237
1467
1.69
11.97
4.5
3.9
1.22
1.23
mmol/l
0.17
216
1276
40
116
3.49
11.82
2.8
2.4
7.89
8.04
mmol/l
0.09
40
116
126
645
2.01
11.75
2.3
1.8
—
—
—
0
0
112
555
2.07
11.42
1.4
1.7
—
—
—
0
0
123
632
2.00
11.36
1.3
1.3
6.22
11.04
u/ml
0.53
25
81
48
161
3.02
11.24
16.6
16.1
737.88
824.70
nmol/l
0.63
48
156
338
2315
1.54
11.21
5.0
4.6
30.89
31.52
%
0.49
272
1607
174
1014
1.77
10.90
1.6
1.5
—
—
—
0
0
39
120
3.29
10.55
1.8
1.5
630109.00
1311466.56
iu/ml
—
6
9
107
538
2.04
10.51
2.0
3.6
1.91
4.06
ratio
1.15
63
296
407
2937
1.47
10.44
2.5
2.1
—
—
—
0
0
57
221
2.62
10.24
1.3
1.9
—
—
—
0
0
518
3925
1.41
10.18
1.8
1.7
409.83
33175214.46
pmol/l
3.75
450
3364
2206
21207
2.05
10.15
30.7
18.5
76.37
76.39
umol/l
0.00
2196
21008
82
377
2.22
10.14
1.1
1.1
16.38
1596.18
iu/ml
0.54
16
84
38
118
3.26
10.14
1.2
1.1
—
—
—
0
0
91
438
2.12
10.04
2.5
2.5
226.49
126.61
ug/min
0.67
54
266
24
54
4.48
10.02
3.1
3.1
9.48
10.28
kpa
0.78
24
54
24
54
4.48
10.02
3.1
3.1
5.10
4.98
kpa
0.20
24
54
336
2371
1.49
9.60
2.7
2.8
11.49
7.47
umol/l
1.37
282
2089
210
1336
1.63
9.52
1.6
1.9
1.39
1.32
g/l
0.15
184
1243
435
3234
1.43
9.45
2.6
2.2
—
—
—
0
0
226
1474
1.59
9.24
2.4
2.4
29.63
19.47
au/ml
0.57
18
169
56
230
2.47
8.98
1.4
1.4
1.56
1.45
nmol/l
0.19
49
210
44
161
2.77
8.88
2.9
2.1
—
—
—
0
0
211
1368
1.60
8.85
1.3
1.3
35.29
55.49
au/ml
—
8
96
83
406
2.08
8.82
1.6
1.6
—
—
—
0
0
79
380
2.12
8.77
1.2
1.3
10.19
4.11
u/ml
0.70
32
141
2191
21100
1.85
8.72
16.7
11.7
28.00
27.17
u/l
0.65
2166
20599
425
3191
1.41
8.67
4.0
3.0
4.35
2.21
e6/l
3.05
240
1540
267
1844
1.51
8.44
3.0
4.5
17.71
20.75
ug/l
0.12
248
1487
44
166
2.68
8.40
2.4
1.5
—
—
—
0
0
103
554
1.90
8.39
1.8
1.7
—
—
—
0
0
18
37
4.90
8.36
2.9
2.1
—
—
—
0
0
50
202
2.51
8.32
1.3
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
34
113
3.04
8.16
1.2
1.1
—
—
—
0
0
88
454
1.98
8.11
3.3
2.0
0.87
0.91
nmol/l
0.14
70
387
99
533
1.90
8.05
1.4
1.7
—
—
—
0
0
69
327
2.14
7.99
1.1
1.1
1.59
1.48
g/l
1.15
57
302
108
603
1.83
7.85
1.6
1.5
265.41
288.67
ug/g
0.47
56
354
124
723
1.76
7.80
1.5
2.4
7.67
7.30
g/l
1.75
119
679
124
723
1.76
7.80
1.5
2.4
4.44
4.21
g/l
1.19
119
678
124
723
1.76
7.80
1.5
2.4
4.14
3.74
g/l
0.46
119
679
77
387
2.02
7.65
6.2
8.2
103.66
105.41
mmol/l
1.84
68
348
1981
18727
1.42
7.65
8.3
5.9
41.32
38.76
mmol/mol
21.34
1885
17770
34
118
2.91
7.59
1.3
1.4
141.14
140.73
nmol/l
0.01
34
118
94
508
1.89
7.58
1.4
1.4
328.25
1092.45
e6/l
0.89
77
397
233
1610
1.50
7.34
2.5
2.6
72.53
70.38
ml/min/173m2
0.24
88
634
194
1290
1.55
7.31
2.7
2.8
191.46
159.42
ng/l
0.47
183
1176
92
500
1.88
7.30
1.3
1.4
65.62
35.81
e6/l
0.21
71
372
152
954
1.64
7.30
1.6
2.0
41.22
39.21
u/l
0.58
141
854
197
1317
1.54
7.24
3.8
3.7
4.53
4.57
pmol/l
0.25
179
1186
74
375
2.01
7.21
1.3
1.3
4.68
5.02
u/ml
0.06
41
176
28
90
3.14
7.14
1.2
1.1
407.33
227.36
ng/l
—
6
25
72
363
2.02
7.12
1.5
2.1
3.63
5.22
umol/l
2.01
53
269
461
3618
1.34
7.02
2.5
2.9
2.44
2.44
mmol/l
0.10
422
3270
106
611
1.77
6.97
2.5
2.2
120.66
4.13
iu/l
0.49
46
266
21
57
3.71
6.91
1.4
1.1
—
—
—
0
0
93
517
1.83
6.89
3.9
3.2
0.87
1.80
index
2.09
66
284
553
4477
1.31
6.75
1.5
1.5
2.58
2.41
g/l
0.43
366
2907
28
94
3.00
6.65
1.1
1.2
—
—
—
0
0
85
465
1.86
6.64
3.0
2.3
129.53
130.95
g/l
0.14
72
369
112
666
1.72
6.62
2.6
2.4
3.94
3.59
g/l
1.37
104
633
21
59
3.58
6.59
1.4
1.1
—
—
—
0
0
56
265
2.14
6.57
1.2
1.1
—
—
—
0
0
27
90
3.02
6.50
3.7
3.1
1.44
1.16
%
0.32
27
90
47
209
2.27
6.41
3.2
2.1
15.08
19.73
mg/l
0.73
24
79
116
705
1.68
6.34
2.0
2.0
95.59
93.27
%
0.45
111
684
21
61
3.47
6.29
2.4
2.2
12.86
14.87
umol/l
0.42
21
61
106
631
1.71
6.26
1.6
2.4
9.45
10.36
g/l
1.30
100
583
72
382
1.91
6.20
1.9
1.8
—
—
—
0
0
71
377
1.91
6.10
4.8
3.5
10.56
8.81
pmol/l
0.59
71
377
47
960
0.48
6.08
1.1
1.1
1.46
1.52
g/l
0.81
47
960
20
58
3.47
6.01
1.4
1.1
—
—
—
0
0
87
496
1.78
5.98
2.0
1.7
19870.27
12477.81
e6/l
0.42
63
351
75
409
1.86
5.95
1.5
1.7
—
—
—
0
0
270
1997
1.40
5.92
3.5
2.5
32.39
41.70
u/l
2.02
231
1693
72
391
1.87
5.80
2.1
3.9
160.26
241.53
u/ml
0.25
64
366
228
1646
1.43
5.74
2.4
2.0
—
—
—
0
0
347
4413
0.75
5.74
2.5
3.1
0.61
0.72
ug/l
2.95
224
2744
132
853
1.58
5.68
1.3
1.2
0.34
1.13
u/ml
1.04
16
59
19
56
3.41
5.58
1.2
1.1
—
—
—
0
0
15
28
5.39
5.53
1.3
1.2
—
—
—
0
0
95
571
1.69
5.45
1.2
1.4
—
—
—
0
0
39
173
2.28
5.40
1.3
1.8
—
—
—
0
0
39
173
2.28
5.40
1.3
1.8
—
—
—
0
0
39
173
2.28
5.40
1.3
1.8
—
—
—
0
0
56
288
1.97
5.32
1.1
1.1
—
—
—
0
0
20
63
3.19
5.32
1.4
1.1
—
—
—
0
0
66
360
1.86
5.27
1.6
1.3
—
—
—
0
0
66
360
1.86
5.27
1.6
1.3
—
—
—
0
0
1995
19102
1.34
5.23
5.8
4.8
6.28
5.88
mmol/l
21.88
1872
17802
96
586
1.67
5.22
1.8
2.1
11.92
11.40
mg/l
0.29
89
551
41
189
2.19
5.20
3.0
4.3
—
—
—
0
0
34
145
2.37
5.16
1.1
1.2
0.57
0.59
ratio
0.16
25
85
88
527
1.70
5.14
1.8
1.4
—
—
—
0
0
64
349
1.86
5.13
1.5
1.9
—
—
—
0
0
23
81
2.86
5.08
3.3
4.2
—
—
—
0
0
108
687
1.60
5.00
1.6
2.4
2.97
2.93
g/l
0.21
103
643
262
1990
1.36
4.89
2.8
2.1
—
—
—
0
0
600
5081
1.24
4.87
1.4
1.3
1.15
1.65
u/ml
0.66
185
1432
68
385
1.79
4.85
6.1
4.4
5.00
4.99
kpa
0.03
68
380
65
363
1.81
4.85
1.1
1.3
35.24
32.73
u/l
0.08
56
306
45
223
2.04
4.77
1.2
1.5
272.78
280.67
mosm/kgh2o
1.50
36
172
1135
10273
1.21
4.74
3.6
3.2
127.87
118.37
ug/l
0.48
1056
9714
707
6115
1.23
4.68
4.0
3.1
0.00
0.06
estimate
1.15
227
1869
43
212
2.05
4.63
1.3
1.6
—
—
—
0
0
100
642
1.58
4.49
1.5
2.6
1.24
1.01
g/l
0.14
92
575
490
5791
0.80
4.34
3.7
4.2
21.85
21.45
%
0.19
210
2681
1968
18908
1.29
4.27
4.9
4.1
1.52
1.31
mmol/l
19.30
1838
17731
20
73
2.76
4.18
1.1
1.5
—
—
—
0
0
14
41
3.43
4.18
1.0
1.1
—
—
—
0
0
12
25
4.82
4.18
1.0
1.1
—
—
—
0
0
42
216
1.96
4.07
1.3
1.2
—
28.80
—
0
5
350
2841
1.27
4.04
2.4
2.6
128.37
123.52
ug/g
0.11
269
2282
14
42
3.35
4.04
1.2
1.2
232.13
330.96
pmol/l
—
8
26
36
176
2.06
4.00
1.6
1.4
43128.45
87924.37
e6/l
0.37
20
120
114
780
1.49
3.87
1.4
1.4
8.57
9.01
u/l
0.14
96
635
35
172
2.05
3.85
1.2
1.8
—
—
—
0
0
44
235
1.89
3.84
1.2
1.1
—
—
—
0
0
20
78
2.58
3.72
1.2
4.8
46.14
62.67
mg/l
0.67
14
57
30
142
2.13
3.65
2.2
2.4
668.89
636.55
ml
0.17
18
92
40
213
1.89
3.54
1.2
1.1
—
—
—
0
0
42
228
1.86
3.51
1.1
1.3
0.19
0.26
nmol/l
0.41
35
177
11
26
4.25
3.50
1.1
1.0
—
—
—
0
0
22
93
2.38
3.48
1.3
1.4
—
—
—
0
0
22
94
2.35
3.41
1.3
1.4
—
—
—
0
0
85
563
1.53
3.40
1.5
2.5
0.08
0.01
g/l
0.52
80
519
11
27
4.09
3.39
1.5
1.2
—
—
—
0
0
12
32
3.76
3.38
1.2
1.2
37.92
111.47
ng/l
—
5
21
18
70
2.58
3.38
1.8
2.9
33.58
31.11
umol/l
0.26
12
52
13
42
3.11
3.37
3.1
3.0
4.92
4.69
ug/l
0.08
13
42
41
225
1.84
3.33
1.2
1.6
—
—
—
0
0
61
376
1.64
3.31
1.1
1.1
—
—
—
0
0
81
535
1.53
3.29
1.2
1.1
—
—
—
0
0
41
226
1.83
3.29
1.2
1.6
—
—
—
0
0
145
1071
1.38
3.29
1.3
1.4
—
—
—
0
0
62
385
1.63
3.27
4.1
3.5
24.33
26.33
mg/l
0.21
46
259
76
496
1.55
3.26
1.2
1.2
—
—
—
0
0
45
256
1.77
3.26
1.2
1.6
18.37
29.06
ng/l
1.43
45
256
13
43
3.03
3.25
1.2
1.1
—
—
—
0
0
41
227
1.82
3.25
1.2
1.6
—
—
—
0
0
35
184
1.92
3.24
1.1
1.1
—
—
—
0
0
118
846
1.42
3.19
1.4
1.3
142.12
223.59
miu/ml
1.56
35
401
8
15
5.35
3.19
1.1
1.1
—
42.80
—
0
5
246
1973
1.28
3.15
4.4
3.2
—
—
—
0
0
80
534
1.52
3.12
1.2
1.1
—
—
—
0
0
9
20
4.51
3.11
1.9
1.4
37.89
52.85
umol/l
—
9
20
13
45
2.90
3.02
1.3
1.0
5.69
8.91
mg/g
1.53
13
45
2224
21895
1.52
3.00
38.3
22.6
270.06
251.91
e9/l
28.17
2202
21543
72
475
1.53
2.97
4.8
6.2
58129.18
276.60
iu/ml
0.47
11
63
18
75
2.41
2.97
1.3
1.5
—
—
—
0
0
18
75
2.41
2.97
1.3
1.5
—
—
—
0
0
41
235
1.76
2.93
1.3
1.6
—
—
—
0
0
41
235
1.76
2.93
1.3
1.6
—
—
—
0
0
2224
21901
1.51
2.92
38.2
22.5
91.96
90.79
fl
26.43
2216
21730
8
17
4.72
2.92
1.3
1.2
—
—
—
0
0
2224
21903
1.50
2.90
38.3
22.5
4.46
4.55
e12/l
14.66
2197
21499
2224
21903
1.50
2.90
39.3
23.0
40.46
40.84
%
2.91
2215
21720
18
76
2.38
2.89
2.9
2.9
0.58
0.61
mmol/l
1.15
18
76
6
9
6.68
2.87
1.0
1.0
—
—
—
0
0
28
143
1.97
2.85
1.1
1.2
1.12
1.06
ratio
0.66
20
117
2224
21907
1.50
2.85
38.4
22.6
8.15
6.76
e9/l
125.02
2197
21498
57
361
1.59
2.82
1.2
1.1
—
—
—
0
0
2224
21911
1.49
2.80
38.7
22.7
135.21
136.97
g/l
6.31
2215
21739
10
28
3.58
2.78
1.3
1.1
—
—
—
0
0
10
28
3.58
2.78
1.5
1.2
—
—
—
0
0
19
84
2.27
2.77
2.2
2.4
—
—
—
0
0
40
232
1.74
2.76
1.3
1.6
—
—
—
0
0
33
181
1.84
2.74
1.6
1.7
—
—
—
0
0
72
485
1.50
2.73
1.2
1.3
266.45
270.80
u/ml
0.05
44
305
80
551
1.47
2.72
1.5
2.5
0.00
0.00
g/l
-0.00
75
491
30
160
1.89
2.71
2.0
3.2
136.73
37.88
mg/l
0.57
22
118
31
168
1.86
2.67
4.7
2.5
—
—
—
0
0
46
281
1.65
2.65
1.2
1.3
0.17
0.31
nmol/l
—
6
18
16
67
2.40
2.63
1.1
1.8
37.46
41.35
g/l
1.26
16
67
22
106
2.09
2.63
1.1
1.2
—
—
—
0
0
90
639
1.43
2.62
4.1
3.0
1.74
1.50
mg/l
1.67
80
583
10
30
3.34
2.60
1.3
1.1
—
—
—
0
0
12
44
2.74
2.54
1.7
1.3
—
—
—
0
0
6
11
5.47
2.54
5.3
5.3
—
—
—
0
0
8
21
3.82
2.46
1.1
1.1
—
—
—
0
0
12
45
2.68
2.45
1.6
1.2
—
—
—
0
0
44
272
1.63
2.44
1.2
1.1
104.59
96.11
%
1.33
44
257
2062
20142
1.23
2.42
6.3
5.5
2.54
2.74
mmol/l
19.31
1963
19040
102
752
1.37
2.41
1.4
1.6
—
—
—
0
0
18
83
2.18
2.41
1.5
1.2
0.33
0.29
g/l
1.53
18
68
15
64
2.35
2.38
1.7
1.5
10.48
8.64
ug/l
0.33
15
64
37
220
1.69
2.38
1.6
1.6
59.97
57.44
%
0.14
24
138
73
510
1.45
2.35
1.2
1.2
11.52
48.76
u/ml
—
5
49
20
98
2.05
2.31
1.3
1.8
—
—
—
0
0
9
28
3.22
2.30
12.8
7.8
4.26
5.84
mmol/l
—
9
28
107
802
1.35
2.30
1.4
1.4
—
—
—
0
0
25
134
1.88
2.26
1.7
1.6
—
—
—
0
0
17
79
2.16
2.24
1.2
1.3
—
—
—
0
0
41
255
1.62
2.24
1.5
1.4
297.58
350.30
pmol/l
0.55
36
222
35
209
1.69
2.23
1.1
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
21
107
1.97
2.20
1.7
2.0
143.33
144.73
%
0.03
21
102
17
80
2.13
2.18
1.8
2.4
2662.00
43515.82
u/ml
—
5
11
23
122
1.89
2.16
1.4
1.5
1.43
1.31
nmol/l
0.21
18
96
17
81
2.11
2.12
1.4
2.4
—
—
—
0
0
17
81
2.11
2.12
1.4
2.4
—
—
—
0
0
5
10
5.01
2.07
5.8
5.0
331.80
422.40
umol/l
—
5
10
17
82
2.08
2.07
1.4
2.4
—
—
—
0
0
19
96
1.99
2.05
3.5
3.3
5.75
8.00
mg/l
1.36
19
80
16
76
2.11
2.02
1.1
1.0
—
—
—
0
0
2038
19947
1.19
1.96
5.7
4.9
4.38
4.64
mmol/l
27.07
1944
18931
8
27
2.97
1.93
1.0
1.2
—
—
—
0
0
6
16
3.76
1.93
1.0
1.1
—
—
—
0
0
6
16
3.76
1.93
1.3
1.1
—
—
—
0
0
485
4350
1.15
1.91
1.9
1.6
—
—
—
0
0
40
259
1.55
1.90
1.5
1.6
—
—
—
0
0
90
681
1.33
1.87
1.8
1.8
—
—
—
0
0
8
28
2.86
1.86
1.0
1.0
—
—
—
0
0
8
28
2.86
1.86
1.0
1.0
—
—
—
0
0
79
587
1.36
1.85
1.4
1.5
52.00
60.33
ug/l
1.03
79
587
24
137
1.76
1.83
1.5
2.9
604.00
592.47
e6/l
0.04
19
120
5
12
4.17
1.82
1.2
1.8
—
—
—
0
0
7
23
3.05
1.80
1.1
2.2
—
—
—
0
0
41
271
1.52
1.79
2.8
3.3
0.87
0.82
nmol/l
0.26
33
218
20
109
1.84
1.77
1.2
1.1
—
—
—
0
0
25
147
1.71
1.74
1.2
1.3
—
—
—
0
0
28
170
1.66
1.74
3.5
2.3
32.78
32.61
mg/l
0.01
23
125
2027
19865
1.18
1.72
5.6
4.8
1.32
1.43
mmol/l
32.72
1920
18750
8
30
2.67
1.72
1.3
1.3
—
—
—
0
0
19
104
1.83
1.67
1.0
1.0
135.36
91.08
%
2.66
14
84
25
149
1.69
1.67
1.2
1.3
—
—
—
0
0
21
120
1.76
1.62
1.8
1.6
—
—
—
0
0
5
14
3.58
1.61
1.4
1.2
35.52
40.59
nmol/l
—
5
14
18
98
1.84
1.61
1.0
1.1
—
—
—
0
0
44
303
1.46
1.61
2.4
2.5
30.52
41.60
iu/ml
—
6
30
8
32
2.51
1.59
1.0
1.1
5.03
6.03
nmol/l
—
8
32
187
1579
1.20
1.59
1.3
1.2
170.43
153.49
u/ml
0.19
73
606
6
20
3.00
1.58
1.0
1.1
0.70
1.24
mom
—
6
20
31
200
1.56
1.54
1.4
1.6
—
—
—
0
0
60
442
1.37
1.53
1.5
1.4
163.56
159.53
au/ml
—
9
122
16
86
1.87
1.50
2.0
2.5
26.80
113.23
ug/l
0.45
16
75
25
154
1.63
1.50
1.1
1.1
0.96
1.11
u/l
1.29
12
69
26
163
1.60
1.46
1.0
1.5
—
—
—
0
0
22
132
1.67
1.46
1.2
1.0
1814.00
1540.09
miu/ml
0.42
22
132
18
102
1.77
1.44
1.4
2.2
—
—
—
0
0
18
102
1.77
1.44
1.4
2.2
—
—
—
0
0
18
102
1.77
1.44
1.4
2.2
—
—
—
0
0
18
102
1.77
1.44
1.4
2.2
—
—
—
0
0
7
29
2.42
1.39
2.1
2.2
—
—
—
0
0
48
347
1.39
1.39
1.8
2.0
4.76
5.15
mmol/24h
0.33
42
307
13
67
1.95
1.38
1.2
1.3
—
—
—
0
0
183
1570
1.18
1.33
1.4
1.6
836.39
1008.35
mu/l
2.05
144
1340
9
42
2.15
1.33
1.0
1.0
—
—
—
0
0
21
128
1.65
1.33
1.2
2.1
—
—
—
0
0
10
193
0.52
1.29
1.3
1.4
135.77
206.92
pmol/l
—
10
193
69
536
1.30
1.27
1.2
1.1
6.23
2.68
u/ml
0.55
34
287
8
35
2.29
1.27
1.1
1.1
98.00
98.34
%
—
8
35
26
170
1.54
1.26
1.6
1.5
44.13
33.67
%
0.64
18
103
29
197
1.48
1.19
1.1
1.1
277.59
284.33
mg/l
0.18
22
182
19
117
1.63
1.18
1.9
1.6
—
—
—
0
0
1424
13788
1.09
1.16
3.5
3.2
—
—
—
0
0
7
30
2.34
1.12
2.1
2.2
—
—
—
0
0
28
192
1.46
1.11
1.2
1.1
—
—
—
0
0
49
371
1.33
1.11
2.8
3.0
—
1667.57
—
0
28
29
411
0.70
1.10
1.1
1.1
7.65
15.26
au/ml
—
6
113
12
66
1.82
1.09
1.9
1.8
136.87
51.70
ug/l
0.40
12
66
12
66
1.82
1.09
1.1
1.0
—
—
—
0
0
25
363
0.69
1.09
1.2
1.6
—
—
—
0
0
19
120
1.59
1.08
1.9
1.6
—
—
—
0
0
100
831
1.21
1.07
1.6
1.7
13.73
12.46
u/ml
0.09
15
208
22
326
0.67
1.06
1.0
1.0
3.54
2.34
eliau/ml
—
10
156
26
179
1.46
1.03
1.2
1.1
—
—
—
0
0
40
298
1.35
1.02
1.2
1.3
—
—
—
0
0
25
171
1.47
1.02
1.3
1.1
98.80
109.85
pmol/l
0.39
25
171
24
163
1.48
1.01
3.5
3.3
10.69
12.76
index
0.92
16
106
59
467
1.27
0.99
1.1
1.1
8.70
5.85
u/ml
0.50
25
249
11
61
1.81
0.98
1.0
1.3
—
—
—
0
0
22
148
1.49
0.98
1.7
1.7
—
—
—
0
0
7
36
1.95
0.97
1.0
1.6
—
9070.00
—
0
5
9
50
1.80
0.96
1.0
1.1
76.33
71.36
ug/l
—
9
50
13
77
1.69
0.95
1.1
1.1
—
—
—
0
0
20
133
1.51
0.94
1.1
1.2
—
—
—
0
0
29
394
0.73
0.90
1.3
1.4
2.73
3.61
ug/l
0.96
24
363
26
185
1.41
0.89
1.2
1.1
—
—
—
0
0
26
185
1.41
0.89
1.2
1.1
—
—
—
0
0
6
29
2.07
0.89
1.2
1.2
—
—
—
0
0
34
256
1.33
0.85
1.8
1.7
—
—
—
0
0
15
96
1.57
0.84
1.3
1.3
206.40
182.83
mmol/24h
0.37
15
96
25
179
1.40
0.84
1.2
1.1
—
—
—
0
0
55
449
1.23
0.76
1.1
1.1
0.62
1.44
u/ml
1.11
18
179
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
19
133
1.43
0.73
1.1
1.2
—
—
—
0
0
90
774
1.17
0.73
1.6
1.8
—
—
—
0
0
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
78
911
0.85
0.70
2.2
1.9
45.18
40.25
nmol/l
0.60
78
885
198
2171
0.90
0.69
2.7
2.4
11.98
13.23
nmol/l
1.19
172
1992
83
714
1.17
0.68
2.9
3.7
299.98
2240.30
u/ml
0.78
72
621
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
15
103
1.46
0.65
1.1
1.1
338.90
202.07
iu/ml
0.54
15
103
5
30
1.67
0.61
1.0
1.7
—
—
—
0
0
35
434
0.80
0.61
1.3
1.5
0.43
0.39
nmol/l
0.09
23
356
8
52
1.54
0.59
1.3
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
4.05
—
0
17
6
39
1.54
0.53
1.5
1.2
1.20
1.19
mmol/l
—
6
39
18
134
1.35
0.53
1.0
1.0
29.85
38.59
ng/l
0.72
13
83
16
117
1.37
0.52
1.9
2.7
454.19
1005.18
u/ml
1.73
16
117
11
75
1.47
0.50
1.0
1.5
97.09
88.11
nmol/24h
0.15
11
75
108
1196
0.90
0.49
1.4
1.4
23.10
23.30
iu/l
0.02
91
1025
25
198
1.27
0.49
1.0
1.3
—
—
—
0
0
13
93
1.40
0.48
1.2
1.0
3.11
11.27
u/ml
—
7
64
80
896
0.89
0.46
1.5
1.6
65.53
60.18
ug/l
0.50
68
765
8
61
1.31
0.39
1.1
1.1
—
—
—
0
0
13
98
1.33
0.37
1.5
1.6
1.71
3.91
u/field
—
7
73
111
1022
1.09
0.37
1.9
1.6
341.40
282.24
mu/l
0.75
100
925
16
125
1.28
0.37
1.3
1.3
—
—
—
0
0
9
70
1.29
0.36
1.0
1.1
—
—
—
0
0
74
818
0.90
0.36
1.5
1.5
—
—
—
0
0
65
589
1.11
0.31
1.2
1.1
3.18
3.72
—
5
86
7
54
1.30
0.30
1.3
1.4
—
—
—
0
0
15
120
1.25
0.30
1.1
1.3
17.65
28.61
umol/l
1.05
15
110
1744
17298
1.03
0.28
31.6
18.5
332.31
333.14
g/l
3.11
1736
17210
353
3412
1.04
0.28
1.7
1.6
—
—
—
0
0
109
1161
0.94
0.26
1.1
1.1
—
—
—
0
0
22
188
1.17
0.25
1.1
1.3
0.22
0.86
u/ml
1.34
14
104
0
11
0.00
0.21
0.0
1.1
—
36.23
—
0
11
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
8.13
—
0
11
0
11
0.00
0.21
0.0
1.1
—
20.99
—
0
11
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
4782.71
—
0
7
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
47
432
1.09
0.20
1.3
1.3
—
—
—
0
0
78
828
0.94
0.19
1.4
1.5
1.30
1.14
ratio
0.90
53
509
10
121
0.83
0.18
10.4
7.8
44.00
60.77
u/ml
—
5
31
1719
17096
1.02
0.16
29.9
18.0
14.15
13.50
%
51.19
1713
16886
11
130
0.85
0.16
1.3
1.2
—
—
—
0
0
79
829
0.95
0.14
1.5
1.5
0.92
0.94
ratio
0.27
54
510
79
829
0.95
0.14
1.5
1.5
1.35
1.19
ratio
0.67
54
511
11
93
1.18
0.14
1.2
1.8
—
—
—
0
0
11
93
1.18
0.14
1.2
1.8
—
—
—
0
0
25
274
0.91
0.13
1.6
1.3
—
—
—
0
0
12
103
1.17
0.13
2.1
1.9
79.93
112.50
ng/l
0.83
12
103
14
159
0.88
0.13
1.3
1.1
—
—
—
0
0
33
353
0.93
0.11
1.0
1.0
0.22
0.26
u/ml
—
10
117
5
46
1.09
0.09
10.8
6.6
7.72
5.53
kpa
—
5
46
5
47
1.06
0.09
1.0
1.6
—
—
—
0
0
714
7184
0.99
0.06
4.1
5.1
2.74
2.29
ug/l
0.16
629
6583
78
760
1.03
0.06
1.9
1.5
—
—
—
0
0
14
152
0.92
0.06
2.2
1.5
70.43
78.59
umol/l
1.93
14
152
43
445
0.97
0.05
1.5
1.4
157.24
155.75
pmol/l
0.01
43
435
66
677
0.97
0.05
1.2
1.3
—
—
—
0
0
13
139
0.93
0.03
1.7
2.0
1.60
1.73
u/field
—
5
82
28
270
1.04
0.03
1.1
1.2
—
—
—
0
0
44
448
0.98
0.01
1.0
1.1
3.35
1.86
u/ml
0.53
22
216
869
8703
1.00
0.01
2.0
1.9
1.57
1.38
mmol/l
6.15
786
7462
12
126
0.95
0.00
1.4
1.2
4.92
8.37
mm/h
1.95
12
126
38
376
1.01
0.00
1.0
1.1
1.85
4.27
u/ml
0.89
13
165
41
408
1.00
0.00
1.1
1.1
13.76
3.48
u/ml
0.39
19
201
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
7.91
—
0
8
7
74
0.95
0.00
1.4
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
1.37
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint Z21_TOBAC_USE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_TOBAC_USE | 4.091 [3.36, 4.98] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 563 out of 6759 females with Z21_TOBAC_USE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_TOBAC_USE | 3.572 [3.04, 4.19] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.014 |
During the follow-up period (1.1.1998 — 31.12.2019), 1187 out of 5385 males with Z21_TOBAC_USE died.
Mortality risk
Mortality risk for people of age
years, who have Z21_TOBAC_USE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.354% | 0.697% |
| 5 | 1.971% | 4.435% |
| 10 | 4.785% | 10.632% |
| 15 | 9.024% | 19.49% |
| 20 | 15.459% | 32.185% |
Relationships between endpoints
↥Index endpoint: Z21_TOBAC_USE – Tobacco use
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data